data_1mmc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mmc _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.234 0.277 0 CA-C-O 123.386 1.565 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.23 69.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 48.46 51.94 14.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 112.691 -2.049 . . . . 0.0 110.649 -173.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.28 28.36 36.88 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.953 0.787 . . . . 0.0 113.584 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -135.32 140.53 45.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.136 2.175 . . . . 0.0 106.302 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.53 164.36 36.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 124.233 1.013 . . . . 0.0 109.154 168.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.83 172.97 10.65 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.234 2.623 . . . . 0.0 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.7 t 37.8 41.87 0.37 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.515 1.926 . . . . 0.0 114.163 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.15 46.01 8.02 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.229 1.871 . . . . 0.0 111.942 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 mtt -77.68 141.92 39.11 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -83.74 134.56 34.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.5 m -76.06 116.68 17.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -55.11 164.8 0.79 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.438 0.695 . . . . 0.0 110.586 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.27 -20.89 20.61 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.929 166.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.33 2.44 56.38 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.224 2.21 . . . . 0.0 111.972 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.03 9.32 66.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.134 0.874 . . . . 0.0 114.002 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -91.73 -173.64 3.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 166.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 151.52 27.2 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.617 1.099 . . . . 0.0 113.745 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.1 148.59 6.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 106.686 -2.566 . . . . 0.0 106.686 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -82.77 66.38 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.054 -0.674 . . . . 0.0 110.191 -170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.89 165.23 37.51 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.406 -0.902 . . . . 0.0 114.684 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.34 -29.93 18.84 Favored 'Trans proline' 0 C--N 1.351 0.664 1 C-N-CA 125.856 4.371 . . . . 0.0 115.051 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.2 -44.29 32.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -92.79 -60.66 1.76 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.332 -0.176 0 C-N-CA 126.584 1.954 . . . . 0.0 114.024 -165.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.34 59.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? 53.64 55.59 8.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 112.385 -2.188 . . . . 0.0 111.453 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.61 11.85 32.01 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.822 1.677 . . . . 0.0 114.242 168.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -137.05 125.55 23.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 126.798 2.039 . . . . 0.0 107.245 -169.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -135.78 163.33 51.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 107.704 167.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.59 175.02 11.51 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.234 1.956 . . . . 0.0 111.349 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t 34.82 53.19 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.85 2.06 . . . . 0.0 113.633 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.96 46.87 40.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.837 1.208 . . . . 0.0 112.224 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -85.81 136.36 33.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.7 m -83.6 140.08 32.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.34 114.89 8.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -57.48 148.8 22.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.903 1.281 . . . . 0.0 111.328 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.4 -27.96 4.62 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.836 167.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.93 7.55 43.47 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 128.029 2.532 . . . . 0.0 112.579 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 2.73 84.72 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.501 1.048 . . . . 0.0 114.591 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -91.2 -163.38 1.03 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.89 162.81 38.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 120.265 1.393 . . . . 0.0 111.33 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.46 161.21 13.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -83.74 77.51 9.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.23 165.36 37.16 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.623 -0.673 . . . . 0.0 113.319 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.35 -41.19 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.438 3.426 . . . . 0.0 112.149 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -49.35 -32.34 11.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.048 0.939 . . . . 0.0 111.799 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -93.2 -57.71 2.54 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.719 1.208 . . . . 0.0 109.653 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.604 -170.773 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 m . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 122.6 1.191 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.12 77.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.768 1.627 . . . . 0.0 107.284 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 58.19 53.5 6.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.884 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.95 28.07 55.14 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -140.15 138.14 34.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.25 2.22 . . . . 0.0 106.697 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 168.91 11.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 125.024 1.33 . . . . 0.0 107.987 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.53 172.5 3.47 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.528 2.152 . . . . 0.0 111.869 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t 32.48 47.51 0.1 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.784 2.434 . . . . 0.0 115.134 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.94 48.0 14.2 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.512 1.529 . . . . 0.0 112.356 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 mmt -73.0 149.44 43.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.7 m -82.33 137.87 34.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 m -73.34 122.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -57.04 157.23 6.04 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.56 -13.12 12.24 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 169.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -92.09 2.26 56.69 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.742 2.417 . . . . 0.0 112.244 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.55 0.51 87.48 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.372 0.987 . . . . 0.0 114.737 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -89.65 -169.33 2.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 167.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 p -159.43 151.49 20.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.471 1.032 . . . . 0.0 113.424 -170.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.3 151.09 9.86 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -82.78 72.04 9.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.76 165.02 32.1 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.784 -1.198 . . . . 0.0 114.981 169.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.71 -35.27 17.08 Favored 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 125.899 4.4 . . . . 0.0 114.584 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.7 -42.12 11.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -93.13 -59.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 C-N-CA 126.776 2.03 . . . . 0.0 115.114 -165.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 122.591 1.186 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -106.87 100.15 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.167 1.787 . . . . 0.0 106.365 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 51.72 44.64 29.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 110.549 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.45 82.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.734 0.683 . . . . 0.0 113.172 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -141.03 148.42 40.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.78 2.032 . . . . 0.0 107.65 172.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.72 163.75 48.61 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.349 1.86 . . . . 0.0 106.644 166.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.62 174.97 9.25 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.281 1.987 . . . . 0.0 110.855 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t 34.65 54.1 0.65 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 127.073 2.149 . . . . 0.0 113.872 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.41 46.28 36.34 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.857 1.217 . . . . 0.0 112.239 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmm -90.15 133.77 34.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 168.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.1 m -83.99 134.95 34.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.8 m -67.91 120.47 14.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 165.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.3 p -69.6 163.26 25.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.337 1.055 . . . . 0.0 111.15 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -50.15 -26.41 4.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.434 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.1 -1.41 56.48 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 126.859 2.064 . . . . 0.0 112.828 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.17 6.65 83.54 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.106 0.86 . . . . 0.0 113.974 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -90.36 -160.13 0.67 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.35 158.87 27.63 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.006 1.275 . . . . 0.0 112.989 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.61 157.92 11.98 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.97 77.31 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.53 158.4 27.65 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.382 -1.39 . . . . 0.0 114.914 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.99 -39.69 59.48 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.806 3.671 . . . . 0.0 113.764 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -43.42 -45.89 6.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 110.288 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -90.54 -55.17 3.69 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.286 1.034 . . . . 0.0 109.192 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 130.558 3.543 . . . . 0.0 113.475 -168.451 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -89.6 61.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 123.344 1.545 . . . . 0.0 108.33 -171.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? 63.06 53.73 2.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.687 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.33 27.62 54.8 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.762 1.172 . . . . 0.0 113.119 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -135.99 156.31 48.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 128.029 2.531 . . . . 0.0 106.122 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 m -135.87 165.78 33.35 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 127.108 2.163 . . . . 0.0 108.599 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.3 175.13 4.12 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.946 3.097 . . . . 0.0 109.272 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 33.21 48.97 0.18 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.535 2.334 . . . . 0.0 115.159 170.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.06 44.02 5.73 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.675 1.607 . . . . 0.0 112.083 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.1 mtt -85.69 165.01 17.31 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -101.74 133.49 46.38 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.45 106.97 1.89 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -57.54 148.08 24.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.906 0.882 . . . . 0.0 110.569 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -51.93 -25.21 7.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -92.63 7.55 42.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.987 2.515 . . . . 0.0 112.374 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.91 8.83 87.59 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.473 1.511 . . . . 0.0 114.825 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -93.24 -163.82 1.1 Allowed 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.766 1.226 . . . . 0.0 108.828 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.7 t -141.11 138.5 33.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 119.22 0.918 . . . . 0.0 109.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.08 22.19 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -90.24 70.14 7.16 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.635 1.574 . . . . 0.0 110.458 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.82 160.46 33.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.016 -1.087 . . . . 0.0 115.492 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.99 -46.92 29.33 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.787 3.658 . . . . 0.0 114.249 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -48.6 -35.36 13.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.208 1.003 . . . . 0.0 111.933 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -93.43 -51.11 5.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 108.503 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.304 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.234 0.259 0 CA-C-O 123.263 1.506 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -85.98 69.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.533 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? 49.78 52.98 13.56 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.195 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.05 25.22 32.27 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 114.351 170.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -139.9 138.94 36.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 128.101 2.56 . . . . 0.0 105.665 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 164.87 35.99 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 124.106 0.963 . . . . 0.0 109.415 168.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.34 174.3 6.12 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.36 2.707 . . . . 0.0 110.281 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t 34.42 51.15 0.44 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.011 2.125 . . . . 0.0 113.866 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.07 46.21 26.77 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.128 1.347 . . . . 0.0 112.247 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -92.4 133.68 35.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.68 140.44 29.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.0 m -71.27 117.71 13.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.877 0.846 . . . . 0.0 110.244 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -55.03 173.07 0.1 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.368 1.467 . . . . 0.0 111.636 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -63.13 -24.24 67.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.574 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -94.66 4.86 53.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.214 2.206 . . . . 0.0 112.823 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.47 11.54 65.15 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.005 0.812 . . . . 0.0 113.677 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -92.07 -164.59 1.2 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 160.11 22.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.105 1.321 . . . . 0.0 113.378 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.08 162.06 25.16 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -83.8 79.15 9.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.24 162.43 35.72 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.288 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.79 -35.58 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.486 3.457 . . . . 0.0 111.687 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -43.72 -41.99 5.14 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.911 1.284 . . . . 0.0 111.113 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -94.44 -50.6 5.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 110.372 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.125 -170.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.322 0 CA-C-O 123.074 1.416 . . . . 0.0 108.269 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.49 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.643 1.687 . . . . 0.0 106.742 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 53.54 53.26 11.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.956 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.77 16.17 49.6 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.047 1.784 . . . . 0.0 115.575 169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.49 147.17 32.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.185 2.594 . . . . 0.0 105.415 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.56 168.24 18.44 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 124.654 1.182 . . . . 0.0 108.01 167.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.75 169.94 6.45 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.53 2.153 . . . . 0.0 112.953 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.5 p 32.71 51.33 0.24 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.44 2.296 . . . . 0.0 115.031 169.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.7 47.9 37.2 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.92 1.248 . . . . 0.0 112.5 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.2 mtt -78.24 144.03 36.58 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -84.91 136.44 33.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 m -69.52 139.04 53.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -73.32 -174.19 1.56 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.853 0.835 . . . . 0.0 111.857 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.255 2.0 pm0 -69.43 -28.95 66.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.749 -0.594 . . . . 0.0 111.324 168.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.44 9.26 35.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.518 2.327 . . . . 0.0 111.264 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.27 28.16 70.4 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.372 0.987 . . . . 0.0 112.667 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -90.41 -156.02 0.41 Allowed 'General case' 0 C--N 1.338 0.077 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.79 152.18 13.4 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.93 159.99 23.18 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 107.161 -2.375 . . . . 0.0 107.161 169.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -83.5 79.15 9.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.27 163.49 37.16 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.858 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.48 -35.48 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.455 3.437 . . . . 0.0 111.434 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.29 -39.6 6.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.043 1.337 . . . . 0.0 111.295 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -93.75 -51.8 4.74 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.068 1.347 . . . . 0.0 109.782 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -171.418 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 122.576 1.179 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -114.17 101.0 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 106.188 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 52.48 45.71 28.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.19 0.596 . . . . 0.0 110.38 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.33 85.67 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.781 1.181 . . . . 0.0 113.168 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -141.45 144.32 34.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.308 2.243 . . . . 0.0 106.293 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.86 19.19 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.807 1.243 . . . . 0.0 108.468 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.75 172.62 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.604 2.203 . . . . 0.0 111.839 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t 33.02 49.0 0.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.74 2.416 . . . . 0.0 115.211 168.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.96 49.18 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.383 1.468 . . . . 0.0 112.276 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 mmt -88.09 135.13 33.56 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -82.65 140.37 33.19 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.1 m -73.63 124.42 25.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 p -59.89 156.66 13.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -56.75 -19.49 17.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -90.06 -7.36 54.05 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 127.002 2.121 . . . . 0.0 112.307 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.12 65.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 115.094 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -92.55 -172.52 3.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.92 150.27 29.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.626 1.103 . . . . 0.0 113.516 -173.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.92 148.62 7.49 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -82.42 74.09 9.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.89 166.99 39.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.393 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.62 -24.68 41.33 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.88 3.72 . . . . 0.0 112.194 -169.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -49.75 -40.39 40.85 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -92.62 -65.86 0.97 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 C-N-CA 126.319 1.848 . . . . 0.0 113.696 -165.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.6 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 122.171 0.986 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.19 69.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 69.82 51.4 0.44 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.758 2.023 . . . . 0.0 109.184 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.23 26.26 74.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.414 1.007 . . . . 0.0 113.258 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -136.47 124.31 22.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.371 2.268 . . . . 0.0 106.352 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.2 m -106.74 160.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.88 1.272 . . . . 0.0 109.849 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.54 167.49 22.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.998 1.798 . . . . 0.0 111.747 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.8 p 32.68 47.67 0.11 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 127.373 2.269 . . . . 0.0 116.373 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.9 44.7 61.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.732 1.158 . . . . 0.0 112.818 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.32 151.43 25.58 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.5 m -89.86 145.26 25.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -66.43 132.87 49.25 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.674 164.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 33.0 p -61.68 161.23 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.516 -1.274 . . . . 0.0 108.463 168.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -58.57 -19.86 41.82 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.566 -0.709 . . . . 0.0 111.447 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -92.8 6.51 47.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.206 2.602 . . . . 0.0 112.328 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.13 24.0 77.12 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.951 1.262 . . . . 0.0 115.314 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -97.64 -168.51 1.69 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.24 134.81 46.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.512 1.506 . . . . 0.0 111.302 -171.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.55 138.54 4.63 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -84.7 72.02 10.76 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.839 0.856 . . . . 0.0 108.717 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.19 163.71 33.23 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.515 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.35 -39.98 35.72 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 125.131 3.887 . . . . 0.0 114.205 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.97 -35.79 16.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.589 0.756 . . . . 0.0 111.436 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 23.7 m-85 -94.98 -57.14 2.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 123.622 0.769 . . . . 0.0 112.732 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 123.395 1.569 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.29 66.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.163 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 59.59 54.56 4.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.787 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.96 23.45 45.37 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 167.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm-85 -139.57 141.45 37.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.545 2.338 . . . . 0.0 106.005 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 169.57 10.14 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.556 1.142 . . . . 0.0 109.57 168.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.99 171.57 5.95 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.842 2.361 . . . . 0.0 112.017 173.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t 34.23 44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.69 2.396 . . . . 0.0 114.942 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.63 46.62 18.14 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.865 1.697 . . . . 0.0 112.043 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.6 mtt -78.41 142.57 37.48 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 167.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.5 m -83.64 145.81 28.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.2 m -75.05 154.12 38.11 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p -89.61 170.39 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -56.79 -24.82 53.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.795 -0.565 . . . . 0.0 111.514 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -92.11 5.36 50.57 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 127.834 2.453 . . . . 0.0 111.996 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.17 71.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.651 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -91.11 -172.63 3.38 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 166.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.0 154.11 36.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 147.08 7.56 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -81.85 72.16 8.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.55 161.27 32.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.817 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.04 -35.98 34.03 Favored 'Trans proline' 0 C--N 1.351 0.658 1 C-N-CA 125.431 4.087 . . . . 0.0 114.489 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -49.59 -37.97 29.75 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.97 -59.5 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.246 0 C-N-CA 124.84 1.256 . . . . 0.0 114.331 -166.044 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 122.984 1.373 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.75 101.18 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 127.155 2.182 . . . . 0.0 105.64 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.3 44.57 28.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.675 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.57 36.05 92.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.571 0.605 . . . . 0.0 112.899 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -139.16 146.34 40.48 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.482 1.913 . . . . 0.0 107.959 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.7 166.35 27.89 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 126.9 2.08 . . . . 0.0 107.063 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.77 164.19 19.5 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.372 2.048 . . . . 0.0 113.294 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.5 p 42.15 36.92 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.943 2.097 . . . . 0.0 115.59 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.27 41.14 46.78 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.611 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.3 mtt -59.77 146.83 40.18 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 166.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -83.42 133.25 34.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.42 135.32 51.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.1 p -69.52 -166.13 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.041 2.136 . . . . 0.0 111.514 -170.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -87.47 -11.61 48.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 110.739 166.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.0 17.51 14.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.077 2.151 . . . . 0.0 112.704 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 -0.13 30.6 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.761 1.172 . . . . 0.0 114.723 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -90.05 -159.24 0.58 Allowed 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.27 173.5 14.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.106 0.867 . . . . 0.0 112.221 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.53 154.58 8.41 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -83.8 65.45 8.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.634 0.774 . . . . 0.0 109.17 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.98 159.86 32.59 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.269 -0.967 . . . . 0.0 114.75 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.36 -42.2 41.44 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 125.297 3.998 . . . . 0.0 114.775 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -48.64 -38.98 22.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.399 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -93.21 -51.13 5.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.375 1.083 . . . . 0.0 108.909 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.861 -168.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 123.494 1.616 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.25 59.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 123.876 1.798 . . . . 0.0 108.41 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? 58.88 54.65 5.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.194 -2.276 . . . . 0.0 110.124 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.5 25.02 34.28 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.407 1.003 . . . . 0.0 113.659 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -144.9 136.21 25.15 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.874 2.47 . . . . 0.0 107.249 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.89 166.28 28.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 109.201 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.82 164.8 17.81 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.7 2.266 . . . . 0.0 112.452 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p 34.96 38.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.85 2.46 . . . . 0.0 115.751 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.85 43.04 30.1 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.345 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mmm -62.01 138.95 58.44 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 167.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.94 136.39 35.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.2 m -64.55 138.77 58.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 t -69.06 -169.99 0.22 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.058 1.343 . . . . 0.0 112.12 -168.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -87.5 -27.13 22.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.567 162.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.57 14.39 24.9 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 128.412 2.685 . . . . 0.0 112.309 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.46 4.55 65.19 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.559 1.552 . . . . 0.0 114.727 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -88.94 -154.55 0.3 Allowed 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.097 1.359 . . . . 0.0 107.758 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -155.31 147.52 23.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.479 1.036 . . . . 0.0 112.422 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.99 137.53 3.9 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -83.16 64.92 7.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.917 -0.755 . . . . 0.0 109.397 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.12 161.89 34.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.121 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.06 -45.31 21.59 Favored 'Trans proline' 0 C--N 1.349 0.593 1 C-N-CA 125.323 4.016 . . . . 0.0 115.088 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -50.22 -33.78 20.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.788 0.835 . . . . 0.0 111.747 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.4 -52.06 4.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.122 0.969 . . . . 0.0 109.105 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.626 -168.006 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 123.544 1.64 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.41 61.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.262 -169.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 63.24 53.98 2.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.896 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.11 41.56 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.417 1.008 . . . . 0.0 113.402 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -141.94 130.61 22.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 107.707 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.77 166.87 25.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.167 1.387 . . . . 0.0 108.492 166.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.56 170.33 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.799 2.333 . . . . 0.0 112.661 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p 33.87 46.16 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.658 2.383 . . . . 0.0 115.403 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.9 48.45 9.34 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.37 1.462 . . . . 0.0 112.031 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.2 151.12 46.93 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -82.69 134.33 35.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -74.1 116.43 14.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.2 p -56.28 162.04 2.24 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.178 0.514 . . . . 0.0 111.045 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -53.02 -23.9 8.47 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.756 165.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -94.33 1.76 55.88 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 128.609 2.763 . . . . 0.0 113.406 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.57 2.18 84.37 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.252 0.93 . . . . 0.0 115.367 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.77 -164.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.42 146.62 21.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.792 1.178 . . . . 0.0 113.115 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.18 145.65 6.08 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -83.63 65.56 8.54 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.048 -0.677 . . . . 0.0 110.084 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.41 165.23 36.02 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.216 -0.992 . . . . 0.0 114.935 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.36 -39.37 27.89 Favored 'Trans proline' 0 C--N 1.349 0.582 1 C-N-CA 125.454 4.102 . . . . 0.0 114.478 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -51.21 -32.57 24.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.0 0.52 . . . . 0.0 111.629 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -94.23 -60.13 1.8 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.457 -0.098 0 C-N-CA 125.874 1.67 . . . . 0.0 113.114 -165.142 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.511 0.672 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.04 67.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.556 1.646 . . . . 0.0 106.838 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 47.83 51.64 13.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.633 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.07 29.8 10.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.949 1.737 . . . . 0.0 113.792 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -141.86 128.44 20.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.733 2.013 . . . . 0.0 106.804 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.49 164.33 42.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.2 1.0 . . . . 0.0 109.059 166.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -65.03 171.33 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.431 2.087 . . . . 0.0 112.602 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p 40.54 43.74 1.61 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.967 1.707 . . . . 0.0 115.32 169.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.38 47.55 28.27 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.818 1.199 . . . . 0.0 112.152 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 60.9 mtt -71.46 148.8 46.48 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.6 m -83.71 136.98 33.98 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 170.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -73.06 138.27 45.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 166.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -69.81 -166.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 123.037 1.399 . . . . 0.0 109.576 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -102.44 -22.15 14.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.36 1.864 . . . . 0.0 107.855 162.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.12 9.63 37.0 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 127.777 2.431 . . . . 0.0 112.253 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.92 83.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.525 1.536 . . . . 0.0 115.0 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.54 -169.1 2.12 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.0 p -157.89 155.43 29.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 109.971 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.0 152.37 8.16 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -83.22 77.57 9.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.26 162.08 33.2 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.14 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.59 -42.41 29.36 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 125.179 3.92 . . . . 0.0 114.076 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -50.59 -31.67 16.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.072 0.949 . . . . 0.0 111.592 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.97 -56.4 2.88 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.759 0.824 . . . . 0.0 109.185 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.467 0.419 0 C-N-CA 123.723 0.809 . . . . 0.0 111.516 -167.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 122.993 1.378 . . . . 0.0 107.776 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.95 81.13 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 52.61 51.1 16.75 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.63 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.73 27.24 73.51 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.611 0.625 . . . . 0.0 113.354 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -145.34 152.67 40.25 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.2 2.6 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.47 165.37 34.75 Favored Pre-proline 0 C--N 1.325 -0.468 0 C-N-CA 123.614 0.766 . . . . 0.0 109.63 167.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.2 170.96 17.82 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.735 2.29 . . . . 0.0 109.641 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.0 p 43.52 35.29 0.93 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.08 1.752 . . . . 0.0 114.688 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.45 48.01 5.75 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 126.204 1.859 . . . . 0.0 111.527 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.32 142.43 47.11 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 168.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.6 m -83.22 139.36 33.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.21 127.97 34.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 t -62.52 170.76 2.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.465 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.26 -28.83 69.98 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -93.58 8.23 41.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.037 2.535 . . . . 0.0 112.335 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.42 77.9 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.122 0.868 . . . . 0.0 114.636 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.18 -153.17 0.26 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.9 149.77 23.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.552 1.069 . . . . 0.0 112.557 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.14 138.02 2.66 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -83.95 72.64 10.42 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.765 -0.844 . . . . 0.0 110.366 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.01 162.72 34.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.297 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.07 -49.58 11.11 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.0 3.8 . . . . 0.0 114.343 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -53.18 -29.95 34.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.848 0.859 . . . . 0.0 112.371 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -94.98 -48.28 6.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.841 -178.046 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 122.028 0.918 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.87 73.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 59.58 54.68 4.41 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.067 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.88 15.62 77.07 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.449 1.023 . . . . 0.0 115.086 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -137.52 136.96 38.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.5 m -121.11 160.21 46.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.86 1.264 . . . . 0.0 110.199 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.78 169.22 19.45 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.443 2.095 . . . . 0.0 112.097 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t 33.61 47.26 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.645 2.378 . . . . 0.0 115.524 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.57 40.5 55.18 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.798 1.189 . . . . 0.0 112.795 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.86 149.13 28.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 166.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -83.34 137.8 33.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.8 t -72.35 114.06 10.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -62.0 151.39 35.28 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.009 1.724 . . . . 0.0 110.944 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.45 -28.08 18.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 168.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -93.73 9.18 38.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.037 2.535 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.48 8.05 83.5 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.786 1.184 . . . . 0.0 114.972 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.07 -167.69 1.78 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 124.612 1.165 . . . . 0.0 109.638 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.0 m -127.36 145.87 50.66 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.059 -1.026 . . . . 0.0 109.604 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.67 144.64 4.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 165.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -83.83 67.44 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.482 1.113 . . . . 0.0 108.12 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.16 164.83 35.67 Favored Glycine 0 CA--C 1.528 0.901 0 O-C-N 122.145 -0.347 . . . . 0.0 113.077 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -66.76 -42.96 7.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.686 3.59 . . . . 0.0 113.312 -167.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -49.53 -33.4 14.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.913 0.885 . . . . 0.0 111.903 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.02 -54.63 3.65 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.958 1.303 . . . . 0.0 108.901 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.449 -0.52 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 -171.409 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 122.158 0.98 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.32 97.49 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 49.4 45.56 23.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.552 0.741 . . . . 0.0 110.671 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.21 68.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.314 1.435 . . . . 0.0 114.078 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -132.25 160.78 35.17 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 127.392 2.277 . . . . 0.0 105.698 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -137.2 161.52 60.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 C-N-CA 125.669 1.587 . . . . 0.0 109.414 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.58 168.28 18.65 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.222 1.948 . . . . 0.0 111.938 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t 31.87 49.53 0.13 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.998 2.519 . . . . 0.0 115.251 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.22 44.3 51.73 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.214 0.911 . . . . 0.0 112.86 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.82 153.06 26.62 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 166.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.03 134.82 35.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -72.7 107.23 5.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 165.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p -54.47 156.57 3.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.383 1.473 . . . . 0.0 110.003 -170.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -56.53 -23.61 40.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 170.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.82 11.56 31.13 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.465 2.306 . . . . 0.0 112.281 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.0 84.97 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.244 1.402 . . . . 0.0 114.494 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -113.32 -169.97 1.6 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.468 1.907 . . . . 0.0 107.378 169.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -126.58 136.34 52.42 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 120.197 1.362 . . . . 0.0 110.198 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.92 142.77 5.28 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 166.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -83.8 68.32 9.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.02 168.33 41.1 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.911 -1.138 . . . . 0.0 114.531 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.31 -35.18 32.76 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.549 3.499 . . . . 0.0 111.771 -169.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -49.68 -34.78 19.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.68 0.392 . . . . 0.0 111.436 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -94.65 -60.34 1.73 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.0 109.945 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.235 0.309 0 C-N-CA 126.418 1.887 . . . . 0.0 113.747 -168.722 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 122.612 1.196 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -83.79 75.4 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 mmt-85 49.94 51.22 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.711 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 4.78 72.86 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.818 1.199 . . . . 0.0 114.702 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -132.75 165.79 23.72 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.07 167.83 18.53 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.184 . . . . 0.0 109.133 167.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -68.1 175.03 7.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.027 2.485 . . . . 0.0 112.69 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 32.19 55.22 0.34 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.501 2.32 . . . . 0.0 115.335 166.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.46 44.21 36.28 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.726 1.155 . . . . 0.0 112.35 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.0 mmt -91.77 134.85 34.37 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.8 m -81.66 133.31 35.35 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.8 t -74.13 114.2 12.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.5 p -60.36 154.95 19.05 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.57 -16.34 24.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 167.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.66 3.63 55.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.931 2.492 . . . . 0.0 112.95 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.0 90.52 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -96.28 -170.85 2.17 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -156.51 157.16 34.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.237 1.38 . . . . 0.0 112.483 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.76 155.9 8.7 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -84.08 79.05 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.036 0.935 . . . . 0.0 109.047 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.3 171.05 38.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.986 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.36 -25.5 10.22 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 126.079 4.52 . . . . 0.0 115.165 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -51.04 -54.86 20.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.653 -0.655 . . . . 0.0 109.593 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.86 -66.19 0.95 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.533 -0.729 . . . . 0.0 109.236 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 122.653 1.216 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.46 92.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.933 2.093 . . . . 0.0 106.656 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 49.24 52.14 14.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.45 0.643 . . . . 0.0 110.015 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.16 31.62 66.29 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.972 1.273 . . . . 0.0 113.686 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -141.74 139.82 32.96 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.749 2.02 . . . . 0.0 107.185 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.23 168.94 14.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 125.432 1.493 . . . . 0.0 108.502 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.82 169.38 5.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.543 2.162 . . . . 0.0 112.746 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.4 p 33.08 49.22 0.17 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.562 2.345 . . . . 0.0 115.078 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.29 48.08 27.22 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.313 1.435 . . . . 0.0 112.465 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.7 mtt -75.81 145.79 40.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.4 m -83.98 139.25 32.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 m -75.42 125.13 28.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 p -63.06 159.94 16.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.24 -20.72 29.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -91.58 2.96 56.09 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 127.54 2.336 . . . . 0.0 111.858 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.71 6.78 85.42 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.332 0.968 . . . . 0.0 114.655 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.89 -167.15 1.67 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -158.55 152.82 24.09 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.466 1.03 . . . . 0.0 112.928 -172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.14 149.65 7.9 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -82.55 72.27 9.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.32 160.39 33.16 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 119.964 -1.112 . . . . 0.0 114.307 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.16 -40.75 42.26 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.052 3.835 . . . . 0.0 113.942 -176.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -49.73 -34.53 19.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.881 0.872 . . . . 0.0 111.391 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.44 -60.15 1.78 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.451 -0.421 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.124 -165.562 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 122.039 0.923 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -84.94 67.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.69 53.18 8.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.137 2.575 . . . . 0.0 110.103 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.76 -10.24 30.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.875 2.655 . . . . 0.0 113.793 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.4 mtt85 -106.93 110.84 23.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.0 m -113.51 157.95 39.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.703 1.601 . . . . 0.0 109.567 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.87 170.55 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.909 2.406 . . . . 0.0 111.024 -171.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p 43.41 42.69 3.94 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.837 1.655 . . . . 0.0 114.941 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.56 42.96 27.91 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.918 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -82.7 151.03 26.4 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 167.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.1 m -91.12 138.09 31.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.19 116.49 13.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.5 p -68.64 -177.46 0.97 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.006 1.722 . . . . 0.0 113.295 -169.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.32 -26.06 61.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 167.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.54 8.41 42.29 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.645 2.378 . . . . 0.0 112.403 -173.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.24 13.32 57.74 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.679 1.133 . . . . 0.0 114.055 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -94.77 -175.93 3.72 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.191 1.396 . . . . 0.0 109.41 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.7 m -127.17 137.06 52.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 109.278 -170.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 146.36 7.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.66 75.99 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.98 155.81 27.31 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 120.493 -0.861 . . . . 0.0 114.159 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.98 -46.38 28.26 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.108 3.872 . . . . 0.0 115.127 -169.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -51.23 -31.77 21.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.756 0.823 . . . . 0.0 111.68 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -95.73 -53.7 3.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.558 1.143 . . . . 0.0 108.562 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -170.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.134 1.445 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.26 78.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 127.03 2.132 . . . . 0.0 106.243 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 46.97 50.42 13.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.219 -1.81 . . . . 0.0 110.225 -172.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.45 23.53 12.37 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.443 1.497 . . . . 0.0 114.928 172.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -138.41 118.14 13.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.604 1.962 . . . . 0.0 109.305 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.32 162.93 39.26 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 166.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.23 170.54 7.67 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.594 2.196 . . . . 0.0 112.627 -178.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.2 p 42.23 39.58 1.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.232 1.813 . . . . 0.0 115.481 171.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.84 48.81 9.21 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.656 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.7 mtt -64.19 150.6 45.43 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -83.69 136.37 34.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.0 m -69.82 138.38 52.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -73.33 -168.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.594 0.712 . . . . 0.0 109.787 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 -7.19 26.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.355 0.662 . . . . 0.0 110.418 165.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.93 1.65 55.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.845 2.458 . . . . 0.0 112.494 -176.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.97 4.63 72.7 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.022 1.296 . . . . 0.0 113.763 -169.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -93.95 -158.83 0.65 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.38 165.11 29.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.655 0.782 . . . . 0.0 110.834 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.05 152.17 6.93 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -83.51 65.73 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.098 -0.648 . . . . 0.0 109.915 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.89 160.8 33.93 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.514 -0.85 . . . . 0.0 114.38 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.65 -41.87 37.01 Favored 'Trans proline' 0 C--N 1.35 0.64 1 C-N-CA 125.361 4.041 . . . . 0.0 114.611 -174.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -50.8 -33.55 23.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 111.582 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -94.93 -54.36 3.49 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.531 0.732 . . . . 0.0 109.772 173.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 112.679 -167.194 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.235 0.314 0 CA-C-O 122.361 1.077 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -86.21 59.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 124.05 1.881 . . . . 0.0 108.059 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? 57.85 54.98 5.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.043 -169.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.69 25.0 36.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.427 1.489 . . . . 0.0 115.093 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -138.13 146.97 43.45 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 127.757 2.423 . . . . 0.0 105.201 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.4 m -129.24 163.4 46.36 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 125.888 1.675 . . . . 0.0 110.199 -176.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.62 172.44 3.96 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.25 2.633 . . . . 0.0 110.3 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 42.6 41.84 2.56 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.139 1.776 . . . . 0.0 115.215 171.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.89 45.05 18.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.018 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mtt -84.92 157.14 20.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 167.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -98.07 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.35 117.58 9.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.155 163.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 9.4 p -50.86 154.52 1.42 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 168.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -59.04 -16.42 18.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.773 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.26 4.32 53.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.915 2.886 . . . . 0.0 112.498 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 9.3 86.97 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.455 1.502 . . . . 0.0 116.031 169.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.24 178.95 5.57 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 118.479 1.14 . . . . 0.0 108.91 168.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.7 m -112.8 138.18 50.02 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.896 -174.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.76 138.0 4.48 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -84.22 75.27 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.94 162.62 32.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.856 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.44 -41.17 44.32 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.834 3.69 . . . . 0.0 113.763 -176.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -49.83 -33.5 17.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.539 0.735 . . . . 0.0 111.652 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 14.0 m-85 -96.22 -60.35 1.64 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.573 -166.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.12 80.11 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -176.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 68.04 50.06 0.83 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.751 2.42 . . . . 0.0 109.799 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.77 10.44 50.26 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -141.65 167.54 21.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.719 2.808 . . . . 0.0 104.585 173.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.7 167.22 20.29 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 124.752 1.221 . . . . 0.0 108.844 169.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.78 174.91 11.87 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.429 2.086 . . . . 0.0 110.773 -171.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p 46.92 39.95 8.39 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.884 1.674 . . . . 0.0 114.322 178.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.19 44.89 27.25 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.974 -175.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -70.62 148.98 47.51 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.07 133.69 34.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.12 114.87 10.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 164.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 p -63.01 179.94 0.34 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.779 1.632 . . . . 0.0 112.959 -166.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -78.67 -16.37 57.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.767 1.627 . . . . 0.0 111.857 167.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -96.77 5.54 50.41 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.117 2.167 . . . . 0.0 112.885 -178.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 6.87 43.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.254 0.93 . . . . 0.0 114.076 -171.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.9 -165.05 1.26 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 167.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.26 153.83 28.15 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 110.156 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.61 158.02 17.59 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -84.97 69.08 10.76 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.245 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.4 162.18 33.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.865 170.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -50.09 -39.36 51.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 125.14 3.893 . . . . 0.0 113.817 -178.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -48.0 -39.1 18.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.998 178.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.17 -54.54 3.9 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.239 0.533 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.133 -167.332 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.912 0.863 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.13 97.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 47.89 45.94 18.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.74 0.816 . . . . 0.0 110.682 -174.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.15 13.24 72.94 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.078 -0.846 . . . . 0.0 114.751 175.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.22 173.01 12.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.022 2.129 . . . . 0.0 108.394 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.01 167.63 18.49 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 125.487 1.515 . . . . 0.0 108.157 165.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -61.64 174.72 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.035 3.157 . . . . 0.0 113.288 -178.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.9 p 46.15 41.61 8.82 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.842 1.657 . . . . 0.0 114.403 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.84 45.32 25.15 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.873 -175.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.8 mtt -69.67 156.03 39.59 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.07 151.34 21.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -93.12 114.29 26.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.0 p -59.3 161.52 5.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.022 0.529 . . . . 0.0 111.09 -171.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.86 -24.6 37.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.343 167.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.17 3.83 54.49 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.742 2.417 . . . . 0.0 112.313 -174.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 6.01 83.77 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.861 -0.966 . . . . 0.0 115.145 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -94.78 -171.47 2.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 164.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 150.8 36.44 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.659 1.118 . . . . 0.0 112.086 -173.175 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.72 153.88 10.14 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -88.46 68.9 8.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.334 1.053 . . . . 0.0 109.705 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.86 44.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 119.561 -1.304 . . . . 0.0 115.007 175.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.58 -19.7 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.048 3.832 . . . . 0.0 112.186 -171.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -53.85 -43.7 69.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -91.49 -63.62 1.23 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 O-C-N 124.824 1.328 . . . . 0.0 109.788 -167.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -86.38 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 123.673 1.701 . . . . 0.0 106.468 174.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 49.64 53.54 12.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 111.776 -2.466 . . . . 0.0 110.83 -174.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.93 31.72 7.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.435 1.969 . . . . 0.0 113.408 172.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -139.06 123.49 18.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.27 2.228 . . . . 0.0 105.155 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -129.49 159.75 67.82 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.724 1.21 . . . . 0.0 109.578 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.25 168.95 21.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.416 2.077 . . . . 0.0 111.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 32.21 51.21 0.2 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.787 2.435 . . . . 0.0 115.127 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.81 45.29 8.94 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.824 1.202 . . . . 0.0 111.959 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -82.51 151.01 26.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 169.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.0 m -84.58 134.97 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -68.75 109.55 3.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.85 155.19 10.81 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.812 0.845 . . . . 0.0 111.304 -170.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -52.55 -26.48 13.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 168.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.01 1.1 57.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.89 2.476 . . . . 0.0 112.52 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.67 16.02 79.87 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.35 1.452 . . . . 0.0 114.782 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -94.77 -164.48 1.17 Allowed 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -136.6 132.22 34.81 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.36 -0.837 . . . . 0.0 109.069 -172.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.33 147.27 8.16 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 168.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -83.34 70.6 10.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 108.616 -178.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.32 164.59 33.49 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 122.077 -0.39 . . . . 0.0 113.318 177.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.97 -41.95 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.674 3.582 . . . . 0.0 112.914 -167.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -47.82 -34.96 9.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.424 1.09 . . . . 0.0 111.672 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -93.34 -52.08 4.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.123 1.369 . . . . 0.0 108.756 -176.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.821 -174.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 m . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 122.245 1.021 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.51 99.97 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 127.025 2.13 . . . . 0.0 105.996 175.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 49.08 44.63 22.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.888 0.875 . . . . 0.0 111.374 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.33 73.65 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.779 0.705 . . . . 0.0 114.019 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -136.59 171.58 14.28 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 127.409 2.283 . . . . 0.0 105.617 171.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.15 167.97 17.91 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.794 0.837 . . . . 0.0 109.437 168.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.19 172.37 5.21 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.839 2.359 . . . . 0.0 112.1 176.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.8 p 43.48 42.19 3.77 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.077 1.751 . . . . 0.0 114.863 171.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.59 16.07 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.427 1.489 . . . . 0.0 111.867 -177.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.58 133.91 33.68 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -84.89 142.11 29.93 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.26 122.12 22.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 109.843 174.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.0 p -60.32 -177.55 0.07 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.667 1.187 . . . . 0.0 111.546 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -81.3 -21.44 39.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.949 0.9 . . . . 0.0 110.727 166.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.68 7.28 46.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.472 2.309 . . . . 0.0 112.456 -172.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.29 9.1 76.67 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.548 1.071 . . . . 0.0 114.19 -178.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -98.55 -167.93 1.57 Allowed 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 166.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -160.47 158.96 30.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.962 1.255 . . . . 0.0 111.384 -172.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.8 152.52 8.21 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -82.82 76.15 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.68 161.43 31.81 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.873 172.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.81 -36.05 19.58 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.633 3.555 . . . . 0.0 111.698 -168.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -46.22 -42.58 14.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.882 0.873 . . . . 0.0 111.102 174.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.16 -44.69 7.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.018 1.327 . . . . 0.0 110.695 -172.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.229 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.24 -59.45 7.88 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.223 0.952 . . . . 0.0 112.224 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -164.59 148.37 9.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.07 172.05 2.59 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.386 1.565 . . . . 0.0 111.993 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.23 69.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 48.46 51.94 14.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 112.691 -2.049 . . . . 0.0 110.649 -173.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.28 28.36 36.88 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.953 0.787 . . . . 0.0 113.584 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -135.32 140.53 45.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.136 2.175 . . . . 0.0 106.302 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.53 164.36 36.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 124.233 1.013 . . . . 0.0 109.154 168.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.83 172.97 10.65 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.234 2.623 . . . . 0.0 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.7 t 37.8 41.87 0.37 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.515 1.926 . . . . 0.0 114.163 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.15 46.01 8.02 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.229 1.871 . . . . 0.0 111.942 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 mtt -77.68 141.92 39.11 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -83.74 134.56 34.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.5 m -76.06 116.68 17.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -55.11 164.8 0.79 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.438 0.695 . . . . 0.0 110.586 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.27 -20.89 20.61 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.929 166.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.33 2.44 56.38 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.224 2.21 . . . . 0.0 111.972 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.03 9.32 66.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.134 0.874 . . . . 0.0 114.002 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -91.73 -173.64 3.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 166.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 151.52 27.2 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.617 1.099 . . . . 0.0 113.745 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.1 148.59 6.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 106.686 -2.566 . . . . 0.0 106.686 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -82.77 66.38 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.054 -0.674 . . . . 0.0 110.191 -170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.89 165.23 37.51 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.406 -0.902 . . . . 0.0 114.684 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.34 -29.93 18.84 Favored 'Trans proline' 0 C--N 1.351 0.664 1 C-N-CA 125.856 4.371 . . . . 0.0 115.051 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.2 -44.29 32.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -92.79 -60.66 1.76 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.21 -27.09 68.18 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.584 1.954 . . . . 0.0 114.024 -165.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.84 159.19 18.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 126.349 1.86 . . . . 0.0 112.477 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.616 -0.706 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.35 -61.06 0.25 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 101.97 123.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 128.305 2.642 . . . . 0.0 107.181 -170.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.5 147.45 44.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.147 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.34 59.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? 53.64 55.59 8.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 112.385 -2.188 . . . . 0.0 111.453 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.61 11.85 32.01 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.822 1.677 . . . . 0.0 114.242 168.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -137.05 125.55 23.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 126.798 2.039 . . . . 0.0 107.245 -169.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -135.78 163.33 51.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 107.704 167.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.59 175.02 11.51 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.234 1.956 . . . . 0.0 111.349 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t 34.82 53.19 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.85 2.06 . . . . 0.0 113.633 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.96 46.87 40.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.837 1.208 . . . . 0.0 112.224 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -85.81 136.36 33.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.7 m -83.6 140.08 32.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.34 114.89 8.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -57.48 148.8 22.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.903 1.281 . . . . 0.0 111.328 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.4 -27.96 4.62 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.836 167.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.93 7.55 43.47 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 128.029 2.532 . . . . 0.0 112.579 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 2.73 84.72 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.501 1.048 . . . . 0.0 114.591 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -91.2 -163.38 1.03 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.89 162.81 38.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 120.265 1.393 . . . . 0.0 111.33 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.46 161.21 13.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -83.74 77.51 9.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.23 165.36 37.16 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.623 -0.673 . . . . 0.0 113.319 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.35 -41.19 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.438 3.426 . . . . 0.0 112.149 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -49.35 -32.34 11.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.048 0.939 . . . . 0.0 111.799 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -93.2 -57.71 2.54 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.719 1.208 . . . . 0.0 109.653 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -63.38 -37.69 88.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.604 -170.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 146.92 26.21 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.795 1.188 . . . . 0.0 112.936 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 . . . . . 0 C--O 1.225 -0.205 0 C-N-CA 125.105 1.362 . . . . 0.0 108.395 171.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 158.45 -49.95 0.41 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 76.2 mt-10 83.11 118.27 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 126.703 2.001 . . . . 0.0 108.411 -168.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 m -73.4 164.21 26.99 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.6 1.191 . . . . 0.0 110.541 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.12 77.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.768 1.627 . . . . 0.0 107.284 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 58.19 53.5 6.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.884 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.95 28.07 55.14 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -140.15 138.14 34.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.25 2.22 . . . . 0.0 106.697 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 168.91 11.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 125.024 1.33 . . . . 0.0 107.987 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.53 172.5 3.47 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.528 2.152 . . . . 0.0 111.869 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t 32.48 47.51 0.1 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.784 2.434 . . . . 0.0 115.134 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.94 48.0 14.2 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.512 1.529 . . . . 0.0 112.356 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 mmt -73.0 149.44 43.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.7 m -82.33 137.87 34.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 m -73.34 122.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -57.04 157.23 6.04 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.56 -13.12 12.24 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 169.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -92.09 2.26 56.69 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.742 2.417 . . . . 0.0 112.244 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.55 0.51 87.48 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.372 0.987 . . . . 0.0 114.737 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 59.6 m-85 -89.65 -169.33 2.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 167.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 p -159.43 151.49 20.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.471 1.032 . . . . 0.0 113.424 -170.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.3 151.09 9.86 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -82.78 72.04 9.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.76 165.02 32.1 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.784 -1.198 . . . . 0.0 114.981 169.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.71 -35.27 17.08 Favored 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 125.899 4.4 . . . . 0.0 114.584 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.7 -42.12 11.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -93.13 -59.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.57 -29.83 69.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.776 2.03 . . . . 0.0 115.114 -165.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.56 -176.9 37.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.33 0.967 . . . . 0.0 114.353 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 . . . . . 0 CA--C 1.531 0.236 0 C-N-CA 126.181 1.793 . . . . 0.0 110.612 170.448 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.99 58.28 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -164.1 169.32 17.98 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.7 171.13 3.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.591 1.186 . . . . 0.0 108.783 165.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -106.87 100.15 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.167 1.787 . . . . 0.0 106.365 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 51.72 44.64 29.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 110.549 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.45 82.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.734 0.683 . . . . 0.0 113.172 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -141.03 148.42 40.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.78 2.032 . . . . 0.0 107.65 172.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.72 163.75 48.61 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.349 1.86 . . . . 0.0 106.644 166.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.62 174.97 9.25 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.281 1.987 . . . . 0.0 110.855 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t 34.65 54.1 0.65 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 127.073 2.149 . . . . 0.0 113.872 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.41 46.28 36.34 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.857 1.217 . . . . 0.0 112.239 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmm -90.15 133.77 34.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 168.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.1 m -83.99 134.95 34.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.8 m -67.91 120.47 14.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 165.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.3 p -69.6 163.26 25.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.337 1.055 . . . . 0.0 111.15 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -50.15 -26.41 4.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.434 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.1 -1.41 56.48 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 126.859 2.064 . . . . 0.0 112.828 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.17 6.65 83.54 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.106 0.86 . . . . 0.0 113.974 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -90.36 -160.13 0.67 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.35 158.87 27.63 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.006 1.275 . . . . 0.0 112.989 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.61 157.92 11.98 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.97 77.31 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.53 158.4 27.65 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.382 -1.39 . . . . 0.0 114.914 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.99 -39.69 59.48 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.806 3.671 . . . . 0.0 113.764 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -43.42 -45.89 6.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 110.288 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -90.54 -55.17 3.69 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.286 1.034 . . . . 0.0 109.192 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t -71.34 37.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.558 3.543 . . . . 0.0 113.475 -168.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.24 -161.74 52.09 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 125.423 1.487 . . . . 0.0 112.157 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? . . . . . 0 C--O 1.226 -0.134 0 C-N-CA 124.123 0.969 . . . . 0.0 108.724 -176.175 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 117.162 -1.399 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.97 -85.17 1.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.45 154.04 2.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.059 2.144 . . . . 0.0 105.478 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -61.14 146.13 48.59 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.54 1.064 . . . . 0.0 109.052 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -89.6 61.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 123.344 1.545 . . . . 0.0 108.33 -171.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? 63.06 53.73 2.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.687 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.33 27.62 54.8 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.762 1.172 . . . . 0.0 113.119 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -135.99 156.31 48.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 128.029 2.531 . . . . 0.0 106.122 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 m -135.87 165.78 33.35 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 127.108 2.163 . . . . 0.0 108.599 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.3 175.13 4.12 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.946 3.097 . . . . 0.0 109.272 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 33.21 48.97 0.18 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.535 2.334 . . . . 0.0 115.159 170.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.06 44.02 5.73 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.675 1.607 . . . . 0.0 112.083 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.1 mtt -85.69 165.01 17.31 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -101.74 133.49 46.38 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.45 106.97 1.89 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -57.54 148.08 24.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.906 0.882 . . . . 0.0 110.569 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -51.93 -25.21 7.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -92.63 7.55 42.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.987 2.515 . . . . 0.0 112.374 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.91 8.83 87.59 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.473 1.511 . . . . 0.0 114.825 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -93.24 -163.82 1.1 Allowed 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.766 1.226 . . . . 0.0 108.828 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.7 t -141.11 138.5 33.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 119.22 0.918 . . . . 0.0 109.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.08 22.19 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -90.24 70.14 7.16 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.635 1.574 . . . . 0.0 110.458 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.82 160.46 33.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.016 -1.087 . . . . 0.0 115.492 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.99 -46.92 29.33 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.787 3.658 . . . . 0.0 114.249 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -48.6 -35.36 13.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.208 1.003 . . . . 0.0 111.933 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -93.43 -51.11 5.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 108.503 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -66.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.304 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.23 -146.46 1.53 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.559 1.552 . . . . 0.0 112.078 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.874 1.27 . . . . 0.0 112.983 169.291 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.307 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.9 61.96 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.099 0.874 . . . . 0.0 113.177 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.64 153.18 10.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -72.93 165.38 25.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.263 1.506 . . . . 0.0 108.981 167.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -85.98 69.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.533 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? 49.78 52.98 13.56 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.195 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.05 25.22 32.27 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 114.351 170.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -139.9 138.94 36.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 128.101 2.56 . . . . 0.0 105.665 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 164.87 35.99 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 124.106 0.963 . . . . 0.0 109.415 168.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.34 174.3 6.12 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.36 2.707 . . . . 0.0 110.281 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t 34.42 51.15 0.44 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.011 2.125 . . . . 0.0 113.866 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.07 46.21 26.77 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.128 1.347 . . . . 0.0 112.247 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -92.4 133.68 35.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.68 140.44 29.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.0 m -71.27 117.71 13.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.877 0.846 . . . . 0.0 110.244 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -55.03 173.07 0.1 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.368 1.467 . . . . 0.0 111.636 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -63.13 -24.24 67.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.574 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -94.66 4.86 53.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.214 2.206 . . . . 0.0 112.823 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.47 11.54 65.15 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.005 0.812 . . . . 0.0 113.677 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -92.07 -164.59 1.2 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 160.11 22.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.105 1.321 . . . . 0.0 113.378 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.08 162.06 25.16 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -83.8 79.15 9.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.24 162.43 35.72 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.288 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.79 -35.58 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.486 3.457 . . . . 0.0 111.687 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -43.72 -41.99 5.14 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.911 1.284 . . . . 0.0 111.113 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -94.44 -50.6 5.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 110.372 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -43.1 99.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.125 -170.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.25 -117.81 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 127.704 2.402 . . . . 0.0 114.33 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.04 -43.56 3.15 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.712 1.148 . . . . 0.0 110.29 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.24 144.73 0.05 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.757 2.423 . . . . 0.0 107.906 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.61 168.79 17.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 123.074 1.416 . . . . 0.0 108.269 166.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.49 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.643 1.687 . . . . 0.0 106.742 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 53.54 53.26 11.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.956 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.77 16.17 49.6 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.047 1.784 . . . . 0.0 115.575 169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.49 147.17 32.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.185 2.594 . . . . 0.0 105.415 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.56 168.24 18.44 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 124.654 1.182 . . . . 0.0 108.01 167.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.75 169.94 6.45 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.53 2.153 . . . . 0.0 112.953 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.5 p 32.71 51.33 0.24 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.44 2.296 . . . . 0.0 115.031 169.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.7 47.9 37.2 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.92 1.248 . . . . 0.0 112.5 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.2 mtt -78.24 144.03 36.58 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -84.91 136.44 33.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 m -69.52 139.04 53.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -73.32 -174.19 1.56 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.853 0.835 . . . . 0.0 111.857 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.255 2.0 pm0 -69.43 -28.95 66.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.749 -0.594 . . . . 0.0 111.324 168.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.44 9.26 35.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.518 2.327 . . . . 0.0 111.264 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.27 28.16 70.4 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.372 0.987 . . . . 0.0 112.667 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -90.41 -156.02 0.41 Allowed 'General case' 0 C--N 1.338 0.077 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.79 152.18 13.4 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.93 159.99 23.18 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 107.161 -2.375 . . . . 0.0 107.161 169.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -83.5 79.15 9.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.27 163.49 37.16 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.858 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.48 -35.48 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.455 3.437 . . . . 0.0 111.434 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.29 -39.6 6.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.043 1.337 . . . . 0.0 111.295 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -93.75 -51.8 4.74 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.068 1.347 . . . . 0.0 109.782 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -59.81 -52.76 64.06 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -171.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 133.02 40.29 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? . . . . . 0 CA--C 1.535 0.382 0 O-C-N 121.785 -0.832 . . . . 0.0 110.525 -173.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.4 -57.0 12.39 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -174.08 170.54 3.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.401 2.28 . . . . 0.0 104.901 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -64.49 169.83 4.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 122.576 1.179 . . . . 0.0 109.281 166.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -114.17 101.0 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 106.188 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 52.48 45.71 28.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.19 0.596 . . . . 0.0 110.38 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.33 85.67 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.781 1.181 . . . . 0.0 113.168 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -141.45 144.32 34.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.308 2.243 . . . . 0.0 106.293 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.86 19.19 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.807 1.243 . . . . 0.0 108.468 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.75 172.62 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.604 2.203 . . . . 0.0 111.839 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t 33.02 49.0 0.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.74 2.416 . . . . 0.0 115.211 168.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.96 49.18 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.383 1.468 . . . . 0.0 112.276 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 mmt -88.09 135.13 33.56 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -82.65 140.37 33.19 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.1 m -73.63 124.42 25.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 p -59.89 156.66 13.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -56.75 -19.49 17.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -90.06 -7.36 54.05 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 127.002 2.121 . . . . 0.0 112.307 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.12 65.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 115.094 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -92.55 -172.52 3.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.92 150.27 29.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.626 1.103 . . . . 0.0 113.516 -173.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.92 148.62 7.49 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -82.42 74.09 9.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.89 166.99 39.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.393 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.62 -24.68 41.33 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.88 3.72 . . . . 0.0 112.194 -169.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -49.75 -40.39 40.85 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -92.62 -65.86 0.97 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.96 -31.27 70.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.319 1.848 . . . . 0.0 113.696 -165.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.61 161.18 39.74 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 . . . . . 0 CA--C 1.53 0.174 0 C-N-CA 126.511 1.925 . . . . 0.0 110.641 169.77 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 116.977 -1.487 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.99 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -174.96 171.77 3.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.034 2.534 . . . . 0.0 104.856 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.6 m -57.78 155.53 10.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.171 0.986 . . . . 0.0 111.166 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.19 69.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 69.82 51.4 0.44 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.758 2.023 . . . . 0.0 109.184 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.23 26.26 74.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.414 1.007 . . . . 0.0 113.258 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -136.47 124.31 22.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.371 2.268 . . . . 0.0 106.352 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.2 m -106.74 160.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.88 1.272 . . . . 0.0 109.849 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.54 167.49 22.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.998 1.798 . . . . 0.0 111.747 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.8 p 32.68 47.67 0.11 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 127.373 2.269 . . . . 0.0 116.373 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.9 44.7 61.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.732 1.158 . . . . 0.0 112.818 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.32 151.43 25.58 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.5 m -89.86 145.26 25.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -66.43 132.87 49.25 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.674 164.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 33.0 p -61.68 161.23 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.516 -1.274 . . . . 0.0 108.463 168.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -58.57 -19.86 41.82 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.566 -0.709 . . . . 0.0 111.447 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -92.8 6.51 47.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.206 2.602 . . . . 0.0 112.328 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.13 24.0 77.12 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.951 1.262 . . . . 0.0 115.314 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -97.64 -168.51 1.69 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.24 134.81 46.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.512 1.506 . . . . 0.0 111.302 -171.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.55 138.54 4.63 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -84.7 72.02 10.76 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.839 0.856 . . . . 0.0 108.717 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.19 163.71 33.23 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.515 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.35 -39.98 35.72 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 125.131 3.887 . . . . 0.0 114.205 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.97 -35.79 16.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.589 0.756 . . . . 0.0 111.436 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 23.7 m-85 -94.98 -57.14 2.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -28.91 67.96 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.622 0.769 . . . . 0.0 112.732 -166.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.42 141.75 16.54 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 168.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? . . . . . 0 C--N 1.332 -0.163 0 O-C-N 121.958 -0.731 . . . . 0.0 110.553 -177.878 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.27 92.18 0.43 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -171.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -53.65 115.9 2.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m -67.54 157.65 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.395 1.569 . . . . 0.0 111.322 -170.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.29 66.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.163 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 59.59 54.56 4.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.787 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.96 23.45 45.37 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 167.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm-85 -139.57 141.45 37.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.545 2.338 . . . . 0.0 106.005 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 169.57 10.14 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.556 1.142 . . . . 0.0 109.57 168.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.99 171.57 5.95 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.842 2.361 . . . . 0.0 112.017 173.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t 34.23 44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.69 2.396 . . . . 0.0 114.942 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.63 46.62 18.14 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.865 1.697 . . . . 0.0 112.043 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.6 mtt -78.41 142.57 37.48 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 167.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.5 m -83.64 145.81 28.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.2 m -75.05 154.12 38.11 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p -89.61 170.39 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -56.79 -24.82 53.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.795 -0.565 . . . . 0.0 111.514 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -92.11 5.36 50.57 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 127.834 2.453 . . . . 0.0 111.996 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.17 71.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.651 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -91.11 -172.63 3.38 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 166.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.0 154.11 36.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 147.08 7.56 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -81.85 72.16 8.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.55 161.27 32.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.817 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.04 -35.98 34.03 Favored 'Trans proline' 0 C--N 1.351 0.658 1 C-N-CA 125.431 4.087 . . . . 0.0 114.489 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -49.59 -37.97 29.75 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.97 -59.5 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.29 -33.24 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.84 1.256 . . . . 0.0 114.331 -166.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.66 155.53 24.61 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.436 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 126.477 1.911 . . . . 0.0 114.979 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 116.583 -1.675 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.41 81.41 0.51 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 121.204 1.82 . . . . 0.0 110.607 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 116.42 1.4 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m -61.79 165.55 5.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.984 1.373 . . . . 0.0 111.143 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.75 101.18 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 127.155 2.182 . . . . 0.0 105.64 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.3 44.57 28.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.675 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.57 36.05 92.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.571 0.605 . . . . 0.0 112.899 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -139.16 146.34 40.48 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.482 1.913 . . . . 0.0 107.959 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.7 166.35 27.89 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 126.9 2.08 . . . . 0.0 107.063 167.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.77 164.19 19.5 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.372 2.048 . . . . 0.0 113.294 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.5 p 42.15 36.92 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.943 2.097 . . . . 0.0 115.59 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.27 41.14 46.78 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.611 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.3 mtt -59.77 146.83 40.18 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 166.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -83.42 133.25 34.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.42 135.32 51.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.1 p -69.52 -166.13 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.041 2.136 . . . . 0.0 111.514 -170.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -87.47 -11.61 48.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 110.739 166.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.0 17.51 14.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.077 2.151 . . . . 0.0 112.704 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 -0.13 30.6 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.761 1.172 . . . . 0.0 114.723 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -90.05 -159.24 0.58 Allowed 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.27 173.5 14.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.106 0.867 . . . . 0.0 112.221 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.53 154.58 8.41 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -83.8 65.45 8.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.634 0.774 . . . . 0.0 109.17 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.98 159.86 32.59 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.269 -0.967 . . . . 0.0 114.75 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.36 -42.2 41.44 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 125.297 3.998 . . . . 0.0 114.775 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -48.64 -38.98 22.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.399 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -93.21 -51.13 5.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.375 1.083 . . . . 0.0 108.909 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -59.02 -52.28 66.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.861 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.33 -139.24 7.09 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.13 0.872 . . . . 0.0 112.459 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 126.648 1.979 . . . . 0.0 113.853 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.95 -87.23 1.49 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.62 166.97 3.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.742 2.417 . . . . 0.0 105.11 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -53.84 166.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.494 1.616 . . . . 0.0 112.221 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.25 59.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 123.876 1.798 . . . . 0.0 108.41 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? 58.88 54.65 5.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.194 -2.276 . . . . 0.0 110.124 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.5 25.02 34.28 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.407 1.003 . . . . 0.0 113.659 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -144.9 136.21 25.15 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.874 2.47 . . . . 0.0 107.249 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.89 166.28 28.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 109.201 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.82 164.8 17.81 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.7 2.266 . . . . 0.0 112.452 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p 34.96 38.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.85 2.46 . . . . 0.0 115.751 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.85 43.04 30.1 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.345 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mmm -62.01 138.95 58.44 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 167.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.94 136.39 35.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.2 m -64.55 138.77 58.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 t -69.06 -169.99 0.22 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.058 1.343 . . . . 0.0 112.12 -168.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -87.5 -27.13 22.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.567 162.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.57 14.39 24.9 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 128.412 2.685 . . . . 0.0 112.309 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.46 4.55 65.19 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.559 1.552 . . . . 0.0 114.727 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -88.94 -154.55 0.3 Allowed 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.097 1.359 . . . . 0.0 107.758 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -155.31 147.52 23.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.479 1.036 . . . . 0.0 112.422 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.99 137.53 3.9 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -83.16 64.92 7.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.917 -0.755 . . . . 0.0 109.397 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.12 161.89 34.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.121 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.06 -45.31 21.59 Favored 'Trans proline' 0 C--N 1.349 0.593 1 C-N-CA 125.323 4.016 . . . . 0.0 115.088 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -50.22 -33.78 20.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.788 0.835 . . . . 0.0 111.747 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.4 -52.06 4.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.122 0.969 . . . . 0.0 109.105 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -60.98 -39.82 91.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.626 -168.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.42 -128.04 10.33 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.768 0.699 . . . . 0.0 112.253 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.023 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.16 31.43 80.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.642 0.589 . . . . 0.0 113.608 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.08 134.69 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.135 1.374 . . . . 0.0 112.561 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.87 156.34 37.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 123.544 1.64 . . . . 0.0 110.594 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.41 61.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.262 -169.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 63.24 53.98 2.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.896 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.11 41.56 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.417 1.008 . . . . 0.0 113.402 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -141.94 130.61 22.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 107.707 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.77 166.87 25.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.167 1.387 . . . . 0.0 108.492 166.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.56 170.33 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.799 2.333 . . . . 0.0 112.661 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p 33.87 46.16 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.658 2.383 . . . . 0.0 115.403 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.9 48.45 9.34 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.37 1.462 . . . . 0.0 112.031 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.2 151.12 46.93 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -82.69 134.33 35.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -74.1 116.43 14.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.2 p -56.28 162.04 2.24 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.178 0.514 . . . . 0.0 111.045 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -53.02 -23.9 8.47 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.756 165.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -94.33 1.76 55.88 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 128.609 2.763 . . . . 0.0 113.406 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.57 2.18 84.37 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.252 0.93 . . . . 0.0 115.367 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.77 -164.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.42 146.62 21.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.792 1.178 . . . . 0.0 113.115 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.18 145.65 6.08 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -83.63 65.56 8.54 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.048 -0.677 . . . . 0.0 110.084 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.41 165.23 36.02 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.216 -0.992 . . . . 0.0 114.935 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.36 -39.37 27.89 Favored 'Trans proline' 0 C--N 1.349 0.582 1 C-N-CA 125.454 4.102 . . . . 0.0 114.478 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -51.21 -32.57 24.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.0 0.52 . . . . 0.0 111.629 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -94.23 -60.13 1.8 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.36 -42.22 95.33 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 125.874 1.67 . . . . 0.0 113.114 -165.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.72 -119.92 6.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.12 0.844 . . . . 0.0 112.749 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 126.206 1.802 . . . . 0.0 110.877 -175.901 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 117.048 -1.453 . . . . 0.0 107.356 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.97 -64.29 3.22 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -178.05 169.03 1.98 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m -63.23 147.36 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.511 0.672 . . . . 0.0 109.856 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.04 67.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.556 1.646 . . . . 0.0 106.838 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 47.83 51.64 13.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.633 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.07 29.8 10.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.949 1.737 . . . . 0.0 113.792 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -141.86 128.44 20.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.733 2.013 . . . . 0.0 106.804 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.49 164.33 42.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.2 1.0 . . . . 0.0 109.059 166.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -65.03 171.33 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.431 2.087 . . . . 0.0 112.602 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p 40.54 43.74 1.61 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.967 1.707 . . . . 0.0 115.32 169.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.38 47.55 28.27 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.818 1.199 . . . . 0.0 112.152 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 60.9 mtt -71.46 148.8 46.48 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.6 m -83.71 136.98 33.98 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 170.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -73.06 138.27 45.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 166.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -69.81 -166.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 123.037 1.399 . . . . 0.0 109.576 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -102.44 -22.15 14.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.36 1.864 . . . . 0.0 107.855 162.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.12 9.63 37.0 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 127.777 2.431 . . . . 0.0 112.253 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.92 83.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.525 1.536 . . . . 0.0 115.0 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.54 -169.1 2.12 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.0 p -157.89 155.43 29.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 109.971 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.0 152.37 8.16 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -83.22 77.57 9.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.26 162.08 33.2 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.14 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.59 -42.41 29.36 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 125.179 3.92 . . . . 0.0 114.076 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -50.59 -31.67 16.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.072 0.949 . . . . 0.0 111.592 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.97 -56.4 2.88 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.759 0.824 . . . . 0.0 109.185 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 m -57.11 -35.82 69.91 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.723 0.809 . . . . 0.0 111.516 -167.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.69 143.06 5.18 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? . . . . . 0 CA--C 1.53 0.183 0 CA-C-N 117.658 0.729 . . . . 0.0 110.646 179.862 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.01 -41.58 3.09 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.45 172.58 8.17 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 129.851 3.261 . . . . 0.0 104.373 169.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.83 170.17 15.25 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.993 1.378 . . . . 0.0 107.776 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.95 81.13 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 52.61 51.1 16.75 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.63 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.73 27.24 73.51 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.611 0.625 . . . . 0.0 113.354 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -145.34 152.67 40.25 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.2 2.6 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.47 165.37 34.75 Favored Pre-proline 0 C--N 1.325 -0.468 0 C-N-CA 123.614 0.766 . . . . 0.0 109.63 167.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.2 170.96 17.82 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.735 2.29 . . . . 0.0 109.641 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.0 p 43.52 35.29 0.93 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.08 1.752 . . . . 0.0 114.688 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.45 48.01 5.75 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 126.204 1.859 . . . . 0.0 111.527 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.32 142.43 47.11 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 168.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.6 m -83.22 139.36 33.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.21 127.97 34.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 t -62.52 170.76 2.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.465 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.26 -28.83 69.98 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -93.58 8.23 41.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.037 2.535 . . . . 0.0 112.335 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.42 77.9 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.122 0.868 . . . . 0.0 114.636 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.18 -153.17 0.26 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.9 149.77 23.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.552 1.069 . . . . 0.0 112.557 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.14 138.02 2.66 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -83.95 72.64 10.42 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.765 -0.844 . . . . 0.0 110.366 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.01 162.72 34.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.297 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.07 -49.58 11.11 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.0 3.8 . . . . 0.0 114.343 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -53.18 -29.95 34.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.848 0.859 . . . . 0.0 112.371 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -94.98 -48.28 6.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.3 m -60.56 -60.36 3.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.841 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.5 -132.36 3.66 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.12 1.343 . . . . 0.0 111.391 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 110.815 167.811 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.67 -72.4 0.15 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 122.23 126.93 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 129.94 3.296 . . . . 0.0 107.086 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -74.64 144.59 43.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.028 0.918 . . . . 0.0 110.175 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.87 73.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 59.58 54.68 4.41 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.067 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.88 15.62 77.07 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.449 1.023 . . . . 0.0 115.086 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -137.52 136.96 38.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.5 m -121.11 160.21 46.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.86 1.264 . . . . 0.0 110.199 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.78 169.22 19.45 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.443 2.095 . . . . 0.0 112.097 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t 33.61 47.26 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.645 2.378 . . . . 0.0 115.524 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.57 40.5 55.18 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.798 1.189 . . . . 0.0 112.795 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.86 149.13 28.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 166.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -83.34 137.8 33.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.8 t -72.35 114.06 10.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -62.0 151.39 35.28 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.009 1.724 . . . . 0.0 110.944 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.45 -28.08 18.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 168.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -93.73 9.18 38.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.037 2.535 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.48 8.05 83.5 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.786 1.184 . . . . 0.0 114.972 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.07 -167.69 1.78 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 124.612 1.165 . . . . 0.0 109.638 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.0 m -127.36 145.87 50.66 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.059 -1.026 . . . . 0.0 109.604 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.67 144.64 4.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 165.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -83.83 67.44 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.482 1.113 . . . . 0.0 108.12 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.16 164.83 35.67 Favored Glycine 0 CA--C 1.528 0.901 0 O-C-N 122.145 -0.347 . . . . 0.0 113.077 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -66.76 -42.96 7.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.686 3.59 . . . . 0.0 113.312 -167.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -49.53 -33.4 14.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.913 0.885 . . . . 0.0 111.903 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.02 -54.63 3.65 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.958 1.303 . . . . 0.0 108.901 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -60.66 -52.01 66.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.12 -136.0 6.95 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.187 0.899 . . . . 0.0 112.11 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 126.352 1.861 . . . . 0.0 112.306 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 117.041 -1.456 . . . . 0.0 107.468 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.09 -56.61 15.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.74 178.48 7.84 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.916 2.087 . . . . 0.0 105.537 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.8 160.49 5.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.158 0.98 . . . . 0.0 111.835 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.32 97.49 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 49.4 45.56 23.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.552 0.741 . . . . 0.0 110.671 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.21 68.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.314 1.435 . . . . 0.0 114.078 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -132.25 160.78 35.17 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 127.392 2.277 . . . . 0.0 105.698 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -137.2 161.52 60.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 C-N-CA 125.669 1.587 . . . . 0.0 109.414 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.58 168.28 18.65 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.222 1.948 . . . . 0.0 111.938 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t 31.87 49.53 0.13 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.998 2.519 . . . . 0.0 115.251 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.22 44.3 51.73 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.214 0.911 . . . . 0.0 112.86 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.82 153.06 26.62 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 166.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.03 134.82 35.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -72.7 107.23 5.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 165.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p -54.47 156.57 3.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.383 1.473 . . . . 0.0 110.003 -170.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -56.53 -23.61 40.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 170.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.82 11.56 31.13 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.465 2.306 . . . . 0.0 112.281 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.0 84.97 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.244 1.402 . . . . 0.0 114.494 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -113.32 -169.97 1.6 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.468 1.907 . . . . 0.0 107.378 169.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -126.58 136.34 52.42 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 120.197 1.362 . . . . 0.0 110.198 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.92 142.77 5.28 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 166.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -83.8 68.32 9.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.02 168.33 41.1 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.911 -1.138 . . . . 0.0 114.531 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.31 -35.18 32.76 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.549 3.499 . . . . 0.0 111.771 -169.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -49.68 -34.78 19.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.68 0.392 . . . . 0.0 111.436 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -94.65 -60.34 1.73 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.0 109.945 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -73.39 -38.89 65.48 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.418 1.887 . . . . 0.0 113.747 -168.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.99 123.14 1.21 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 126.792 2.139 . . . . 0.0 113.44 -167.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 126.06 1.744 . . . . 0.0 108.911 178.599 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.57 -54.67 14.5 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 124.408 1.068 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.39 172.07 3.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -57.15 153.34 11.91 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.612 1.196 . . . . 0.0 110.643 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -83.79 75.4 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 mmt-85 49.94 51.22 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.711 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 4.78 72.86 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.818 1.199 . . . . 0.0 114.702 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -132.75 165.79 23.72 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.07 167.83 18.53 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.184 . . . . 0.0 109.133 167.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -68.1 175.03 7.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.027 2.485 . . . . 0.0 112.69 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 32.19 55.22 0.34 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.501 2.32 . . . . 0.0 115.335 166.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.46 44.21 36.28 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.726 1.155 . . . . 0.0 112.35 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.0 mmt -91.77 134.85 34.37 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.8 m -81.66 133.31 35.35 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.8 t -74.13 114.2 12.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.5 p -60.36 154.95 19.05 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.57 -16.34 24.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 167.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.66 3.63 55.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.931 2.492 . . . . 0.0 112.95 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.0 90.52 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -96.28 -170.85 2.17 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -156.51 157.16 34.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.237 1.38 . . . . 0.0 112.483 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.76 155.9 8.7 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -84.08 79.05 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.036 0.935 . . . . 0.0 109.047 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.3 171.05 38.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.986 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.36 -25.5 10.22 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 126.079 4.52 . . . . 0.0 115.165 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -51.04 -54.86 20.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.653 -0.655 . . . . 0.0 109.593 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.86 -66.19 0.95 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.533 -0.729 . . . . 0.0 109.236 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.5 -127.43 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.52 1.057 . . . . 0.0 111.79 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' H ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 125.272 1.429 . . . . 0.0 112.552 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 117.075 -1.44 . . . . 0.0 107.402 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.77 -84.13 0.59 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 170.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -155.3 174.11 15.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 170.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.59 165.36 14.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 122.653 1.216 . . . . 0.0 109.549 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.46 92.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.933 2.093 . . . . 0.0 106.656 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 49.24 52.14 14.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.45 0.643 . . . . 0.0 110.015 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.16 31.62 66.29 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.972 1.273 . . . . 0.0 113.686 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -141.74 139.82 32.96 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.749 2.02 . . . . 0.0 107.185 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.23 168.94 14.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 125.432 1.493 . . . . 0.0 108.502 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.82 169.38 5.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.543 2.162 . . . . 0.0 112.746 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.4 p 33.08 49.22 0.17 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.562 2.345 . . . . 0.0 115.078 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.29 48.08 27.22 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.313 1.435 . . . . 0.0 112.465 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.7 mtt -75.81 145.79 40.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.4 m -83.98 139.25 32.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 m -75.42 125.13 28.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 p -63.06 159.94 16.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.24 -20.72 29.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -91.58 2.96 56.09 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 127.54 2.336 . . . . 0.0 111.858 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.71 6.78 85.42 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.332 0.968 . . . . 0.0 114.655 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.89 -167.15 1.67 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -158.55 152.82 24.09 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.466 1.03 . . . . 0.0 112.928 -172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.14 149.65 7.9 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -82.55 72.27 9.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.32 160.39 33.16 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 119.964 -1.112 . . . . 0.0 114.307 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.16 -40.75 42.26 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.052 3.835 . . . . 0.0 113.942 -176.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -49.73 -34.53 19.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.881 0.872 . . . . 0.0 111.391 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.44 -60.15 1.78 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -58.4 -51.79 68.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.124 -165.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.3 -17.99 0.02 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 129.148 3.261 . . . . 0.0 120.477 168.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 . . . . . 0 C--N 1.317 -0.831 0 C-N-CA 127.95 2.5 . . . . 0.0 109.636 -172.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.81 -52.5 0.83 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 32.7 tt0 105.34 135.85 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 128.653 2.781 . . . . 0.0 108.651 -171.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.93 148.59 49.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 122.039 0.923 . . . . 0.0 109.232 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -84.94 67.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.69 53.18 8.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.137 2.575 . . . . 0.0 110.103 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.76 -10.24 30.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.875 2.655 . . . . 0.0 113.793 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.4 mtt85 -106.93 110.84 23.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.0 m -113.51 157.95 39.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.703 1.601 . . . . 0.0 109.567 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.87 170.55 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.909 2.406 . . . . 0.0 111.024 -171.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p 43.41 42.69 3.94 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.837 1.655 . . . . 0.0 114.941 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.56 42.96 27.91 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.918 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -82.7 151.03 26.4 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 167.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.1 m -91.12 138.09 31.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.19 116.49 13.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.5 p -68.64 -177.46 0.97 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.006 1.722 . . . . 0.0 113.295 -169.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.32 -26.06 61.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 167.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.54 8.41 42.29 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.645 2.378 . . . . 0.0 112.403 -173.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.24 13.32 57.74 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.679 1.133 . . . . 0.0 114.055 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 31.9 m-85 -94.77 -175.93 3.72 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.191 1.396 . . . . 0.0 109.41 168.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.7 m -127.17 137.06 52.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 109.278 -170.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 146.36 7.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.66 75.99 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.98 155.81 27.31 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 120.493 -0.861 . . . . 0.0 114.159 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.98 -46.38 28.26 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.108 3.872 . . . . 0.0 115.127 -169.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -51.23 -31.77 21.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.756 0.823 . . . . 0.0 111.68 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -95.73 -53.7 3.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.558 1.143 . . . . 0.0 108.562 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -23.69 66.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -170.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.9 163.98 1.96 Allowed Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 168.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.466 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 0.0 115.532 -169.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.96 -52.14 0.78 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 80.27 119.61 0.05 Allowed 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.565 2.346 . . . . 0.0 109.461 -174.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 m -73.84 157.17 36.85 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 123.134 1.445 . . . . 0.0 111.304 -177.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.26 78.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 127.03 2.132 . . . . 0.0 106.243 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 46.97 50.42 13.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.219 -1.81 . . . . 0.0 110.225 -172.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.45 23.53 12.37 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.443 1.497 . . . . 0.0 114.928 172.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -138.41 118.14 13.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.604 1.962 . . . . 0.0 109.305 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.32 162.93 39.26 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 166.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.23 170.54 7.67 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.594 2.196 . . . . 0.0 112.627 -178.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.2 p 42.23 39.58 1.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.232 1.813 . . . . 0.0 115.481 171.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.84 48.81 9.21 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.656 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.7 mtt -64.19 150.6 45.43 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -83.69 136.37 34.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.0 m -69.82 138.38 52.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -73.33 -168.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.594 0.712 . . . . 0.0 109.787 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 -7.19 26.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.355 0.662 . . . . 0.0 110.418 165.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.93 1.65 55.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.845 2.458 . . . . 0.0 112.494 -176.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.97 4.63 72.7 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.022 1.296 . . . . 0.0 113.763 -169.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -93.95 -158.83 0.65 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.38 165.11 29.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.655 0.782 . . . . 0.0 110.834 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.05 152.17 6.93 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -83.51 65.73 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.098 -0.648 . . . . 0.0 109.915 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.89 160.8 33.93 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.514 -0.85 . . . . 0.0 114.38 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.65 -41.87 37.01 Favored 'Trans proline' 0 C--N 1.35 0.64 1 C-N-CA 125.361 4.041 . . . . 0.0 114.611 -174.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -50.8 -33.55 23.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 111.582 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -94.93 -54.36 3.49 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.531 0.732 . . . . 0.0 109.772 173.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -58.76 -32.59 69.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 112.679 -167.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.67 143.85 6.11 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 168.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? . . . . . 0 CA--C 1.532 0.255 0 O-C-N 122.11 -0.641 . . . . 0.0 109.448 176.706 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 117.654 -1.165 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.19 89.65 0.72 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 172.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -44.69 119.13 1.81 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.129 1.372 . . . . 0.0 109.186 172.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.42 163.62 0.16 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.284 1.434 . . . . 0.0 112.131 -169.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -86.21 59.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 124.05 1.881 . . . . 0.0 108.059 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? 57.85 54.98 5.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.043 -169.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.69 25.0 36.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.427 1.489 . . . . 0.0 115.093 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -138.13 146.97 43.45 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 127.757 2.423 . . . . 0.0 105.201 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.4 m -129.24 163.4 46.36 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 125.888 1.675 . . . . 0.0 110.199 -176.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.62 172.44 3.96 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.25 2.633 . . . . 0.0 110.3 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 42.6 41.84 2.56 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.139 1.776 . . . . 0.0 115.215 171.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.89 45.05 18.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.018 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mtt -84.92 157.14 20.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 167.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -98.07 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.35 117.58 9.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.155 163.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 9.4 p -50.86 154.52 1.42 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 168.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -59.04 -16.42 18.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.773 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.26 4.32 53.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.915 2.886 . . . . 0.0 112.498 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 9.3 86.97 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.455 1.502 . . . . 0.0 116.031 169.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.24 178.95 5.57 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 118.479 1.14 . . . . 0.0 108.91 168.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.7 m -112.8 138.18 50.02 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.896 -174.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.76 138.0 4.48 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -84.22 75.27 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.94 162.62 32.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.856 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.44 -41.17 44.32 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.834 3.69 . . . . 0.0 113.763 -176.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -49.83 -33.5 17.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.539 0.735 . . . . 0.0 111.652 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 14.0 m-85 -96.22 -60.35 1.64 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -27.32 67.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.573 -166.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.11 139.8 10.41 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 167.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 109.182 177.146 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.74 -43.9 2.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -176.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -178.96 170.89 1.44 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.138 2.575 . . . . 0.0 106.076 174.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 m -73.89 163.28 28.13 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 165.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.12 80.11 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -176.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 68.04 50.06 0.83 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.751 2.42 . . . . 0.0 109.799 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.77 10.44 50.26 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -141.65 167.54 21.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.719 2.808 . . . . 0.0 104.585 173.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.7 167.22 20.29 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 124.752 1.221 . . . . 0.0 108.844 169.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.78 174.91 11.87 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.429 2.086 . . . . 0.0 110.773 -171.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p 46.92 39.95 8.39 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.884 1.674 . . . . 0.0 114.322 178.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.19 44.89 27.25 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.974 -175.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -70.62 148.98 47.51 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.07 133.69 34.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.12 114.87 10.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 164.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 p -63.01 179.94 0.34 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.779 1.632 . . . . 0.0 112.959 -166.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -78.67 -16.37 57.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.767 1.627 . . . . 0.0 111.857 167.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -96.77 5.54 50.41 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.117 2.167 . . . . 0.0 112.885 -178.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 6.87 43.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.254 0.93 . . . . 0.0 114.076 -171.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.9 -165.05 1.26 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 167.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.26 153.83 28.15 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 110.156 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.61 158.02 17.59 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -84.97 69.08 10.76 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.245 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.4 162.18 33.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.865 170.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -50.09 -39.36 51.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 125.14 3.893 . . . . 0.0 113.817 -178.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -48.0 -39.1 18.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.998 178.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.17 -54.54 3.9 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 t -59.23 -47.05 86.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.133 -167.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.33 -132.82 0.44 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 127.829 2.633 . . . . 0.0 115.018 169.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.001 0.92 . . . . 0.0 111.354 -178.233 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.82 -50.36 3.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 103.487 -3.845 . . . . 0.0 103.487 -162.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.39 -179.67 6.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.517 3.127 . . . . 0.0 105.506 165.646 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -68.94 159.93 31.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.272 1.029 . . . . 0.0 111.159 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.13 97.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 47.89 45.94 18.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.74 0.816 . . . . 0.0 110.682 -174.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.15 13.24 72.94 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.078 -0.846 . . . . 0.0 114.751 175.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.22 173.01 12.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.022 2.129 . . . . 0.0 108.394 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.01 167.63 18.49 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 125.487 1.515 . . . . 0.0 108.157 165.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -61.64 174.72 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.035 3.157 . . . . 0.0 113.288 -178.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.9 p 46.15 41.61 8.82 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.842 1.657 . . . . 0.0 114.403 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.84 45.32 25.15 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.873 -175.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.8 mtt -69.67 156.03 39.59 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.07 151.34 21.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -93.12 114.29 26.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.0 p -59.3 161.52 5.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.022 0.529 . . . . 0.0 111.09 -171.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.86 -24.6 37.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.343 167.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.17 3.83 54.49 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.742 2.417 . . . . 0.0 112.313 -174.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 6.01 83.77 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.861 -0.966 . . . . 0.0 115.145 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -94.78 -171.47 2.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 164.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 150.8 36.44 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.659 1.118 . . . . 0.0 112.086 -173.175 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.72 153.88 10.14 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -88.46 68.9 8.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.334 1.053 . . . . 0.0 109.705 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.86 44.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 119.561 -1.304 . . . . 0.0 115.007 175.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.58 -19.7 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.048 3.832 . . . . 0.0 112.186 -171.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -53.85 -43.7 69.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -91.49 -63.62 1.23 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -65.91 0.62 Allowed 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 124.824 1.328 . . . . 0.0 109.788 -167.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 30.33 -118.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.41 1.957 . . . . 0.0 114.749 168.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.509 0 C-N-CA 126.256 1.822 . . . . 0.0 109.871 -177.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.94 -88.29 1.05 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 175.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -152.28 174.67 13.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.3 m -61.99 147.77 45.98 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -86.38 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 123.673 1.701 . . . . 0.0 106.468 174.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 49.64 53.54 12.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 111.776 -2.466 . . . . 0.0 110.83 -174.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.93 31.72 7.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.435 1.969 . . . . 0.0 113.408 172.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -139.06 123.49 18.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.27 2.228 . . . . 0.0 105.155 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -129.49 159.75 67.82 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.724 1.21 . . . . 0.0 109.578 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.25 168.95 21.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.416 2.077 . . . . 0.0 111.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 32.21 51.21 0.2 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.787 2.435 . . . . 0.0 115.127 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.81 45.29 8.94 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.824 1.202 . . . . 0.0 111.959 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -82.51 151.01 26.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 169.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.0 m -84.58 134.97 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -68.75 109.55 3.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.85 155.19 10.81 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.812 0.845 . . . . 0.0 111.304 -170.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -52.55 -26.48 13.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 168.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.01 1.1 57.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.89 2.476 . . . . 0.0 112.52 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.67 16.02 79.87 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.35 1.452 . . . . 0.0 114.782 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -94.77 -164.48 1.17 Allowed 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -136.6 132.22 34.81 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.36 -0.837 . . . . 0.0 109.069 -172.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.33 147.27 8.16 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 168.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -83.34 70.6 10.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 108.616 -178.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.32 164.59 33.49 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 122.077 -0.39 . . . . 0.0 113.318 177.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.97 -41.95 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.674 3.582 . . . . 0.0 112.914 -167.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -47.82 -34.96 9.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.424 1.09 . . . . 0.0 111.672 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -93.34 -52.08 4.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.123 1.369 . . . . 0.0 108.756 -176.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -53.13 61.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.821 -174.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.92 -134.79 9.2 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.181 0.896 . . . . 0.0 111.912 175.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 127.294 2.237 . . . . 0.0 114.041 169.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.91 -57.92 1.46 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 171.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -166.76 172.07 10.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 m -58.25 153.17 15.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.245 1.021 . . . . 0.0 110.923 175.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.51 99.97 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 127.025 2.13 . . . . 0.0 105.996 175.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 49.08 44.63 22.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.888 0.875 . . . . 0.0 111.374 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.33 73.65 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.779 0.705 . . . . 0.0 114.019 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -136.59 171.58 14.28 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 127.409 2.283 . . . . 0.0 105.617 171.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.15 167.97 17.91 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.794 0.837 . . . . 0.0 109.437 168.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.19 172.37 5.21 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.839 2.359 . . . . 0.0 112.1 176.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.8 p 43.48 42.19 3.77 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.077 1.751 . . . . 0.0 114.863 171.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.59 16.07 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.427 1.489 . . . . 0.0 111.867 -177.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.58 133.91 33.68 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -84.89 142.11 29.93 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.26 122.12 22.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 109.843 174.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.0 p -60.32 -177.55 0.07 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.667 1.187 . . . . 0.0 111.546 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -81.3 -21.44 39.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.949 0.9 . . . . 0.0 110.727 166.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.68 7.28 46.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.472 2.309 . . . . 0.0 112.456 -172.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.29 9.1 76.67 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.548 1.071 . . . . 0.0 114.19 -178.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -98.55 -167.93 1.57 Allowed 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 166.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -160.47 158.96 30.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.962 1.255 . . . . 0.0 111.384 -172.274 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.8 152.52 8.21 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -82.82 76.15 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.68 161.43 31.81 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.873 172.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.81 -36.05 19.58 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.633 3.555 . . . . 0.0 111.698 -168.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -46.22 -42.58 14.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.882 0.873 . . . . 0.0 111.102 174.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.16 -44.69 7.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.018 1.327 . . . . 0.0 110.695 -172.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -50.91 71.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.229 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.35 -130.12 5.88 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.95 1.262 . . . . 0.0 112.307 170.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.292 1.037 . . . . 0.0 111.533 169.269 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.234 0.277 0 CA-C-O 123.386 1.565 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.23 69.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 48.46 51.94 14.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 112.691 -2.049 . . . . 0.0 110.649 -173.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.28 28.36 36.88 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.953 0.787 . . . . 0.0 113.584 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -135.32 140.53 45.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.136 2.175 . . . . 0.0 106.302 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.53 164.36 36.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 124.233 1.013 . . . . 0.0 109.154 168.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.83 172.97 10.65 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.234 2.623 . . . . 0.0 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.7 t 37.8 41.87 0.37 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.515 1.926 . . . . 0.0 114.163 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.15 46.01 8.02 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.229 1.871 . . . . 0.0 111.942 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 mtt -77.68 141.92 39.11 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -83.74 134.56 34.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.5 m -76.06 116.68 17.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -55.11 164.8 0.79 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.438 0.695 . . . . 0.0 110.586 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.27 -20.89 20.61 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.929 166.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.33 2.44 56.38 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.224 2.21 . . . . 0.0 111.972 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.03 9.32 66.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.134 0.874 . . . . 0.0 114.002 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -91.73 -173.64 3.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 166.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 151.52 27.2 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.617 1.099 . . . . 0.0 113.745 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.1 148.59 6.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 106.686 -2.566 . . . . 0.0 106.686 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -82.77 66.38 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.054 -0.674 . . . . 0.0 110.191 -170.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.89 165.23 37.51 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.406 -0.902 . . . . 0.0 114.684 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.34 -29.93 18.84 Favored 'Trans proline' 0 C--N 1.351 0.664 1 C-N-CA 125.856 4.371 . . . . 0.0 115.051 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.2 -44.29 32.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -92.79 -60.66 1.76 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.332 -0.176 0 C-N-CA 126.584 1.954 . . . . 0.0 114.024 -165.94 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.34 59.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? 53.64 55.59 8.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 112.385 -2.188 . . . . 0.0 111.453 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.61 11.85 32.01 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.822 1.677 . . . . 0.0 114.242 168.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -137.05 125.55 23.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 126.798 2.039 . . . . 0.0 107.245 -169.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -135.78 163.33 51.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 107.704 167.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.59 175.02 11.51 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.234 1.956 . . . . 0.0 111.349 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t 34.82 53.19 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.85 2.06 . . . . 0.0 113.633 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.96 46.87 40.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.837 1.208 . . . . 0.0 112.224 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -85.81 136.36 33.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.7 m -83.6 140.08 32.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.34 114.89 8.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -57.48 148.8 22.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.903 1.281 . . . . 0.0 111.328 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.4 -27.96 4.62 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.836 167.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.93 7.55 43.47 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 128.029 2.532 . . . . 0.0 112.579 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 2.73 84.72 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.501 1.048 . . . . 0.0 114.591 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -91.2 -163.38 1.03 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.89 162.81 38.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 120.265 1.393 . . . . 0.0 111.33 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.46 161.21 13.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -83.74 77.51 9.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.23 165.36 37.16 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.623 -0.673 . . . . 0.0 113.319 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.35 -41.19 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.438 3.426 . . . . 0.0 112.149 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -49.35 -32.34 11.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.048 0.939 . . . . 0.0 111.799 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -93.2 -57.71 2.54 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.719 1.208 . . . . 0.0 109.653 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.604 -170.773 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 m . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 122.6 1.191 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.12 77.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.768 1.627 . . . . 0.0 107.284 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 58.19 53.5 6.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.884 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.95 28.07 55.14 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -140.15 138.14 34.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.25 2.22 . . . . 0.0 106.697 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 168.91 11.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 125.024 1.33 . . . . 0.0 107.987 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.53 172.5 3.47 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.528 2.152 . . . . 0.0 111.869 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t 32.48 47.51 0.1 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.784 2.434 . . . . 0.0 115.134 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.94 48.0 14.2 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.512 1.529 . . . . 0.0 112.356 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 mmt -73.0 149.44 43.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.7 m -82.33 137.87 34.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 m -73.34 122.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -57.04 157.23 6.04 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -60.56 -13.12 12.24 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 169.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -92.09 2.26 56.69 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.742 2.417 . . . . 0.0 112.244 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.55 0.51 87.48 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.372 0.987 . . . . 0.0 114.737 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -89.65 -169.33 2.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 167.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 p -159.43 151.49 20.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.471 1.032 . . . . 0.0 113.424 -170.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.3 151.09 9.86 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -82.78 72.04 9.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.76 165.02 32.1 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.784 -1.198 . . . . 0.0 114.981 169.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.71 -35.27 17.08 Favored 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 125.899 4.4 . . . . 0.0 114.584 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.7 -42.12 11.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -93.13 -59.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 C-N-CA 126.776 2.03 . . . . 0.0 115.114 -165.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 122.591 1.186 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -106.87 100.15 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.167 1.787 . . . . 0.0 106.365 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 51.72 44.64 29.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 110.549 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.45 82.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.734 0.683 . . . . 0.0 113.172 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -141.03 148.42 40.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.78 2.032 . . . . 0.0 107.65 172.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -132.72 163.75 48.61 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.349 1.86 . . . . 0.0 106.644 166.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.62 174.97 9.25 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.281 1.987 . . . . 0.0 110.855 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t 34.65 54.1 0.65 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 127.073 2.149 . . . . 0.0 113.872 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.41 46.28 36.34 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.857 1.217 . . . . 0.0 112.239 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.446 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.7 mmm -90.15 133.77 34.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 168.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.1 m -83.99 134.95 34.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.8 m -67.91 120.47 14.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 165.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.3 p -69.6 163.26 25.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.337 1.055 . . . . 0.0 111.15 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -50.15 -26.41 4.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.434 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.1 -1.41 56.48 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 126.859 2.064 . . . . 0.0 112.828 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.17 6.65 83.54 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.106 0.86 . . . . 0.0 113.974 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -90.36 -160.13 0.67 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.35 158.87 27.63 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.006 1.275 . . . . 0.0 112.989 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.61 157.92 11.98 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.97 77.31 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.53 158.4 27.65 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.382 -1.39 . . . . 0.0 114.914 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.99 -39.69 59.48 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.806 3.671 . . . . 0.0 113.764 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -43.42 -45.89 6.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 110.288 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -90.54 -55.17 3.69 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.286 1.034 . . . . 0.0 109.192 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 130.558 3.543 . . . . 0.0 113.475 -168.451 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -89.6 61.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 123.344 1.545 . . . . 0.0 108.33 -171.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? 63.06 53.73 2.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.687 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.33 27.62 54.8 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.762 1.172 . . . . 0.0 113.119 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -135.99 156.31 48.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 128.029 2.531 . . . . 0.0 106.122 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 m -135.87 165.78 33.35 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 127.108 2.163 . . . . 0.0 108.599 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.3 175.13 4.12 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.946 3.097 . . . . 0.0 109.272 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 33.21 48.97 0.18 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.535 2.334 . . . . 0.0 115.159 170.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.06 44.02 5.73 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.675 1.607 . . . . 0.0 112.083 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.1 mtt -85.69 165.01 17.31 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -101.74 133.49 46.38 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.45 106.97 1.89 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -57.54 148.08 24.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.906 0.882 . . . . 0.0 110.569 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -51.93 -25.21 7.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -92.63 7.55 42.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.987 2.515 . . . . 0.0 112.374 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.91 8.83 87.59 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.473 1.511 . . . . 0.0 114.825 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -93.24 -163.82 1.1 Allowed 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.766 1.226 . . . . 0.0 108.828 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.7 t -141.11 138.5 33.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 119.22 0.918 . . . . 0.0 109.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.08 22.19 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -90.24 70.14 7.16 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.635 1.574 . . . . 0.0 110.458 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.82 160.46 33.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.016 -1.087 . . . . 0.0 115.492 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.99 -46.92 29.33 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.787 3.658 . . . . 0.0 114.249 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -48.6 -35.36 13.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.208 1.003 . . . . 0.0 111.933 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -93.43 -51.11 5.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 108.503 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.304 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.234 0.259 0 CA-C-O 123.263 1.506 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -85.98 69.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.533 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? 49.78 52.98 13.56 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.195 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.05 25.22 32.27 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 114.351 170.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -139.9 138.94 36.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 128.101 2.56 . . . . 0.0 105.665 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 164.87 35.99 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 124.106 0.963 . . . . 0.0 109.415 168.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.34 174.3 6.12 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.36 2.707 . . . . 0.0 110.281 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t 34.42 51.15 0.44 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.011 2.125 . . . . 0.0 113.866 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.07 46.21 26.77 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.128 1.347 . . . . 0.0 112.247 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -92.4 133.68 35.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.68 140.44 29.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.0 m -71.27 117.71 13.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.877 0.846 . . . . 0.0 110.244 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -55.03 173.07 0.1 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.368 1.467 . . . . 0.0 111.636 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -63.13 -24.24 67.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.574 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -94.66 4.86 53.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.214 2.206 . . . . 0.0 112.823 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.47 11.54 65.15 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.005 0.812 . . . . 0.0 113.677 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -92.07 -164.59 1.2 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 160.11 22.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.105 1.321 . . . . 0.0 113.378 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.08 162.06 25.16 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -83.8 79.15 9.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.24 162.43 35.72 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.288 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.79 -35.58 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.486 3.457 . . . . 0.0 111.687 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -43.72 -41.99 5.14 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.911 1.284 . . . . 0.0 111.113 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -94.44 -50.6 5.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 110.372 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.125 -170.8 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.322 0 CA-C-O 123.074 1.416 . . . . 0.0 108.269 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.49 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.643 1.687 . . . . 0.0 106.742 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 53.54 53.26 11.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.956 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.77 16.17 49.6 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.047 1.784 . . . . 0.0 115.575 169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.49 147.17 32.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.185 2.594 . . . . 0.0 105.415 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.6 OUTLIER -135.56 168.24 18.44 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 124.654 1.182 . . . . 0.0 108.01 167.243 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.75 169.94 6.45 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.53 2.153 . . . . 0.0 112.953 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.5 p 32.71 51.33 0.24 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.44 2.296 . . . . 0.0 115.031 169.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.7 47.9 37.2 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.92 1.248 . . . . 0.0 112.5 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 61.2 mtt -78.24 144.03 36.58 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 167.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -84.91 136.44 33.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 m -69.52 139.04 53.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -73.32 -174.19 1.56 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.853 0.835 . . . . 0.0 111.857 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.255 2.0 pm0 -69.43 -28.95 66.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.749 -0.594 . . . . 0.0 111.324 168.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.44 9.26 35.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.518 2.327 . . . . 0.0 111.264 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.27 28.16 70.4 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.372 0.987 . . . . 0.0 112.667 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -90.41 -156.02 0.41 Allowed 'General case' 0 C--N 1.338 0.077 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.79 152.18 13.4 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.93 159.99 23.18 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 107.161 -2.375 . . . . 0.0 107.161 169.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -83.5 79.15 9.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.27 163.49 37.16 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.858 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.48 -35.48 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.455 3.437 . . . . 0.0 111.434 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.29 -39.6 6.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.043 1.337 . . . . 0.0 111.295 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -93.75 -51.8 4.74 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.068 1.347 . . . . 0.0 109.782 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -171.418 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 122.576 1.179 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -114.17 101.0 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 106.188 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 52.48 45.71 28.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.19 0.596 . . . . 0.0 110.38 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.33 85.67 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.781 1.181 . . . . 0.0 113.168 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -141.45 144.32 34.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.308 2.243 . . . . 0.0 106.293 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.86 19.19 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.807 1.243 . . . . 0.0 108.468 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.75 172.62 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.604 2.203 . . . . 0.0 111.839 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t 33.02 49.0 0.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.74 2.416 . . . . 0.0 115.211 168.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.96 49.18 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.383 1.468 . . . . 0.0 112.276 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 mmt -88.09 135.13 33.56 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -82.65 140.37 33.19 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.1 m -73.63 124.42 25.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 p -59.89 156.66 13.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -56.75 -19.49 17.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -90.06 -7.36 54.05 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 127.002 2.121 . . . . 0.0 112.307 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.12 65.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 115.094 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -92.55 -172.52 3.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.92 150.27 29.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.626 1.103 . . . . 0.0 113.516 -173.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.92 148.62 7.49 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -82.42 74.09 9.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.89 166.99 39.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.393 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.62 -24.68 41.33 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.88 3.72 . . . . 0.0 112.194 -169.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -49.75 -40.39 40.85 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -92.62 -65.86 0.97 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 C-N-CA 126.319 1.848 . . . . 0.0 113.696 -165.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.6 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 122.171 0.986 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.19 69.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 69.82 51.4 0.44 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.758 2.023 . . . . 0.0 109.184 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.23 26.26 74.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.414 1.007 . . . . 0.0 113.258 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -136.47 124.31 22.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.371 2.268 . . . . 0.0 106.352 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.2 m -106.74 160.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.88 1.272 . . . . 0.0 109.849 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.54 167.49 22.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.998 1.798 . . . . 0.0 111.747 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.8 p 32.68 47.67 0.11 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 127.373 2.269 . . . . 0.0 116.373 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.9 44.7 61.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.732 1.158 . . . . 0.0 112.818 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.32 151.43 25.58 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.5 m -89.86 145.26 25.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -66.43 132.87 49.25 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.674 164.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 33.0 p -61.68 161.23 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.516 -1.274 . . . . 0.0 108.463 168.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -58.57 -19.86 41.82 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.566 -0.709 . . . . 0.0 111.447 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -92.8 6.51 47.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.206 2.602 . . . . 0.0 112.328 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.13 24.0 77.12 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.951 1.262 . . . . 0.0 115.314 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -97.64 -168.51 1.69 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.24 134.81 46.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.512 1.506 . . . . 0.0 111.302 -171.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.55 138.54 4.63 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -84.7 72.02 10.76 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.839 0.856 . . . . 0.0 108.717 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.19 163.71 33.23 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.515 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.35 -39.98 35.72 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 125.131 3.887 . . . . 0.0 114.205 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.97 -35.79 16.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.589 0.756 . . . . 0.0 111.436 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 23.7 m-85 -94.98 -57.14 2.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 123.622 0.769 . . . . 0.0 112.732 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 123.395 1.569 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.29 66.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.163 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 59.59 54.56 4.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.787 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.96 23.45 45.37 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 167.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm-85 -139.57 141.45 37.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.545 2.338 . . . . 0.0 106.005 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 169.57 10.14 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.556 1.142 . . . . 0.0 109.57 168.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.99 171.57 5.95 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.842 2.361 . . . . 0.0 112.017 173.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t 34.23 44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.69 2.396 . . . . 0.0 114.942 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.63 46.62 18.14 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.865 1.697 . . . . 0.0 112.043 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.6 mtt -78.41 142.57 37.48 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 167.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.5 m -83.64 145.81 28.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.2 m -75.05 154.12 38.11 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p -89.61 170.39 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -56.79 -24.82 53.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.795 -0.565 . . . . 0.0 111.514 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -92.11 5.36 50.57 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 127.834 2.453 . . . . 0.0 111.996 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.17 71.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.651 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -91.11 -172.63 3.38 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 166.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.0 154.11 36.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 147.08 7.56 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -81.85 72.16 8.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.55 161.27 32.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.817 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.04 -35.98 34.03 Favored 'Trans proline' 0 C--N 1.351 0.658 1 C-N-CA 125.431 4.087 . . . . 0.0 114.489 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -49.59 -37.97 29.75 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.97 -59.5 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.246 0 C-N-CA 124.84 1.256 . . . . 0.0 114.331 -166.044 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 122.984 1.373 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.75 101.18 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 127.155 2.182 . . . . 0.0 105.64 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.3 44.57 28.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.675 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.57 36.05 92.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.571 0.605 . . . . 0.0 112.899 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -139.16 146.34 40.48 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.482 1.913 . . . . 0.0 107.959 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -130.7 166.35 27.89 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 126.9 2.08 . . . . 0.0 107.063 167.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.77 164.19 19.5 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.372 2.048 . . . . 0.0 113.294 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.5 p 42.15 36.92 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.943 2.097 . . . . 0.0 115.59 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.27 41.14 46.78 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.611 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 50.3 mtt -59.77 146.83 40.18 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 166.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -83.42 133.25 34.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.42 135.32 51.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.1 p -69.52 -166.13 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.041 2.136 . . . . 0.0 111.514 -170.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -87.47 -11.61 48.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 110.739 166.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.0 17.51 14.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.077 2.151 . . . . 0.0 112.704 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 -0.13 30.6 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.761 1.172 . . . . 0.0 114.723 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -90.05 -159.24 0.58 Allowed 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.27 173.5 14.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.106 0.867 . . . . 0.0 112.221 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.53 154.58 8.41 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -83.8 65.45 8.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.634 0.774 . . . . 0.0 109.17 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.98 159.86 32.59 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.269 -0.967 . . . . 0.0 114.75 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.36 -42.2 41.44 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 125.297 3.998 . . . . 0.0 114.775 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -48.64 -38.98 22.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.399 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -93.21 -51.13 5.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.375 1.083 . . . . 0.0 108.909 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.861 -168.973 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 123.494 1.616 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.25 59.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 123.876 1.798 . . . . 0.0 108.41 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? 58.88 54.65 5.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.194 -2.276 . . . . 0.0 110.124 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.5 25.02 34.28 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.407 1.003 . . . . 0.0 113.659 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -144.9 136.21 25.15 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.874 2.47 . . . . 0.0 107.249 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.89 166.28 28.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 109.201 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.82 164.8 17.81 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.7 2.266 . . . . 0.0 112.452 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p 34.96 38.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.85 2.46 . . . . 0.0 115.751 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.85 43.04 30.1 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.345 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mmm -62.01 138.95 58.44 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 167.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.94 136.39 35.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.2 m -64.55 138.77 58.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 t -69.06 -169.99 0.22 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.058 1.343 . . . . 0.0 112.12 -168.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -87.5 -27.13 22.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.567 162.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.57 14.39 24.9 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 128.412 2.685 . . . . 0.0 112.309 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.46 4.55 65.19 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.559 1.552 . . . . 0.0 114.727 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -88.94 -154.55 0.3 Allowed 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.097 1.359 . . . . 0.0 107.758 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -155.31 147.52 23.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.479 1.036 . . . . 0.0 112.422 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.99 137.53 3.9 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -83.16 64.92 7.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.917 -0.755 . . . . 0.0 109.397 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.12 161.89 34.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.121 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.06 -45.31 21.59 Favored 'Trans proline' 0 C--N 1.349 0.593 1 C-N-CA 125.323 4.016 . . . . 0.0 115.088 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -50.22 -33.78 20.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.788 0.835 . . . . 0.0 111.747 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.4 -52.06 4.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.122 0.969 . . . . 0.0 109.105 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.626 -168.006 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 123.544 1.64 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.41 61.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.262 -169.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 63.24 53.98 2.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.896 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.11 41.56 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.417 1.008 . . . . 0.0 113.402 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -141.94 130.61 22.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 107.707 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.77 166.87 25.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.167 1.387 . . . . 0.0 108.492 166.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.56 170.33 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.799 2.333 . . . . 0.0 112.661 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p 33.87 46.16 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.658 2.383 . . . . 0.0 115.403 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.9 48.45 9.34 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.37 1.462 . . . . 0.0 112.031 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.2 151.12 46.93 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -82.69 134.33 35.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -74.1 116.43 14.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.2 p -56.28 162.04 2.24 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.178 0.514 . . . . 0.0 111.045 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -53.02 -23.9 8.47 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.756 165.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -94.33 1.76 55.88 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 128.609 2.763 . . . . 0.0 113.406 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.57 2.18 84.37 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.252 0.93 . . . . 0.0 115.367 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.77 -164.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.42 146.62 21.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.792 1.178 . . . . 0.0 113.115 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.18 145.65 6.08 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -83.63 65.56 8.54 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.048 -0.677 . . . . 0.0 110.084 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.41 165.23 36.02 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.216 -0.992 . . . . 0.0 114.935 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.36 -39.37 27.89 Favored 'Trans proline' 0 C--N 1.349 0.582 1 C-N-CA 125.454 4.102 . . . . 0.0 114.478 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -51.21 -32.57 24.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.0 0.52 . . . . 0.0 111.629 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -94.23 -60.13 1.8 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.457 -0.098 0 C-N-CA 125.874 1.67 . . . . 0.0 113.114 -165.142 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.511 0.672 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.04 67.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.556 1.646 . . . . 0.0 106.838 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 47.83 51.64 13.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.633 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.07 29.8 10.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.949 1.737 . . . . 0.0 113.792 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -141.86 128.44 20.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.733 2.013 . . . . 0.0 106.804 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.49 164.33 42.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.2 1.0 . . . . 0.0 109.059 166.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -65.03 171.33 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.431 2.087 . . . . 0.0 112.602 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p 40.54 43.74 1.61 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.967 1.707 . . . . 0.0 115.32 169.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.38 47.55 28.27 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.818 1.199 . . . . 0.0 112.152 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 60.9 mtt -71.46 148.8 46.48 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.6 m -83.71 136.98 33.98 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 170.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -73.06 138.27 45.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 166.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -69.81 -166.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 123.037 1.399 . . . . 0.0 109.576 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -102.44 -22.15 14.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.36 1.864 . . . . 0.0 107.855 162.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.12 9.63 37.0 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 127.777 2.431 . . . . 0.0 112.253 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.92 83.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.525 1.536 . . . . 0.0 115.0 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.54 -169.1 2.12 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.0 p -157.89 155.43 29.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 109.971 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.0 152.37 8.16 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -83.22 77.57 9.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.26 162.08 33.2 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.14 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.59 -42.41 29.36 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 125.179 3.92 . . . . 0.0 114.076 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -50.59 -31.67 16.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.072 0.949 . . . . 0.0 111.592 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.97 -56.4 2.88 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.759 0.824 . . . . 0.0 109.185 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.467 0.419 0 C-N-CA 123.723 0.809 . . . . 0.0 111.516 -167.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 122.993 1.378 . . . . 0.0 107.776 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.95 81.13 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 52.61 51.1 16.75 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.63 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.73 27.24 73.51 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.611 0.625 . . . . 0.0 113.354 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -145.34 152.67 40.25 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.2 2.6 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.47 165.37 34.75 Favored Pre-proline 0 C--N 1.325 -0.468 0 C-N-CA 123.614 0.766 . . . . 0.0 109.63 167.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.2 170.96 17.82 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.735 2.29 . . . . 0.0 109.641 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.0 p 43.52 35.29 0.93 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.08 1.752 . . . . 0.0 114.688 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.45 48.01 5.75 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 126.204 1.859 . . . . 0.0 111.527 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.32 142.43 47.11 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 168.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.6 m -83.22 139.36 33.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.21 127.97 34.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 t -62.52 170.76 2.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.465 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.26 -28.83 69.98 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -93.58 8.23 41.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.037 2.535 . . . . 0.0 112.335 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.42 77.9 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.122 0.868 . . . . 0.0 114.636 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.18 -153.17 0.26 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.9 149.77 23.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.552 1.069 . . . . 0.0 112.557 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.14 138.02 2.66 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -83.95 72.64 10.42 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.765 -0.844 . . . . 0.0 110.366 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.01 162.72 34.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.297 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.07 -49.58 11.11 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.0 3.8 . . . . 0.0 114.343 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -53.18 -29.95 34.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.848 0.859 . . . . 0.0 112.371 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -94.98 -48.28 6.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.841 -178.046 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 122.028 0.918 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.87 73.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 59.58 54.68 4.41 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.067 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.88 15.62 77.07 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.449 1.023 . . . . 0.0 115.086 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -137.52 136.96 38.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.5 m -121.11 160.21 46.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.86 1.264 . . . . 0.0 110.199 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.78 169.22 19.45 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.443 2.095 . . . . 0.0 112.097 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t 33.61 47.26 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.645 2.378 . . . . 0.0 115.524 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.57 40.5 55.18 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.798 1.189 . . . . 0.0 112.795 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.86 149.13 28.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 166.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -83.34 137.8 33.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.8 t -72.35 114.06 10.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -62.0 151.39 35.28 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.009 1.724 . . . . 0.0 110.944 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.45 -28.08 18.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 168.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -93.73 9.18 38.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.037 2.535 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.48 8.05 83.5 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.786 1.184 . . . . 0.0 114.972 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.07 -167.69 1.78 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 124.612 1.165 . . . . 0.0 109.638 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.0 m -127.36 145.87 50.66 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.059 -1.026 . . . . 0.0 109.604 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.67 144.64 4.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 165.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -83.83 67.44 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.482 1.113 . . . . 0.0 108.12 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.16 164.83 35.67 Favored Glycine 0 CA--C 1.528 0.901 0 O-C-N 122.145 -0.347 . . . . 0.0 113.077 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -66.76 -42.96 7.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.686 3.59 . . . . 0.0 113.312 -167.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -49.53 -33.4 14.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.913 0.885 . . . . 0.0 111.903 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.02 -54.63 3.65 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.958 1.303 . . . . 0.0 108.901 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.449 -0.52 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 -171.409 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 122.158 0.98 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.32 97.49 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 49.4 45.56 23.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.552 0.741 . . . . 0.0 110.671 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.21 68.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.314 1.435 . . . . 0.0 114.078 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -132.25 160.78 35.17 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 127.392 2.277 . . . . 0.0 105.698 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -137.2 161.52 60.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 C-N-CA 125.669 1.587 . . . . 0.0 109.414 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.58 168.28 18.65 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.222 1.948 . . . . 0.0 111.938 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t 31.87 49.53 0.13 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.998 2.519 . . . . 0.0 115.251 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.22 44.3 51.73 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.214 0.911 . . . . 0.0 112.86 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.82 153.06 26.62 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 166.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.03 134.82 35.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -72.7 107.23 5.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 165.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p -54.47 156.57 3.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.383 1.473 . . . . 0.0 110.003 -170.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -56.53 -23.61 40.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 170.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.82 11.56 31.13 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.465 2.306 . . . . 0.0 112.281 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.0 84.97 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.244 1.402 . . . . 0.0 114.494 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -113.32 -169.97 1.6 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.468 1.907 . . . . 0.0 107.378 169.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -126.58 136.34 52.42 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 120.197 1.362 . . . . 0.0 110.198 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.92 142.77 5.28 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 166.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -83.8 68.32 9.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.02 168.33 41.1 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.911 -1.138 . . . . 0.0 114.531 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.31 -35.18 32.76 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.549 3.499 . . . . 0.0 111.771 -169.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -49.68 -34.78 19.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.68 0.392 . . . . 0.0 111.436 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -94.65 -60.34 1.73 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.0 109.945 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.235 0.309 0 C-N-CA 126.418 1.887 . . . . 0.0 113.747 -168.722 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 122.612 1.196 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -83.79 75.4 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 mmt-85 49.94 51.22 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.711 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 4.78 72.86 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.818 1.199 . . . . 0.0 114.702 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -132.75 165.79 23.72 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.07 167.83 18.53 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.184 . . . . 0.0 109.133 167.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -68.1 175.03 7.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.027 2.485 . . . . 0.0 112.69 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 32.19 55.22 0.34 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.501 2.32 . . . . 0.0 115.335 166.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.46 44.21 36.28 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.726 1.155 . . . . 0.0 112.35 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.0 mmt -91.77 134.85 34.37 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.8 m -81.66 133.31 35.35 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.8 t -74.13 114.2 12.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.5 p -60.36 154.95 19.05 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.57 -16.34 24.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 167.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.66 3.63 55.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.931 2.492 . . . . 0.0 112.95 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.0 90.52 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -96.28 -170.85 2.17 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -156.51 157.16 34.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.237 1.38 . . . . 0.0 112.483 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.76 155.9 8.7 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -84.08 79.05 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.036 0.935 . . . . 0.0 109.047 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.3 171.05 38.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.986 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.36 -25.5 10.22 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 126.079 4.52 . . . . 0.0 115.165 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -51.04 -54.86 20.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.653 -0.655 . . . . 0.0 109.593 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.86 -66.19 0.95 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.533 -0.729 . . . . 0.0 109.236 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 122.653 1.216 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.46 92.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.933 2.093 . . . . 0.0 106.656 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 49.24 52.14 14.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.45 0.643 . . . . 0.0 110.015 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.16 31.62 66.29 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.972 1.273 . . . . 0.0 113.686 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -141.74 139.82 32.96 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.749 2.02 . . . . 0.0 107.185 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.23 168.94 14.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 125.432 1.493 . . . . 0.0 108.502 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.82 169.38 5.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.543 2.162 . . . . 0.0 112.746 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.4 p 33.08 49.22 0.17 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.562 2.345 . . . . 0.0 115.078 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.29 48.08 27.22 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.313 1.435 . . . . 0.0 112.465 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.7 mtt -75.81 145.79 40.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.4 m -83.98 139.25 32.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 m -75.42 125.13 28.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 p -63.06 159.94 16.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.24 -20.72 29.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -91.58 2.96 56.09 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 127.54 2.336 . . . . 0.0 111.858 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.71 6.78 85.42 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.332 0.968 . . . . 0.0 114.655 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.89 -167.15 1.67 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -158.55 152.82 24.09 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.466 1.03 . . . . 0.0 112.928 -172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.14 149.65 7.9 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -82.55 72.27 9.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.32 160.39 33.16 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 119.964 -1.112 . . . . 0.0 114.307 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.16 -40.75 42.26 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.052 3.835 . . . . 0.0 113.942 -176.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -49.73 -34.53 19.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.881 0.872 . . . . 0.0 111.391 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.44 -60.15 1.78 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.451 -0.421 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.124 -165.562 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 122.039 0.923 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -84.94 67.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.69 53.18 8.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.137 2.575 . . . . 0.0 110.103 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.76 -10.24 30.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.875 2.655 . . . . 0.0 113.793 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.4 mtt85 -106.93 110.84 23.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.0 m -113.51 157.95 39.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.703 1.601 . . . . 0.0 109.567 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.87 170.55 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.909 2.406 . . . . 0.0 111.024 -171.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p 43.41 42.69 3.94 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.837 1.655 . . . . 0.0 114.941 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.56 42.96 27.91 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.918 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -82.7 151.03 26.4 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 167.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.1 m -91.12 138.09 31.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.19 116.49 13.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.5 p -68.64 -177.46 0.97 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.006 1.722 . . . . 0.0 113.295 -169.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.32 -26.06 61.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 167.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.54 8.41 42.29 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.645 2.378 . . . . 0.0 112.403 -173.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.24 13.32 57.74 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.679 1.133 . . . . 0.0 114.055 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -94.77 -175.93 3.72 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.191 1.396 . . . . 0.0 109.41 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.7 m -127.17 137.06 52.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 109.278 -170.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 146.36 7.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.66 75.99 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.98 155.81 27.31 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 120.493 -0.861 . . . . 0.0 114.159 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.98 -46.38 28.26 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.108 3.872 . . . . 0.0 115.127 -169.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -51.23 -31.77 21.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.756 0.823 . . . . 0.0 111.68 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -95.73 -53.7 3.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.558 1.143 . . . . 0.0 108.562 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -170.034 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.134 1.445 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.26 78.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 127.03 2.132 . . . . 0.0 106.243 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 46.97 50.42 13.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.219 -1.81 . . . . 0.0 110.225 -172.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.45 23.53 12.37 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.443 1.497 . . . . 0.0 114.928 172.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -138.41 118.14 13.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.604 1.962 . . . . 0.0 109.305 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -124.32 162.93 39.26 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 166.06 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.23 170.54 7.67 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.594 2.196 . . . . 0.0 112.627 -178.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.2 p 42.23 39.58 1.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.232 1.813 . . . . 0.0 115.481 171.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.84 48.81 9.21 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.656 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 55.7 mtt -64.19 150.6 45.43 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -83.69 136.37 34.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.0 m -69.82 138.38 52.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -73.33 -168.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.594 0.712 . . . . 0.0 109.787 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 -7.19 26.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.355 0.662 . . . . 0.0 110.418 165.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.93 1.65 55.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.845 2.458 . . . . 0.0 112.494 -176.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.97 4.63 72.7 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.022 1.296 . . . . 0.0 113.763 -169.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -93.95 -158.83 0.65 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.38 165.11 29.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.655 0.782 . . . . 0.0 110.834 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.05 152.17 6.93 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -83.51 65.73 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.098 -0.648 . . . . 0.0 109.915 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.89 160.8 33.93 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.514 -0.85 . . . . 0.0 114.38 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.65 -41.87 37.01 Favored 'Trans proline' 0 C--N 1.35 0.64 1 C-N-CA 125.361 4.041 . . . . 0.0 114.611 -174.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -50.8 -33.55 23.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 111.582 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -94.93 -54.36 3.49 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.531 0.732 . . . . 0.0 109.772 173.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 112.679 -167.194 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.235 0.314 0 CA-C-O 122.361 1.077 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -86.21 59.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 124.05 1.881 . . . . 0.0 108.059 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.454 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 3.4 mmp_? 57.85 54.98 5.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.043 -169.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.69 25.0 36.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.427 1.489 . . . . 0.0 115.093 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -138.13 146.97 43.45 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 127.757 2.423 . . . . 0.0 105.201 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.4 m -129.24 163.4 46.36 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 125.888 1.675 . . . . 0.0 110.199 -176.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.62 172.44 3.96 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.25 2.633 . . . . 0.0 110.3 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 42.6 41.84 2.56 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.139 1.776 . . . . 0.0 115.215 171.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.89 45.05 18.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.018 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mtt -84.92 157.14 20.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 167.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -98.07 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.35 117.58 9.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.155 163.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.503 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 9.4 p -50.86 154.52 1.42 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 168.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -59.04 -16.42 18.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.773 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.26 4.32 53.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.915 2.886 . . . . 0.0 112.498 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 9.3 86.97 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.455 1.502 . . . . 0.0 116.031 169.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.24 178.95 5.57 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 118.479 1.14 . . . . 0.0 108.91 168.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.7 m -112.8 138.18 50.02 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.896 -174.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.76 138.0 4.48 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -84.22 75.27 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.94 162.62 32.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.856 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.44 -41.17 44.32 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.834 3.69 . . . . 0.0 113.763 -176.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -49.83 -33.5 17.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.539 0.735 . . . . 0.0 111.652 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 14.0 m-85 -96.22 -60.35 1.64 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.573 -166.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.12 80.11 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -176.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 68.04 50.06 0.83 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.751 2.42 . . . . 0.0 109.799 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.77 10.44 50.26 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -141.65 167.54 21.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.719 2.808 . . . . 0.0 104.585 173.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.7 167.22 20.29 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 124.752 1.221 . . . . 0.0 108.844 169.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.78 174.91 11.87 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.429 2.086 . . . . 0.0 110.773 -171.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p 46.92 39.95 8.39 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.884 1.674 . . . . 0.0 114.322 178.327 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.19 44.89 27.25 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.974 -175.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -70.62 148.98 47.51 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.07 133.69 34.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.12 114.87 10.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 164.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 p -63.01 179.94 0.34 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.779 1.632 . . . . 0.0 112.959 -166.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -78.67 -16.37 57.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.767 1.627 . . . . 0.0 111.857 167.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -96.77 5.54 50.41 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.117 2.167 . . . . 0.0 112.885 -178.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 6.87 43.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.254 0.93 . . . . 0.0 114.076 -171.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.9 -165.05 1.26 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 167.495 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.26 153.83 28.15 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 110.156 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.61 158.02 17.59 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -84.97 69.08 10.76 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.245 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.4 162.18 33.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.865 170.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -50.09 -39.36 51.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 125.14 3.893 . . . . 0.0 113.817 -178.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -48.0 -39.1 18.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.998 178.29 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.17 -54.54 3.9 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.239 0.533 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.133 -167.332 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.912 0.863 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.13 97.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 47.89 45.94 18.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.74 0.816 . . . . 0.0 110.682 -174.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.15 13.24 72.94 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.078 -0.846 . . . . 0.0 114.751 175.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.22 173.01 12.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.022 2.129 . . . . 0.0 108.394 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.01 167.63 18.49 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 125.487 1.515 . . . . 0.0 108.157 165.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -61.64 174.72 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.035 3.157 . . . . 0.0 113.288 -178.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.9 p 46.15 41.61 8.82 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.842 1.657 . . . . 0.0 114.403 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.84 45.32 25.15 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.873 -175.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.8 mtt -69.67 156.03 39.59 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.07 151.34 21.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -93.12 114.29 26.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.0 p -59.3 161.52 5.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.022 0.529 . . . . 0.0 111.09 -171.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.86 -24.6 37.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.343 167.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.17 3.83 54.49 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.742 2.417 . . . . 0.0 112.313 -174.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 6.01 83.77 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.861 -0.966 . . . . 0.0 115.145 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -94.78 -171.47 2.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 164.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 150.8 36.44 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.659 1.118 . . . . 0.0 112.086 -173.175 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.72 153.88 10.14 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.119 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -88.46 68.9 8.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.334 1.053 . . . . 0.0 109.705 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.86 44.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 119.561 -1.304 . . . . 0.0 115.007 175.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.58 -19.7 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.048 3.832 . . . . 0.0 112.186 -171.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -53.85 -43.7 69.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -91.49 -63.62 1.23 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 O-C-N 124.824 1.328 . . . . 0.0 109.788 -167.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -86.38 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 123.673 1.701 . . . . 0.0 106.468 174.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.404 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? 49.64 53.54 12.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 111.776 -2.466 . . . . 0.0 110.83 -174.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.93 31.72 7.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.435 1.969 . . . . 0.0 113.408 172.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -139.06 123.49 18.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.27 2.228 . . . . 0.0 105.155 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -129.49 159.75 67.82 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.724 1.21 . . . . 0.0 109.578 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.25 168.95 21.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.416 2.077 . . . . 0.0 111.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 32.21 51.21 0.2 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.787 2.435 . . . . 0.0 115.127 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.81 45.29 8.94 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.824 1.202 . . . . 0.0 111.959 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -82.51 151.01 26.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 169.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.0 m -84.58 134.97 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -68.75 109.55 3.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.85 155.19 10.81 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.812 0.845 . . . . 0.0 111.304 -170.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -52.55 -26.48 13.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 168.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.01 1.1 57.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.89 2.476 . . . . 0.0 112.52 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.67 16.02 79.87 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.35 1.452 . . . . 0.0 114.782 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -94.77 -164.48 1.17 Allowed 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -136.6 132.22 34.81 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.36 -0.837 . . . . 0.0 109.069 -172.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.33 147.27 8.16 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 168.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -83.34 70.6 10.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 108.616 -178.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.32 164.59 33.49 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 122.077 -0.39 . . . . 0.0 113.318 177.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.97 -41.95 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.674 3.582 . . . . 0.0 112.914 -167.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -47.82 -34.96 9.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.424 1.09 . . . . 0.0 111.672 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -93.34 -52.08 4.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.123 1.369 . . . . 0.0 108.756 -176.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.821 -174.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 m . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 122.245 1.021 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.51 99.97 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 127.025 2.13 . . . . 0.0 105.996 175.055 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 49.08 44.63 22.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.888 0.875 . . . . 0.0 111.374 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.33 73.65 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.779 0.705 . . . . 0.0 114.019 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -136.59 171.58 14.28 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 127.409 2.283 . . . . 0.0 105.617 171.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.15 167.97 17.91 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.794 0.837 . . . . 0.0 109.437 168.16 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.19 172.37 5.21 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.839 2.359 . . . . 0.0 112.1 176.493 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.8 p 43.48 42.19 3.77 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.077 1.751 . . . . 0.0 114.863 171.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.59 16.07 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.427 1.489 . . . . 0.0 111.867 -177.097 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.58 133.91 33.68 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -84.89 142.11 29.93 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.26 122.12 22.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 109.843 174.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.0 p -60.32 -177.55 0.07 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.667 1.187 . . . . 0.0 111.546 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -81.3 -21.44 39.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.949 0.9 . . . . 0.0 110.727 166.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.68 7.28 46.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.472 2.309 . . . . 0.0 112.456 -172.413 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.29 9.1 76.67 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.548 1.071 . . . . 0.0 114.19 -178.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -98.55 -167.93 1.57 Allowed 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 166.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -160.47 158.96 30.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.962 1.255 . . . . 0.0 111.384 -172.274 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.8 152.52 8.21 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -82.82 76.15 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.811 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.68 161.43 31.81 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.873 172.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.81 -36.05 19.58 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.633 3.555 . . . . 0.0 111.698 -168.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -46.22 -42.58 14.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.882 0.873 . . . . 0.0 111.102 174.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.16 -44.69 7.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.018 1.327 . . . . 0.0 110.695 -172.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.229 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.24 -59.45 7.88 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.223 0.952 . . . . 0.0 112.224 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -164.59 148.37 9.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.07 172.05 2.59 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.386 1.565 . . . . 0.0 111.993 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.23 69.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 48.46 51.94 14.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 112.691 -2.049 . . . . 0.0 110.649 -173.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.28 28.36 36.88 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.953 0.787 . . . . 0.0 113.584 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -135.32 140.53 45.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.136 2.175 . . . . 0.0 106.302 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.53 164.36 36.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 124.233 1.013 . . . . 0.0 109.154 168.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.83 172.97 10.65 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.234 2.623 . . . . 0.0 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.7 t 37.8 41.87 0.37 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.515 1.926 . . . . 0.0 114.163 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.15 46.01 8.02 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.229 1.871 . . . . 0.0 111.942 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 mtt -77.68 141.92 39.11 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -83.74 134.56 34.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.5 m -76.06 116.68 17.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -55.11 164.8 0.79 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.438 0.695 . . . . 0.0 110.586 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.27 -20.89 20.61 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.929 166.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.33 2.44 56.38 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.224 2.21 . . . . 0.0 111.972 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.03 9.32 66.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.134 0.874 . . . . 0.0 114.002 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -91.73 -173.64 3.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 166.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 151.52 27.2 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.617 1.099 . . . . 0.0 113.745 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.1 148.59 6.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 106.686 -2.566 . . . . 0.0 106.686 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -82.77 66.38 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.054 -0.674 . . . . 0.0 110.191 -170.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.89 165.23 37.51 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.406 -0.902 . . . . 0.0 114.684 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.34 -29.93 18.84 Favored 'Trans proline' 0 C--N 1.351 0.664 1 C-N-CA 125.856 4.371 . . . . 0.0 115.051 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.2 -44.29 32.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -92.79 -60.66 1.76 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.21 -27.09 68.18 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.584 1.954 . . . . 0.0 114.024 -165.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.84 159.19 18.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 126.349 1.86 . . . . 0.0 112.477 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.616 -0.706 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.35 -61.06 0.25 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 11.4 tm-20 101.97 123.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 128.305 2.642 . . . . 0.0 107.181 -170.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.5 147.45 44.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.147 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.34 59.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? 53.64 55.59 8.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 112.385 -2.188 . . . . 0.0 111.453 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.61 11.85 32.01 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.822 1.677 . . . . 0.0 114.242 168.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -137.05 125.55 23.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 126.798 2.039 . . . . 0.0 107.245 -169.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -135.78 163.33 51.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 107.704 167.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.59 175.02 11.51 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.234 1.956 . . . . 0.0 111.349 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t 34.82 53.19 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.85 2.06 . . . . 0.0 113.633 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.96 46.87 40.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.837 1.208 . . . . 0.0 112.224 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -85.81 136.36 33.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.7 m -83.6 140.08 32.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.34 114.89 8.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -57.48 148.8 22.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.903 1.281 . . . . 0.0 111.328 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.4 -27.96 4.62 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.836 167.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.93 7.55 43.47 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 128.029 2.532 . . . . 0.0 112.579 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 2.73 84.72 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.501 1.048 . . . . 0.0 114.591 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 84.9 m-85 -91.2 -163.38 1.03 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.89 162.81 38.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 120.265 1.393 . . . . 0.0 111.33 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.46 161.21 13.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -83.74 77.51 9.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.23 165.36 37.16 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.623 -0.673 . . . . 0.0 113.319 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.35 -41.19 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.438 3.426 . . . . 0.0 112.149 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -49.35 -32.34 11.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.048 0.939 . . . . 0.0 111.799 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -93.2 -57.71 2.54 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.719 1.208 . . . . 0.0 109.653 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -63.38 -37.69 88.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.604 -170.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 146.92 26.21 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.795 1.188 . . . . 0.0 112.936 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 . . . . . 0 C--O 1.225 -0.205 0 C-N-CA 125.105 1.362 . . . . 0.0 108.395 171.98 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 158.45 -49.95 0.41 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 76.2 mt-10 83.11 118.27 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 126.703 2.001 . . . . 0.0 108.411 -168.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 m -73.4 164.21 26.99 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.6 1.191 . . . . 0.0 110.541 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.12 77.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.768 1.627 . . . . 0.0 107.284 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 58.19 53.5 6.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.884 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.95 28.07 55.14 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -140.15 138.14 34.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.25 2.22 . . . . 0.0 106.697 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 168.91 11.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 125.024 1.33 . . . . 0.0 107.987 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.53 172.5 3.47 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.528 2.152 . . . . 0.0 111.869 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t 32.48 47.51 0.1 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.784 2.434 . . . . 0.0 115.134 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.94 48.0 14.2 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.512 1.529 . . . . 0.0 112.356 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 mmt -73.0 149.44 43.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.7 m -82.33 137.87 34.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 m -73.34 122.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -57.04 157.23 6.04 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.56 -13.12 12.24 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 169.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -92.09 2.26 56.69 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.742 2.417 . . . . 0.0 112.244 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.55 0.51 87.48 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.372 0.987 . . . . 0.0 114.737 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 59.6 m-85 -89.65 -169.33 2.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 167.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 p -159.43 151.49 20.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.471 1.032 . . . . 0.0 113.424 -170.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.3 151.09 9.86 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -82.78 72.04 9.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.76 165.02 32.1 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.784 -1.198 . . . . 0.0 114.981 169.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.71 -35.27 17.08 Favored 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 125.899 4.4 . . . . 0.0 114.584 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.7 -42.12 11.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -93.13 -59.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.57 -29.83 69.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.776 2.03 . . . . 0.0 115.114 -165.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.56 -176.9 37.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.33 0.967 . . . . 0.0 114.353 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 . . . . . 0 CA--C 1.531 0.236 0 C-N-CA 126.181 1.793 . . . . 0.0 110.612 170.448 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.99 58.28 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -164.1 169.32 17.98 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.7 171.13 3.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.591 1.186 . . . . 0.0 108.783 165.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -106.87 100.15 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.167 1.787 . . . . 0.0 106.365 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 51.72 44.64 29.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 110.549 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.45 82.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.734 0.683 . . . . 0.0 113.172 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -141.03 148.42 40.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.78 2.032 . . . . 0.0 107.65 172.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -132.72 163.75 48.61 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.349 1.86 . . . . 0.0 106.644 166.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.62 174.97 9.25 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.281 1.987 . . . . 0.0 110.855 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t 34.65 54.1 0.65 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 127.073 2.149 . . . . 0.0 113.872 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.41 46.28 36.34 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.857 1.217 . . . . 0.0 112.239 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.446 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.7 mmm -90.15 133.77 34.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 168.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.1 m -83.99 134.95 34.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.8 m -67.91 120.47 14.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 165.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.3 p -69.6 163.26 25.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.337 1.055 . . . . 0.0 111.15 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -50.15 -26.41 4.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.434 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.1 -1.41 56.48 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 126.859 2.064 . . . . 0.0 112.828 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.17 6.65 83.54 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.106 0.86 . . . . 0.0 113.974 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -90.36 -160.13 0.67 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.35 158.87 27.63 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.006 1.275 . . . . 0.0 112.989 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.61 157.92 11.98 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.97 77.31 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.53 158.4 27.65 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.382 -1.39 . . . . 0.0 114.914 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.99 -39.69 59.48 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.806 3.671 . . . . 0.0 113.764 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -43.42 -45.89 6.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 110.288 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -90.54 -55.17 3.69 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.286 1.034 . . . . 0.0 109.192 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t -71.34 37.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.558 3.543 . . . . 0.0 113.475 -168.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.24 -161.74 52.09 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 125.423 1.487 . . . . 0.0 112.157 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? . . . . . 0 C--O 1.226 -0.134 0 C-N-CA 124.123 0.969 . . . . 0.0 108.724 -176.175 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 117.162 -1.399 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.97 -85.17 1.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.45 154.04 2.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.059 2.144 . . . . 0.0 105.478 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -61.14 146.13 48.59 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.54 1.064 . . . . 0.0 109.052 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -89.6 61.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 123.344 1.545 . . . . 0.0 108.33 -171.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? 63.06 53.73 2.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.687 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.33 27.62 54.8 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.762 1.172 . . . . 0.0 113.119 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -135.99 156.31 48.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 128.029 2.531 . . . . 0.0 106.122 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 m -135.87 165.78 33.35 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 127.108 2.163 . . . . 0.0 108.599 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.3 175.13 4.12 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.946 3.097 . . . . 0.0 109.272 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 33.21 48.97 0.18 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.535 2.334 . . . . 0.0 115.159 170.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.06 44.02 5.73 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.675 1.607 . . . . 0.0 112.083 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.1 mtt -85.69 165.01 17.31 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -101.74 133.49 46.38 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.45 106.97 1.89 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -57.54 148.08 24.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.906 0.882 . . . . 0.0 110.569 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -51.93 -25.21 7.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -92.63 7.55 42.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.987 2.515 . . . . 0.0 112.374 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.91 8.83 87.59 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.473 1.511 . . . . 0.0 114.825 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -93.24 -163.82 1.1 Allowed 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.766 1.226 . . . . 0.0 108.828 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.7 t -141.11 138.5 33.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 119.22 0.918 . . . . 0.0 109.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.08 22.19 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -90.24 70.14 7.16 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.635 1.574 . . . . 0.0 110.458 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.82 160.46 33.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.016 -1.087 . . . . 0.0 115.492 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.99 -46.92 29.33 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.787 3.658 . . . . 0.0 114.249 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -48.6 -35.36 13.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.208 1.003 . . . . 0.0 111.933 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -93.43 -51.11 5.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 108.503 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -66.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.304 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.23 -146.46 1.53 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.559 1.552 . . . . 0.0 112.078 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.874 1.27 . . . . 0.0 112.983 169.291 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.307 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.9 61.96 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.099 0.874 . . . . 0.0 113.177 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.64 153.18 10.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -72.93 165.38 25.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.263 1.506 . . . . 0.0 108.981 167.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -85.98 69.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.533 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? 49.78 52.98 13.56 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.195 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.05 25.22 32.27 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 114.351 170.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -139.9 138.94 36.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 128.101 2.56 . . . . 0.0 105.665 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 164.87 35.99 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 124.106 0.963 . . . . 0.0 109.415 168.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.34 174.3 6.12 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.36 2.707 . . . . 0.0 110.281 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t 34.42 51.15 0.44 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.011 2.125 . . . . 0.0 113.866 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.07 46.21 26.77 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.128 1.347 . . . . 0.0 112.247 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -92.4 133.68 35.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.68 140.44 29.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.0 m -71.27 117.71 13.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.877 0.846 . . . . 0.0 110.244 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -55.03 173.07 0.1 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.368 1.467 . . . . 0.0 111.636 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -63.13 -24.24 67.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.574 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -94.66 4.86 53.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.214 2.206 . . . . 0.0 112.823 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.47 11.54 65.15 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.005 0.812 . . . . 0.0 113.677 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -92.07 -164.59 1.2 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 160.11 22.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.105 1.321 . . . . 0.0 113.378 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.08 162.06 25.16 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -83.8 79.15 9.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.24 162.43 35.72 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.288 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.79 -35.58 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.486 3.457 . . . . 0.0 111.687 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -43.72 -41.99 5.14 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.911 1.284 . . . . 0.0 111.113 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -94.44 -50.6 5.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 110.372 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -43.1 99.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.125 -170.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.25 -117.81 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 127.704 2.402 . . . . 0.0 114.33 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.04 -43.56 3.15 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.712 1.148 . . . . 0.0 110.29 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.24 144.73 0.05 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.757 2.423 . . . . 0.0 107.906 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.61 168.79 17.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 123.074 1.416 . . . . 0.0 108.269 166.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.49 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.643 1.687 . . . . 0.0 106.742 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 53.54 53.26 11.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.956 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.77 16.17 49.6 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.047 1.784 . . . . 0.0 115.575 169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.49 147.17 32.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.185 2.594 . . . . 0.0 105.415 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.6 OUTLIER -135.56 168.24 18.44 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 124.654 1.182 . . . . 0.0 108.01 167.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.75 169.94 6.45 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.53 2.153 . . . . 0.0 112.953 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.5 p 32.71 51.33 0.24 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.44 2.296 . . . . 0.0 115.031 169.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.7 47.9 37.2 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.92 1.248 . . . . 0.0 112.5 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 61.2 mtt -78.24 144.03 36.58 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 167.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -84.91 136.44 33.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 m -69.52 139.04 53.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -73.32 -174.19 1.56 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.853 0.835 . . . . 0.0 111.857 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.255 2.0 pm0 -69.43 -28.95 66.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.749 -0.594 . . . . 0.0 111.324 168.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.44 9.26 35.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.518 2.327 . . . . 0.0 111.264 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.27 28.16 70.4 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.372 0.987 . . . . 0.0 112.667 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -90.41 -156.02 0.41 Allowed 'General case' 0 C--N 1.338 0.077 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.79 152.18 13.4 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.93 159.99 23.18 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 107.161 -2.375 . . . . 0.0 107.161 169.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -83.5 79.15 9.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.27 163.49 37.16 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.858 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.48 -35.48 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.455 3.437 . . . . 0.0 111.434 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.29 -39.6 6.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.043 1.337 . . . . 0.0 111.295 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -93.75 -51.8 4.74 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.068 1.347 . . . . 0.0 109.782 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -59.81 -52.76 64.06 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -171.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 133.02 40.29 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? . . . . . 0 CA--C 1.535 0.382 0 O-C-N 121.785 -0.832 . . . . 0.0 110.525 -173.503 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.4 -57.0 12.39 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -174.08 170.54 3.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.401 2.28 . . . . 0.0 104.901 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -64.49 169.83 4.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 122.576 1.179 . . . . 0.0 109.281 166.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -114.17 101.0 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 106.188 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 52.48 45.71 28.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.19 0.596 . . . . 0.0 110.38 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.33 85.67 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.781 1.181 . . . . 0.0 113.168 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -141.45 144.32 34.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.308 2.243 . . . . 0.0 106.293 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.86 19.19 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.807 1.243 . . . . 0.0 108.468 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.75 172.62 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.604 2.203 . . . . 0.0 111.839 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t 33.02 49.0 0.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.74 2.416 . . . . 0.0 115.211 168.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.96 49.18 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.383 1.468 . . . . 0.0 112.276 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 mmt -88.09 135.13 33.56 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -82.65 140.37 33.19 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.1 m -73.63 124.42 25.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 p -59.89 156.66 13.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -56.75 -19.49 17.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -90.06 -7.36 54.05 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 127.002 2.121 . . . . 0.0 112.307 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.12 65.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 115.094 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -92.55 -172.52 3.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.92 150.27 29.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.626 1.103 . . . . 0.0 113.516 -173.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.92 148.62 7.49 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -82.42 74.09 9.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.89 166.99 39.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.393 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.62 -24.68 41.33 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.88 3.72 . . . . 0.0 112.194 -169.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -49.75 -40.39 40.85 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -92.62 -65.86 0.97 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.96 -31.27 70.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.319 1.848 . . . . 0.0 113.696 -165.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.61 161.18 39.74 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 . . . . . 0 CA--C 1.53 0.174 0 C-N-CA 126.511 1.925 . . . . 0.0 110.641 169.77 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 116.977 -1.487 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.99 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -174.96 171.77 3.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.034 2.534 . . . . 0.0 104.856 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.6 m -57.78 155.53 10.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.171 0.986 . . . . 0.0 111.166 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.19 69.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 69.82 51.4 0.44 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.758 2.023 . . . . 0.0 109.184 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.23 26.26 74.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.414 1.007 . . . . 0.0 113.258 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -136.47 124.31 22.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.371 2.268 . . . . 0.0 106.352 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.2 m -106.74 160.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.88 1.272 . . . . 0.0 109.849 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.54 167.49 22.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.998 1.798 . . . . 0.0 111.747 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.8 p 32.68 47.67 0.11 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 127.373 2.269 . . . . 0.0 116.373 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.9 44.7 61.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.732 1.158 . . . . 0.0 112.818 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.32 151.43 25.58 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.5 m -89.86 145.26 25.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -66.43 132.87 49.25 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.674 164.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 33.0 p -61.68 161.23 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.516 -1.274 . . . . 0.0 108.463 168.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -58.57 -19.86 41.82 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.566 -0.709 . . . . 0.0 111.447 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -92.8 6.51 47.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.206 2.602 . . . . 0.0 112.328 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.13 24.0 77.12 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.951 1.262 . . . . 0.0 115.314 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -97.64 -168.51 1.69 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.24 134.81 46.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.512 1.506 . . . . 0.0 111.302 -171.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.55 138.54 4.63 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -84.7 72.02 10.76 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.839 0.856 . . . . 0.0 108.717 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.19 163.71 33.23 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.515 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.35 -39.98 35.72 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 125.131 3.887 . . . . 0.0 114.205 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.97 -35.79 16.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.589 0.756 . . . . 0.0 111.436 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 23.7 m-85 -94.98 -57.14 2.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -28.91 67.96 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.622 0.769 . . . . 0.0 112.732 -166.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.42 141.75 16.54 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 168.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? . . . . . 0 C--N 1.332 -0.163 0 O-C-N 121.958 -0.731 . . . . 0.0 110.553 -177.878 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.27 92.18 0.43 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -171.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -53.65 115.9 2.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m -67.54 157.65 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.395 1.569 . . . . 0.0 111.322 -170.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.29 66.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.163 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 59.59 54.56 4.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.787 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.96 23.45 45.37 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 167.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm-85 -139.57 141.45 37.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.545 2.338 . . . . 0.0 106.005 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 169.57 10.14 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.556 1.142 . . . . 0.0 109.57 168.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.99 171.57 5.95 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.842 2.361 . . . . 0.0 112.017 173.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t 34.23 44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.69 2.396 . . . . 0.0 114.942 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.63 46.62 18.14 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.865 1.697 . . . . 0.0 112.043 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.6 mtt -78.41 142.57 37.48 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 167.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.5 m -83.64 145.81 28.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.2 m -75.05 154.12 38.11 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p -89.61 170.39 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -56.79 -24.82 53.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.795 -0.565 . . . . 0.0 111.514 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -92.11 5.36 50.57 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 127.834 2.453 . . . . 0.0 111.996 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.17 71.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.651 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -91.11 -172.63 3.38 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 166.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.0 154.11 36.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 147.08 7.56 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -81.85 72.16 8.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.55 161.27 32.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.817 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.04 -35.98 34.03 Favored 'Trans proline' 0 C--N 1.351 0.658 1 C-N-CA 125.431 4.087 . . . . 0.0 114.489 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -49.59 -37.97 29.75 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.97 -59.5 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.29 -33.24 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.84 1.256 . . . . 0.0 114.331 -166.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.66 155.53 24.61 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.436 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 126.477 1.911 . . . . 0.0 114.979 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 116.583 -1.675 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.41 81.41 0.51 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 121.204 1.82 . . . . 0.0 110.607 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 116.42 1.4 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m -61.79 165.55 5.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.984 1.373 . . . . 0.0 111.143 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.75 101.18 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 127.155 2.182 . . . . 0.0 105.64 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.3 44.57 28.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.675 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.57 36.05 92.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.571 0.605 . . . . 0.0 112.899 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -139.16 146.34 40.48 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.482 1.913 . . . . 0.0 107.959 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -130.7 166.35 27.89 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 126.9 2.08 . . . . 0.0 107.063 167.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.77 164.19 19.5 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.372 2.048 . . . . 0.0 113.294 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.5 p 42.15 36.92 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.943 2.097 . . . . 0.0 115.59 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.27 41.14 46.78 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.611 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 50.3 mtt -59.77 146.83 40.18 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 166.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -83.42 133.25 34.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.42 135.32 51.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.1 p -69.52 -166.13 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.041 2.136 . . . . 0.0 111.514 -170.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -87.47 -11.61 48.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 110.739 166.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.0 17.51 14.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.077 2.151 . . . . 0.0 112.704 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 -0.13 30.6 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.761 1.172 . . . . 0.0 114.723 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -90.05 -159.24 0.58 Allowed 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.27 173.5 14.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.106 0.867 . . . . 0.0 112.221 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.53 154.58 8.41 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -83.8 65.45 8.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.634 0.774 . . . . 0.0 109.17 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.98 159.86 32.59 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.269 -0.967 . . . . 0.0 114.75 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.36 -42.2 41.44 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 125.297 3.998 . . . . 0.0 114.775 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -48.64 -38.98 22.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.399 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -93.21 -51.13 5.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.375 1.083 . . . . 0.0 108.909 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -59.02 -52.28 66.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.861 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.33 -139.24 7.09 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.13 0.872 . . . . 0.0 112.459 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 126.648 1.979 . . . . 0.0 113.853 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.95 -87.23 1.49 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.62 166.97 3.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.742 2.417 . . . . 0.0 105.11 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -53.84 166.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.494 1.616 . . . . 0.0 112.221 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.25 59.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 123.876 1.798 . . . . 0.0 108.41 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? 58.88 54.65 5.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.194 -2.276 . . . . 0.0 110.124 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.5 25.02 34.28 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.407 1.003 . . . . 0.0 113.659 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -144.9 136.21 25.15 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.874 2.47 . . . . 0.0 107.249 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.89 166.28 28.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 109.201 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.82 164.8 17.81 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.7 2.266 . . . . 0.0 112.452 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p 34.96 38.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.85 2.46 . . . . 0.0 115.751 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.85 43.04 30.1 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.345 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mmm -62.01 138.95 58.44 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 167.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.94 136.39 35.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.2 m -64.55 138.77 58.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 t -69.06 -169.99 0.22 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.058 1.343 . . . . 0.0 112.12 -168.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -87.5 -27.13 22.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.567 162.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.57 14.39 24.9 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 128.412 2.685 . . . . 0.0 112.309 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.46 4.55 65.19 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.559 1.552 . . . . 0.0 114.727 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -88.94 -154.55 0.3 Allowed 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.097 1.359 . . . . 0.0 107.758 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -155.31 147.52 23.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.479 1.036 . . . . 0.0 112.422 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.99 137.53 3.9 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -83.16 64.92 7.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.917 -0.755 . . . . 0.0 109.397 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.12 161.89 34.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.121 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.06 -45.31 21.59 Favored 'Trans proline' 0 C--N 1.349 0.593 1 C-N-CA 125.323 4.016 . . . . 0.0 115.088 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -50.22 -33.78 20.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.788 0.835 . . . . 0.0 111.747 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.4 -52.06 4.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.122 0.969 . . . . 0.0 109.105 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -60.98 -39.82 91.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.626 -168.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.42 -128.04 10.33 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.768 0.699 . . . . 0.0 112.253 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.409 ' HD3' ' H ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.023 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.16 31.43 80.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.642 0.589 . . . . 0.0 113.608 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.08 134.69 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.135 1.374 . . . . 0.0 112.561 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.87 156.34 37.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 123.544 1.64 . . . . 0.0 110.594 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.41 61.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.262 -169.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 63.24 53.98 2.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.896 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.11 41.56 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.417 1.008 . . . . 0.0 113.402 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -141.94 130.61 22.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 107.707 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.77 166.87 25.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.167 1.387 . . . . 0.0 108.492 166.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.56 170.33 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.799 2.333 . . . . 0.0 112.661 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p 33.87 46.16 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.658 2.383 . . . . 0.0 115.403 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.9 48.45 9.34 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.37 1.462 . . . . 0.0 112.031 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.2 151.12 46.93 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -82.69 134.33 35.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -74.1 116.43 14.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.2 p -56.28 162.04 2.24 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.178 0.514 . . . . 0.0 111.045 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -53.02 -23.9 8.47 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.756 165.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -94.33 1.76 55.88 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 128.609 2.763 . . . . 0.0 113.406 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.57 2.18 84.37 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.252 0.93 . . . . 0.0 115.367 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.77 -164.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.42 146.62 21.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.792 1.178 . . . . 0.0 113.115 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.18 145.65 6.08 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -83.63 65.56 8.54 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.048 -0.677 . . . . 0.0 110.084 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.41 165.23 36.02 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.216 -0.992 . . . . 0.0 114.935 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.36 -39.37 27.89 Favored 'Trans proline' 0 C--N 1.349 0.582 1 C-N-CA 125.454 4.102 . . . . 0.0 114.478 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -51.21 -32.57 24.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.0 0.52 . . . . 0.0 111.629 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -94.23 -60.13 1.8 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.36 -42.22 95.33 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 125.874 1.67 . . . . 0.0 113.114 -165.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.72 -119.92 6.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.12 0.844 . . . . 0.0 112.749 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 126.206 1.802 . . . . 0.0 110.877 -175.901 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 117.048 -1.453 . . . . 0.0 107.356 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.97 -64.29 3.22 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -178.05 169.03 1.98 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m -63.23 147.36 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.511 0.672 . . . . 0.0 109.856 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.04 67.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.556 1.646 . . . . 0.0 106.838 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 47.83 51.64 13.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.633 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.07 29.8 10.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.949 1.737 . . . . 0.0 113.792 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -141.86 128.44 20.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.733 2.013 . . . . 0.0 106.804 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.49 164.33 42.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.2 1.0 . . . . 0.0 109.059 166.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -65.03 171.33 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.431 2.087 . . . . 0.0 112.602 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p 40.54 43.74 1.61 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.967 1.707 . . . . 0.0 115.32 169.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.38 47.55 28.27 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.818 1.199 . . . . 0.0 112.152 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 60.9 mtt -71.46 148.8 46.48 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.6 m -83.71 136.98 33.98 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 170.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -73.06 138.27 45.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 166.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -69.81 -166.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 123.037 1.399 . . . . 0.0 109.576 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -102.44 -22.15 14.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.36 1.864 . . . . 0.0 107.855 162.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.12 9.63 37.0 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 127.777 2.431 . . . . 0.0 112.253 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.92 83.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.525 1.536 . . . . 0.0 115.0 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.54 -169.1 2.12 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.0 p -157.89 155.43 29.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 109.971 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.0 152.37 8.16 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -83.22 77.57 9.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.26 162.08 33.2 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.14 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.59 -42.41 29.36 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 125.179 3.92 . . . . 0.0 114.076 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -50.59 -31.67 16.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.072 0.949 . . . . 0.0 111.592 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.97 -56.4 2.88 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.759 0.824 . . . . 0.0 109.185 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 m -57.11 -35.82 69.91 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.723 0.809 . . . . 0.0 111.516 -167.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.69 143.06 5.18 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? . . . . . 0 CA--C 1.53 0.183 0 CA-C-N 117.658 0.729 . . . . 0.0 110.646 179.862 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.01 -41.58 3.09 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.45 172.58 8.17 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 129.851 3.261 . . . . 0.0 104.373 169.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.83 170.17 15.25 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.993 1.378 . . . . 0.0 107.776 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.95 81.13 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 52.61 51.1 16.75 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.63 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.73 27.24 73.51 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.611 0.625 . . . . 0.0 113.354 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -145.34 152.67 40.25 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.2 2.6 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.47 165.37 34.75 Favored Pre-proline 0 C--N 1.325 -0.468 0 C-N-CA 123.614 0.766 . . . . 0.0 109.63 167.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.2 170.96 17.82 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.735 2.29 . . . . 0.0 109.641 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.0 p 43.52 35.29 0.93 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.08 1.752 . . . . 0.0 114.688 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.45 48.01 5.75 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 126.204 1.859 . . . . 0.0 111.527 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.32 142.43 47.11 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 168.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.6 m -83.22 139.36 33.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.21 127.97 34.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 t -62.52 170.76 2.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.465 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.26 -28.83 69.98 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -93.58 8.23 41.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.037 2.535 . . . . 0.0 112.335 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.42 77.9 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.122 0.868 . . . . 0.0 114.636 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.18 -153.17 0.26 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.9 149.77 23.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.552 1.069 . . . . 0.0 112.557 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.14 138.02 2.66 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -83.95 72.64 10.42 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.765 -0.844 . . . . 0.0 110.366 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.01 162.72 34.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.297 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.07 -49.58 11.11 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.0 3.8 . . . . 0.0 114.343 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -53.18 -29.95 34.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.848 0.859 . . . . 0.0 112.371 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -94.98 -48.28 6.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.3 m -60.56 -60.36 3.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.841 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.5 -132.36 3.66 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.12 1.343 . . . . 0.0 111.391 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 110.815 167.811 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.67 -72.4 0.15 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 122.23 126.93 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 129.94 3.296 . . . . 0.0 107.086 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -74.64 144.59 43.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.028 0.918 . . . . 0.0 110.175 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.87 73.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 59.58 54.68 4.41 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.067 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.88 15.62 77.07 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.449 1.023 . . . . 0.0 115.086 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -137.52 136.96 38.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.5 m -121.11 160.21 46.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.86 1.264 . . . . 0.0 110.199 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.78 169.22 19.45 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.443 2.095 . . . . 0.0 112.097 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t 33.61 47.26 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.645 2.378 . . . . 0.0 115.524 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.57 40.5 55.18 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.798 1.189 . . . . 0.0 112.795 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.86 149.13 28.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 166.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -83.34 137.8 33.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.8 t -72.35 114.06 10.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -62.0 151.39 35.28 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.009 1.724 . . . . 0.0 110.944 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.45 -28.08 18.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 168.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -93.73 9.18 38.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.037 2.535 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.48 8.05 83.5 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.786 1.184 . . . . 0.0 114.972 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.07 -167.69 1.78 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 124.612 1.165 . . . . 0.0 109.638 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.0 m -127.36 145.87 50.66 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.059 -1.026 . . . . 0.0 109.604 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.67 144.64 4.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 165.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -83.83 67.44 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.482 1.113 . . . . 0.0 108.12 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.16 164.83 35.67 Favored Glycine 0 CA--C 1.528 0.901 0 O-C-N 122.145 -0.347 . . . . 0.0 113.077 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -66.76 -42.96 7.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.686 3.59 . . . . 0.0 113.312 -167.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -49.53 -33.4 14.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.913 0.885 . . . . 0.0 111.903 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.02 -54.63 3.65 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.958 1.303 . . . . 0.0 108.901 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -60.66 -52.01 66.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.12 -136.0 6.95 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.187 0.899 . . . . 0.0 112.11 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 126.352 1.861 . . . . 0.0 112.306 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 117.041 -1.456 . . . . 0.0 107.468 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.09 -56.61 15.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.74 178.48 7.84 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.916 2.087 . . . . 0.0 105.537 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.8 160.49 5.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.158 0.98 . . . . 0.0 111.835 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.32 97.49 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 49.4 45.56 23.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.552 0.741 . . . . 0.0 110.671 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.21 68.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.314 1.435 . . . . 0.0 114.078 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -132.25 160.78 35.17 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 127.392 2.277 . . . . 0.0 105.698 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -137.2 161.52 60.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 C-N-CA 125.669 1.587 . . . . 0.0 109.414 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.58 168.28 18.65 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.222 1.948 . . . . 0.0 111.938 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t 31.87 49.53 0.13 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.998 2.519 . . . . 0.0 115.251 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.22 44.3 51.73 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.214 0.911 . . . . 0.0 112.86 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.82 153.06 26.62 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 166.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.03 134.82 35.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -72.7 107.23 5.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 165.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p -54.47 156.57 3.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.383 1.473 . . . . 0.0 110.003 -170.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -56.53 -23.61 40.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 170.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.82 11.56 31.13 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.465 2.306 . . . . 0.0 112.281 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.0 84.97 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.244 1.402 . . . . 0.0 114.494 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -113.32 -169.97 1.6 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.468 1.907 . . . . 0.0 107.378 169.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -126.58 136.34 52.42 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 120.197 1.362 . . . . 0.0 110.198 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.92 142.77 5.28 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 166.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -83.8 68.32 9.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.02 168.33 41.1 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.911 -1.138 . . . . 0.0 114.531 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.31 -35.18 32.76 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.549 3.499 . . . . 0.0 111.771 -169.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -49.68 -34.78 19.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.68 0.392 . . . . 0.0 111.436 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -94.65 -60.34 1.73 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.0 109.945 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -73.39 -38.89 65.48 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.418 1.887 . . . . 0.0 113.747 -168.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.99 123.14 1.21 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 126.792 2.139 . . . . 0.0 113.44 -167.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 126.06 1.744 . . . . 0.0 108.911 178.599 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.57 -54.67 14.5 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 124.408 1.068 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.39 172.07 3.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -57.15 153.34 11.91 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.612 1.196 . . . . 0.0 110.643 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -83.79 75.4 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 mmt-85 49.94 51.22 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.711 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 4.78 72.86 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.818 1.199 . . . . 0.0 114.702 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -132.75 165.79 23.72 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.07 167.83 18.53 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.184 . . . . 0.0 109.133 167.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -68.1 175.03 7.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.027 2.485 . . . . 0.0 112.69 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 32.19 55.22 0.34 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.501 2.32 . . . . 0.0 115.335 166.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.46 44.21 36.28 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.726 1.155 . . . . 0.0 112.35 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.0 mmt -91.77 134.85 34.37 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.8 m -81.66 133.31 35.35 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.8 t -74.13 114.2 12.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.5 p -60.36 154.95 19.05 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.57 -16.34 24.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 167.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.66 3.63 55.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.931 2.492 . . . . 0.0 112.95 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.0 90.52 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -96.28 -170.85 2.17 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -156.51 157.16 34.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.237 1.38 . . . . 0.0 112.483 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.76 155.9 8.7 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -84.08 79.05 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.036 0.935 . . . . 0.0 109.047 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.3 171.05 38.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.986 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.36 -25.5 10.22 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 126.079 4.52 . . . . 0.0 115.165 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -51.04 -54.86 20.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.653 -0.655 . . . . 0.0 109.593 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.86 -66.19 0.95 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.533 -0.729 . . . . 0.0 109.236 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.5 -127.43 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.52 1.057 . . . . 0.0 111.79 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.509 ' H ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 125.272 1.429 . . . . 0.0 112.552 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 117.075 -1.44 . . . . 0.0 107.402 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.77 -84.13 0.59 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 170.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -155.3 174.11 15.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 170.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.59 165.36 14.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 122.653 1.216 . . . . 0.0 109.549 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.46 92.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.933 2.093 . . . . 0.0 106.656 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 49.24 52.14 14.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.45 0.643 . . . . 0.0 110.015 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.16 31.62 66.29 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.972 1.273 . . . . 0.0 113.686 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -141.74 139.82 32.96 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.749 2.02 . . . . 0.0 107.185 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.23 168.94 14.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 125.432 1.493 . . . . 0.0 108.502 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.82 169.38 5.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.543 2.162 . . . . 0.0 112.746 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.4 p 33.08 49.22 0.17 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.562 2.345 . . . . 0.0 115.078 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.29 48.08 27.22 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.313 1.435 . . . . 0.0 112.465 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.7 mtt -75.81 145.79 40.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.4 m -83.98 139.25 32.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 m -75.42 125.13 28.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 p -63.06 159.94 16.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.24 -20.72 29.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -91.58 2.96 56.09 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 127.54 2.336 . . . . 0.0 111.858 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.71 6.78 85.42 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.332 0.968 . . . . 0.0 114.655 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.89 -167.15 1.67 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -158.55 152.82 24.09 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.466 1.03 . . . . 0.0 112.928 -172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.14 149.65 7.9 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -82.55 72.27 9.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.32 160.39 33.16 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 119.964 -1.112 . . . . 0.0 114.307 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.16 -40.75 42.26 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.052 3.835 . . . . 0.0 113.942 -176.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -49.73 -34.53 19.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.881 0.872 . . . . 0.0 111.391 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.44 -60.15 1.78 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -58.4 -51.79 68.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.124 -165.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.3 -17.99 0.02 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 129.148 3.261 . . . . 0.0 120.477 168.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 . . . . . 0 C--N 1.317 -0.831 0 C-N-CA 127.95 2.5 . . . . 0.0 109.636 -172.84 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.81 -52.5 0.83 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 32.7 tt0 105.34 135.85 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 128.653 2.781 . . . . 0.0 108.651 -171.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.93 148.59 49.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 122.039 0.923 . . . . 0.0 109.232 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -84.94 67.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.69 53.18 8.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.137 2.575 . . . . 0.0 110.103 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.76 -10.24 30.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.875 2.655 . . . . 0.0 113.793 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.4 mtt85 -106.93 110.84 23.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.0 m -113.51 157.95 39.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.703 1.601 . . . . 0.0 109.567 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.87 170.55 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.909 2.406 . . . . 0.0 111.024 -171.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p 43.41 42.69 3.94 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.837 1.655 . . . . 0.0 114.941 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.56 42.96 27.91 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.918 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -82.7 151.03 26.4 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 167.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.1 m -91.12 138.09 31.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.19 116.49 13.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.5 p -68.64 -177.46 0.97 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.006 1.722 . . . . 0.0 113.295 -169.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.32 -26.06 61.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 167.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.54 8.41 42.29 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.645 2.378 . . . . 0.0 112.403 -173.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.24 13.32 57.74 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.679 1.133 . . . . 0.0 114.055 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 31.9 m-85 -94.77 -175.93 3.72 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.191 1.396 . . . . 0.0 109.41 168.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.7 m -127.17 137.06 52.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 109.278 -170.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 146.36 7.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.66 75.99 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.98 155.81 27.31 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 120.493 -0.861 . . . . 0.0 114.159 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.98 -46.38 28.26 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.108 3.872 . . . . 0.0 115.127 -169.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -51.23 -31.77 21.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.756 0.823 . . . . 0.0 111.68 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -95.73 -53.7 3.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.558 1.143 . . . . 0.0 108.562 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -23.69 66.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -170.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.9 163.98 1.96 Allowed Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 168.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.466 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 0.0 115.532 -169.021 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.96 -52.14 0.78 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 80.27 119.61 0.05 Allowed 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.565 2.346 . . . . 0.0 109.461 -174.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 m -73.84 157.17 36.85 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 123.134 1.445 . . . . 0.0 111.304 -177.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.26 78.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 127.03 2.132 . . . . 0.0 106.243 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 46.97 50.42 13.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.219 -1.81 . . . . 0.0 110.225 -172.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.45 23.53 12.37 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.443 1.497 . . . . 0.0 114.928 172.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -138.41 118.14 13.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.604 1.962 . . . . 0.0 109.305 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -124.32 162.93 39.26 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 166.06 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.23 170.54 7.67 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.594 2.196 . . . . 0.0 112.627 -178.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.2 p 42.23 39.58 1.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.232 1.813 . . . . 0.0 115.481 171.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.84 48.81 9.21 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.656 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 55.7 mtt -64.19 150.6 45.43 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -83.69 136.37 34.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.0 m -69.82 138.38 52.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.463 ' C ' HH22 ' A' ' 30' ' ' ARG . 79.2 p -73.33 -168.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.594 0.712 . . . . 0.0 109.787 -173.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 -7.19 26.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.355 0.662 . . . . 0.0 110.418 165.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.93 1.65 55.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.845 2.458 . . . . 0.0 112.494 -176.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.97 4.63 72.7 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.022 1.296 . . . . 0.0 113.763 -169.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -93.95 -158.83 0.65 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.38 165.11 29.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.655 0.782 . . . . 0.0 110.834 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.05 152.17 6.93 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -83.51 65.73 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.098 -0.648 . . . . 0.0 109.915 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.89 160.8 33.93 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.514 -0.85 . . . . 0.0 114.38 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.65 -41.87 37.01 Favored 'Trans proline' 0 C--N 1.35 0.64 1 C-N-CA 125.361 4.041 . . . . 0.0 114.611 -174.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -50.8 -33.55 23.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 111.582 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -94.93 -54.36 3.49 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.531 0.732 . . . . 0.0 109.772 173.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -58.76 -32.59 69.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 112.679 -167.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.67 143.85 6.11 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 168.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.463 HH22 ' C ' ' A' ' 16' ' ' SER . 6.8 mmp_? . . . . . 0 CA--C 1.532 0.255 0 O-C-N 122.11 -0.641 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 117.654 -1.165 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.19 89.65 0.72 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 172.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -44.69 119.13 1.81 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.129 1.372 . . . . 0.0 109.186 172.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.42 163.62 0.16 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.284 1.434 . . . . 0.0 112.131 -169.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -86.21 59.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 124.05 1.881 . . . . 0.0 108.059 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.454 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 3.4 mmp_? 57.85 54.98 5.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.043 -169.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.69 25.0 36.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.427 1.489 . . . . 0.0 115.093 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -138.13 146.97 43.45 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 127.757 2.423 . . . . 0.0 105.201 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.4 m -129.24 163.4 46.36 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 125.888 1.675 . . . . 0.0 110.199 -176.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.62 172.44 3.96 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.25 2.633 . . . . 0.0 110.3 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 42.6 41.84 2.56 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.139 1.776 . . . . 0.0 115.215 171.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.89 45.05 18.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.018 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mtt -84.92 157.14 20.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 167.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -98.07 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.35 117.58 9.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.155 163.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.503 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 9.4 p -50.86 154.52 1.42 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 168.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -59.04 -16.42 18.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.773 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.26 4.32 53.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.915 2.886 . . . . 0.0 112.498 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 9.3 86.97 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.455 1.502 . . . . 0.0 116.031 169.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.24 178.95 5.57 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 118.479 1.14 . . . . 0.0 108.91 168.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.7 m -112.8 138.18 50.02 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.896 -174.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.76 138.0 4.48 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -84.22 75.27 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.94 162.62 32.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.856 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.44 -41.17 44.32 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.834 3.69 . . . . 0.0 113.763 -176.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -49.83 -33.5 17.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.539 0.735 . . . . 0.0 111.652 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 14.0 m-85 -96.22 -60.35 1.64 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -27.32 67.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.573 -166.463 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.11 139.8 10.41 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 167.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 109.182 177.146 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.74 -43.9 2.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -176.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -178.96 170.89 1.44 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.138 2.575 . . . . 0.0 106.076 174.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 m -73.89 163.28 28.13 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 165.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.12 80.11 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -176.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 68.04 50.06 0.83 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.751 2.42 . . . . 0.0 109.799 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.77 10.44 50.26 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -141.65 167.54 21.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.719 2.808 . . . . 0.0 104.585 173.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.7 167.22 20.29 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 124.752 1.221 . . . . 0.0 108.844 169.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.78 174.91 11.87 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.429 2.086 . . . . 0.0 110.773 -171.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p 46.92 39.95 8.39 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.884 1.674 . . . . 0.0 114.322 178.327 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.19 44.89 27.25 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.974 -175.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -70.62 148.98 47.51 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.07 133.69 34.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.12 114.87 10.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 164.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 p -63.01 179.94 0.34 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.779 1.632 . . . . 0.0 112.959 -166.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -78.67 -16.37 57.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.767 1.627 . . . . 0.0 111.857 167.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -96.77 5.54 50.41 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.117 2.167 . . . . 0.0 112.885 -178.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 6.87 43.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.254 0.93 . . . . 0.0 114.076 -171.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.9 -165.05 1.26 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 167.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.26 153.83 28.15 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 110.156 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.61 158.02 17.59 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -84.97 69.08 10.76 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.245 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.4 162.18 33.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.865 170.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -50.09 -39.36 51.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 125.14 3.893 . . . . 0.0 113.817 -178.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -48.0 -39.1 18.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.998 178.29 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.17 -54.54 3.9 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 t -59.23 -47.05 86.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.133 -167.332 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.33 -132.82 0.44 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 127.829 2.633 . . . . 0.0 115.018 169.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.001 0.92 . . . . 0.0 111.354 -178.233 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.82 -50.36 3.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 103.487 -3.845 . . . . 0.0 103.487 -162.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.39 -179.67 6.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.517 3.127 . . . . 0.0 105.506 165.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -68.94 159.93 31.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.272 1.029 . . . . 0.0 111.159 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.13 97.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 47.89 45.94 18.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.74 0.816 . . . . 0.0 110.682 -174.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.15 13.24 72.94 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.078 -0.846 . . . . 0.0 114.751 175.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.22 173.01 12.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.022 2.129 . . . . 0.0 108.394 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.01 167.63 18.49 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 125.487 1.515 . . . . 0.0 108.157 165.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -61.64 174.72 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.035 3.157 . . . . 0.0 113.288 -178.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.9 p 46.15 41.61 8.82 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.842 1.657 . . . . 0.0 114.403 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.84 45.32 25.15 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.873 -175.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.8 mtt -69.67 156.03 39.59 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.07 151.34 21.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -93.12 114.29 26.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.0 p -59.3 161.52 5.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.022 0.529 . . . . 0.0 111.09 -171.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.86 -24.6 37.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.343 167.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.17 3.83 54.49 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.742 2.417 . . . . 0.0 112.313 -174.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 6.01 83.77 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.861 -0.966 . . . . 0.0 115.145 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -94.78 -171.47 2.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 164.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 150.8 36.44 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.659 1.118 . . . . 0.0 112.086 -173.175 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.72 153.88 10.14 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -88.46 68.9 8.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.334 1.053 . . . . 0.0 109.705 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.86 44.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 119.561 -1.304 . . . . 0.0 115.007 175.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.58 -19.7 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.048 3.832 . . . . 0.0 112.186 -171.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -53.85 -43.7 69.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -91.49 -63.62 1.23 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -65.91 0.62 Allowed 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 124.824 1.328 . . . . 0.0 109.788 -167.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 30.33 -118.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.41 1.957 . . . . 0.0 114.749 168.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.509 0 C-N-CA 126.256 1.822 . . . . 0.0 109.871 -177.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.94 -88.29 1.05 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 175.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -152.28 174.67 13.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.3 m -61.99 147.77 45.98 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -86.38 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 123.673 1.701 . . . . 0.0 106.468 174.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? 49.64 53.54 12.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 111.776 -2.466 . . . . 0.0 110.83 -174.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.93 31.72 7.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.435 1.969 . . . . 0.0 113.408 172.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -139.06 123.49 18.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.27 2.228 . . . . 0.0 105.155 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -129.49 159.75 67.82 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.724 1.21 . . . . 0.0 109.578 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.25 168.95 21.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.416 2.077 . . . . 0.0 111.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 32.21 51.21 0.2 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.787 2.435 . . . . 0.0 115.127 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.81 45.29 8.94 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.824 1.202 . . . . 0.0 111.959 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -82.51 151.01 26.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 169.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.0 m -84.58 134.97 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -68.75 109.55 3.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.85 155.19 10.81 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.812 0.845 . . . . 0.0 111.304 -170.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -52.55 -26.48 13.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 168.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.01 1.1 57.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.89 2.476 . . . . 0.0 112.52 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.67 16.02 79.87 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.35 1.452 . . . . 0.0 114.782 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -94.77 -164.48 1.17 Allowed 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -136.6 132.22 34.81 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.36 -0.837 . . . . 0.0 109.069 -172.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.33 147.27 8.16 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 168.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -83.34 70.6 10.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 108.616 -178.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.32 164.59 33.49 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 122.077 -0.39 . . . . 0.0 113.318 177.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.97 -41.95 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.674 3.582 . . . . 0.0 112.914 -167.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -47.82 -34.96 9.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.424 1.09 . . . . 0.0 111.672 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -93.34 -52.08 4.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.123 1.369 . . . . 0.0 108.756 -176.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -53.13 61.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.821 -174.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.92 -134.79 9.2 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.181 0.896 . . . . 0.0 111.912 175.532 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 127.294 2.237 . . . . 0.0 114.041 169.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.91 -57.92 1.46 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 171.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -166.76 172.07 10.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 m -58.25 153.17 15.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.245 1.021 . . . . 0.0 110.923 175.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.51 99.97 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 127.025 2.13 . . . . 0.0 105.996 175.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 49.08 44.63 22.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.888 0.875 . . . . 0.0 111.374 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.33 73.65 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.779 0.705 . . . . 0.0 114.019 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -136.59 171.58 14.28 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 127.409 2.283 . . . . 0.0 105.617 171.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.15 167.97 17.91 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.794 0.837 . . . . 0.0 109.437 168.16 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.19 172.37 5.21 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.839 2.359 . . . . 0.0 112.1 176.493 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.8 p 43.48 42.19 3.77 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.077 1.751 . . . . 0.0 114.863 171.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.59 16.07 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.427 1.489 . . . . 0.0 111.867 -177.097 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.58 133.91 33.68 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -84.89 142.11 29.93 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.26 122.12 22.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 109.843 174.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.0 p -60.32 -177.55 0.07 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.667 1.187 . . . . 0.0 111.546 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -81.3 -21.44 39.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.949 0.9 . . . . 0.0 110.727 166.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.68 7.28 46.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.472 2.309 . . . . 0.0 112.456 -172.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.29 9.1 76.67 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.548 1.071 . . . . 0.0 114.19 -178.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -98.55 -167.93 1.57 Allowed 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 166.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -160.47 158.96 30.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.962 1.255 . . . . 0.0 111.384 -172.274 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.8 152.52 8.21 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -82.82 76.15 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.68 161.43 31.81 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.873 172.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.81 -36.05 19.58 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.633 3.555 . . . . 0.0 111.698 -168.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -46.22 -42.58 14.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.882 0.873 . . . . 0.0 111.102 174.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.16 -44.69 7.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.018 1.327 . . . . 0.0 110.695 -172.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -50.91 71.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.229 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.35 -130.12 5.88 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.95 1.262 . . . . 0.0 112.307 170.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.292 1.037 . . . . 0.0 111.533 169.269 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.234 0.277 0 CA-C-O 123.386 1.565 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.23 69.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 48.46 51.94 14.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 112.691 -2.049 . . . . 0.0 110.649 -173.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.28 28.36 36.88 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.953 0.787 . . . . 0.0 113.584 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -135.32 140.53 45.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.136 2.175 . . . . 0.0 106.302 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.53 164.36 36.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 124.233 1.013 . . . . 0.0 109.154 168.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.83 172.97 10.65 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.234 2.623 . . . . 0.0 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.7 t 37.8 41.87 0.37 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.515 1.926 . . . . 0.0 114.163 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.15 46.01 8.02 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.229 1.871 . . . . 0.0 111.942 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 mtt -77.68 141.92 39.11 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -83.74 134.56 34.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.5 m -76.06 116.68 17.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -55.11 164.8 0.79 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.438 0.695 . . . . 0.0 110.586 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.27 -20.89 20.61 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.929 166.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.33 2.44 56.38 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.224 2.21 . . . . 0.0 111.972 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.03 9.32 66.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.134 0.874 . . . . 0.0 114.002 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -91.73 -173.64 3.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 166.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 151.52 27.2 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.617 1.099 . . . . 0.0 113.745 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.1 148.59 6.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 106.686 -2.566 . . . . 0.0 106.686 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -82.77 66.38 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.054 -0.674 . . . . 0.0 110.191 -170.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.89 165.23 37.51 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.406 -0.902 . . . . 0.0 114.684 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.34 -29.93 18.84 Favored 'Trans proline' 0 C--N 1.351 0.664 1 C-N-CA 125.856 4.371 . . . . 0.0 115.051 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.2 -44.29 32.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -92.79 -60.66 1.76 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.332 -0.176 0 C-N-CA 126.584 1.954 . . . . 0.0 114.024 -165.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.34 59.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? 53.64 55.59 8.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 112.385 -2.188 . . . . 0.0 111.453 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.61 11.85 32.01 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.822 1.677 . . . . 0.0 114.242 168.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -137.05 125.55 23.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 126.798 2.039 . . . . 0.0 107.245 -169.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -135.78 163.33 51.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 107.704 167.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.59 175.02 11.51 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.234 1.956 . . . . 0.0 111.349 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t 34.82 53.19 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.85 2.06 . . . . 0.0 113.633 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.96 46.87 40.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.837 1.208 . . . . 0.0 112.224 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -85.81 136.36 33.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.7 m -83.6 140.08 32.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.34 114.89 8.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -57.48 148.8 22.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.903 1.281 . . . . 0.0 111.328 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.4 -27.96 4.62 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.836 167.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.93 7.55 43.47 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 128.029 2.532 . . . . 0.0 112.579 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 2.73 84.72 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.501 1.048 . . . . 0.0 114.591 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -91.2 -163.38 1.03 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.89 162.81 38.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 120.265 1.393 . . . . 0.0 111.33 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.46 161.21 13.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -83.74 77.51 9.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.23 165.36 37.16 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.623 -0.673 . . . . 0.0 113.319 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.35 -41.19 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.438 3.426 . . . . 0.0 112.149 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -49.35 -32.34 11.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.048 0.939 . . . . 0.0 111.799 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -93.2 -57.71 2.54 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.719 1.208 . . . . 0.0 109.653 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.604 -170.773 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 m . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 122.6 1.191 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.12 77.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.768 1.627 . . . . 0.0 107.284 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 58.19 53.5 6.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.884 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.95 28.07 55.14 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -140.15 138.14 34.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.25 2.22 . . . . 0.0 106.697 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 168.91 11.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 125.024 1.33 . . . . 0.0 107.987 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.53 172.5 3.47 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.528 2.152 . . . . 0.0 111.869 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t 32.48 47.51 0.1 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.784 2.434 . . . . 0.0 115.134 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.94 48.0 14.2 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.512 1.529 . . . . 0.0 112.356 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 mmt -73.0 149.44 43.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.7 m -82.33 137.87 34.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 m -73.34 122.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -57.04 157.23 6.04 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.56 -13.12 12.24 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 169.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -92.09 2.26 56.69 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.742 2.417 . . . . 0.0 112.244 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.55 0.51 87.48 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.372 0.987 . . . . 0.0 114.737 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -89.65 -169.33 2.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 167.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 p -159.43 151.49 20.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.471 1.032 . . . . 0.0 113.424 -170.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.3 151.09 9.86 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -82.78 72.04 9.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.76 165.02 32.1 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.784 -1.198 . . . . 0.0 114.981 169.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.71 -35.27 17.08 Favored 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 125.899 4.4 . . . . 0.0 114.584 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.7 -42.12 11.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -93.13 -59.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.236 0 C-N-CA 126.776 2.03 . . . . 0.0 115.114 -165.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 122.591 1.186 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -106.87 100.15 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.167 1.787 . . . . 0.0 106.365 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 51.72 44.64 29.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 110.549 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.45 82.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.734 0.683 . . . . 0.0 113.172 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -141.03 148.42 40.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.78 2.032 . . . . 0.0 107.65 172.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -132.72 163.75 48.61 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.349 1.86 . . . . 0.0 106.644 166.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.62 174.97 9.25 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.281 1.987 . . . . 0.0 110.855 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t 34.65 54.1 0.65 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 127.073 2.149 . . . . 0.0 113.872 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.41 46.28 36.34 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.857 1.217 . . . . 0.0 112.239 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.446 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.7 mmm -90.15 133.77 34.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 168.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.1 m -83.99 134.95 34.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.8 m -67.91 120.47 14.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 165.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.3 p -69.6 163.26 25.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.337 1.055 . . . . 0.0 111.15 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -50.15 -26.41 4.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.434 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.1 -1.41 56.48 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 126.859 2.064 . . . . 0.0 112.828 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.17 6.65 83.54 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.106 0.86 . . . . 0.0 113.974 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -90.36 -160.13 0.67 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.35 158.87 27.63 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.006 1.275 . . . . 0.0 112.989 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.61 157.92 11.98 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.97 77.31 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.53 158.4 27.65 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.382 -1.39 . . . . 0.0 114.914 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.99 -39.69 59.48 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.806 3.671 . . . . 0.0 113.764 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -43.42 -45.89 6.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 110.288 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -90.54 -55.17 3.69 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.286 1.034 . . . . 0.0 109.192 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 130.558 3.543 . . . . 0.0 113.475 -168.451 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -89.6 61.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 123.344 1.545 . . . . 0.0 108.33 -171.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? 63.06 53.73 2.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.687 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.33 27.62 54.8 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.762 1.172 . . . . 0.0 113.119 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -135.99 156.31 48.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 128.029 2.531 . . . . 0.0 106.122 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 m -135.87 165.78 33.35 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 127.108 2.163 . . . . 0.0 108.599 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.3 175.13 4.12 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.946 3.097 . . . . 0.0 109.272 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 33.21 48.97 0.18 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.535 2.334 . . . . 0.0 115.159 170.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.06 44.02 5.73 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.675 1.607 . . . . 0.0 112.083 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.1 mtt -85.69 165.01 17.31 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -101.74 133.49 46.38 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.45 106.97 1.89 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -57.54 148.08 24.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.906 0.882 . . . . 0.0 110.569 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -51.93 -25.21 7.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -92.63 7.55 42.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.987 2.515 . . . . 0.0 112.374 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.91 8.83 87.59 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.473 1.511 . . . . 0.0 114.825 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -93.24 -163.82 1.1 Allowed 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.766 1.226 . . . . 0.0 108.828 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.7 t -141.11 138.5 33.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 119.22 0.918 . . . . 0.0 109.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.08 22.19 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -90.24 70.14 7.16 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.635 1.574 . . . . 0.0 110.458 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.82 160.46 33.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.016 -1.087 . . . . 0.0 115.492 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.99 -46.92 29.33 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.787 3.658 . . . . 0.0 114.249 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -48.6 -35.36 13.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.208 1.003 . . . . 0.0 111.933 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -93.43 -51.11 5.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 108.503 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.304 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.234 0.259 0 CA-C-O 123.263 1.506 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -85.98 69.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.533 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? 49.78 52.98 13.56 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.195 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.05 25.22 32.27 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 114.351 170.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -139.9 138.94 36.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 128.101 2.56 . . . . 0.0 105.665 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 164.87 35.99 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 124.106 0.963 . . . . 0.0 109.415 168.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.34 174.3 6.12 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.36 2.707 . . . . 0.0 110.281 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t 34.42 51.15 0.44 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.011 2.125 . . . . 0.0 113.866 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.07 46.21 26.77 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.128 1.347 . . . . 0.0 112.247 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -92.4 133.68 35.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.68 140.44 29.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.0 m -71.27 117.71 13.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.877 0.846 . . . . 0.0 110.244 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -55.03 173.07 0.1 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.368 1.467 . . . . 0.0 111.636 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -63.13 -24.24 67.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.574 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -94.66 4.86 53.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.214 2.206 . . . . 0.0 112.823 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.47 11.54 65.15 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.005 0.812 . . . . 0.0 113.677 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -92.07 -164.59 1.2 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 160.11 22.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.105 1.321 . . . . 0.0 113.378 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.08 162.06 25.16 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -83.8 79.15 9.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.24 162.43 35.72 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.288 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.79 -35.58 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.486 3.457 . . . . 0.0 111.687 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -43.72 -41.99 5.14 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.911 1.284 . . . . 0.0 111.113 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -94.44 -50.6 5.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 110.372 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.125 -170.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.322 0 CA-C-O 123.074 1.416 . . . . 0.0 108.269 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.49 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.643 1.687 . . . . 0.0 106.742 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 53.54 53.26 11.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.956 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.77 16.17 49.6 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.047 1.784 . . . . 0.0 115.575 169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.49 147.17 32.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.185 2.594 . . . . 0.0 105.415 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.6 OUTLIER -135.56 168.24 18.44 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 124.654 1.182 . . . . 0.0 108.01 167.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.75 169.94 6.45 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.53 2.153 . . . . 0.0 112.953 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.5 p 32.71 51.33 0.24 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.44 2.296 . . . . 0.0 115.031 169.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.7 47.9 37.2 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.92 1.248 . . . . 0.0 112.5 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 61.2 mtt -78.24 144.03 36.58 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 167.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -84.91 136.44 33.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 m -69.52 139.04 53.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -73.32 -174.19 1.56 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.853 0.835 . . . . 0.0 111.857 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.255 2.0 pm0 -69.43 -28.95 66.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.749 -0.594 . . . . 0.0 111.324 168.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.44 9.26 35.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.518 2.327 . . . . 0.0 111.264 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.27 28.16 70.4 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.372 0.987 . . . . 0.0 112.667 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -90.41 -156.02 0.41 Allowed 'General case' 0 C--N 1.338 0.077 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.79 152.18 13.4 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.93 159.99 23.18 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 107.161 -2.375 . . . . 0.0 107.161 169.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -83.5 79.15 9.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.27 163.49 37.16 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.858 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.48 -35.48 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.455 3.437 . . . . 0.0 111.434 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.29 -39.6 6.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.043 1.337 . . . . 0.0 111.295 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -93.75 -51.8 4.74 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.068 1.347 . . . . 0.0 109.782 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -171.418 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 122.576 1.179 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -114.17 101.0 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 106.188 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 52.48 45.71 28.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.19 0.596 . . . . 0.0 110.38 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.33 85.67 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.781 1.181 . . . . 0.0 113.168 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -141.45 144.32 34.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.308 2.243 . . . . 0.0 106.293 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.86 19.19 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.807 1.243 . . . . 0.0 108.468 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.75 172.62 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.604 2.203 . . . . 0.0 111.839 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t 33.02 49.0 0.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.74 2.416 . . . . 0.0 115.211 168.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.96 49.18 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.383 1.468 . . . . 0.0 112.276 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 mmt -88.09 135.13 33.56 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -82.65 140.37 33.19 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.1 m -73.63 124.42 25.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 p -59.89 156.66 13.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -56.75 -19.49 17.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -90.06 -7.36 54.05 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 127.002 2.121 . . . . 0.0 112.307 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.12 65.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 115.094 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -92.55 -172.52 3.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.92 150.27 29.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.626 1.103 . . . . 0.0 113.516 -173.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.92 148.62 7.49 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -82.42 74.09 9.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.89 166.99 39.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.393 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.62 -24.68 41.33 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.88 3.72 . . . . 0.0 112.194 -169.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -49.75 -40.39 40.85 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -92.62 -65.86 0.97 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 C-N-CA 126.319 1.848 . . . . 0.0 113.696 -165.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.6 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 122.171 0.986 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.19 69.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 69.82 51.4 0.44 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.758 2.023 . . . . 0.0 109.184 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.23 26.26 74.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.414 1.007 . . . . 0.0 113.258 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -136.47 124.31 22.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.371 2.268 . . . . 0.0 106.352 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.2 m -106.74 160.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.88 1.272 . . . . 0.0 109.849 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.54 167.49 22.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.998 1.798 . . . . 0.0 111.747 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.8 p 32.68 47.67 0.11 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 127.373 2.269 . . . . 0.0 116.373 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.9 44.7 61.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.732 1.158 . . . . 0.0 112.818 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.32 151.43 25.58 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.5 m -89.86 145.26 25.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -66.43 132.87 49.25 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.674 164.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 33.0 p -61.68 161.23 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.516 -1.274 . . . . 0.0 108.463 168.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -58.57 -19.86 41.82 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.566 -0.709 . . . . 0.0 111.447 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -92.8 6.51 47.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.206 2.602 . . . . 0.0 112.328 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.13 24.0 77.12 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.951 1.262 . . . . 0.0 115.314 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -97.64 -168.51 1.69 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.24 134.81 46.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.512 1.506 . . . . 0.0 111.302 -171.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.55 138.54 4.63 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -84.7 72.02 10.76 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.839 0.856 . . . . 0.0 108.717 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.19 163.71 33.23 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.515 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.35 -39.98 35.72 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 125.131 3.887 . . . . 0.0 114.205 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.97 -35.79 16.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.589 0.756 . . . . 0.0 111.436 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 23.7 m-85 -94.98 -57.14 2.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 123.622 0.769 . . . . 0.0 112.732 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 123.395 1.569 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.29 66.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.163 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 59.59 54.56 4.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.787 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.96 23.45 45.37 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 167.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm-85 -139.57 141.45 37.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.545 2.338 . . . . 0.0 106.005 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 169.57 10.14 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.556 1.142 . . . . 0.0 109.57 168.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.99 171.57 5.95 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.842 2.361 . . . . 0.0 112.017 173.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t 34.23 44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.69 2.396 . . . . 0.0 114.942 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.63 46.62 18.14 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.865 1.697 . . . . 0.0 112.043 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.6 mtt -78.41 142.57 37.48 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 167.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.5 m -83.64 145.81 28.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.2 m -75.05 154.12 38.11 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p -89.61 170.39 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -56.79 -24.82 53.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.795 -0.565 . . . . 0.0 111.514 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -92.11 5.36 50.57 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 127.834 2.453 . . . . 0.0 111.996 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.17 71.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.651 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -91.11 -172.63 3.38 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 166.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.0 154.11 36.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 147.08 7.56 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -81.85 72.16 8.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.55 161.27 32.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.817 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.04 -35.98 34.03 Favored 'Trans proline' 0 C--N 1.351 0.658 1 C-N-CA 125.431 4.087 . . . . 0.0 114.489 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -49.59 -37.97 29.75 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.97 -59.5 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.33 -0.246 0 C-N-CA 124.84 1.256 . . . . 0.0 114.331 -166.044 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 122.984 1.373 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.75 101.18 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 127.155 2.182 . . . . 0.0 105.64 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.3 44.57 28.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.675 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.57 36.05 92.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.571 0.605 . . . . 0.0 112.899 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -139.16 146.34 40.48 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.482 1.913 . . . . 0.0 107.959 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -130.7 166.35 27.89 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 126.9 2.08 . . . . 0.0 107.063 167.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.77 164.19 19.5 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.372 2.048 . . . . 0.0 113.294 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.5 p 42.15 36.92 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.943 2.097 . . . . 0.0 115.59 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.27 41.14 46.78 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.611 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 50.3 mtt -59.77 146.83 40.18 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 166.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -83.42 133.25 34.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.42 135.32 51.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.1 p -69.52 -166.13 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.041 2.136 . . . . 0.0 111.514 -170.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -87.47 -11.61 48.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 110.739 166.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.0 17.51 14.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.077 2.151 . . . . 0.0 112.704 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 -0.13 30.6 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.761 1.172 . . . . 0.0 114.723 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -90.05 -159.24 0.58 Allowed 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.27 173.5 14.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.106 0.867 . . . . 0.0 112.221 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.53 154.58 8.41 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -83.8 65.45 8.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.634 0.774 . . . . 0.0 109.17 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.98 159.86 32.59 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.269 -0.967 . . . . 0.0 114.75 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.36 -42.2 41.44 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 125.297 3.998 . . . . 0.0 114.775 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -48.64 -38.98 22.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.399 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -93.21 -51.13 5.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.375 1.083 . . . . 0.0 108.909 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.861 -168.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 123.494 1.616 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.25 59.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 123.876 1.798 . . . . 0.0 108.41 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? 58.88 54.65 5.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.194 -2.276 . . . . 0.0 110.124 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.5 25.02 34.28 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.407 1.003 . . . . 0.0 113.659 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -144.9 136.21 25.15 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.874 2.47 . . . . 0.0 107.249 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.89 166.28 28.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 109.201 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.82 164.8 17.81 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.7 2.266 . . . . 0.0 112.452 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p 34.96 38.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.85 2.46 . . . . 0.0 115.751 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.85 43.04 30.1 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.345 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mmm -62.01 138.95 58.44 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 167.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.94 136.39 35.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.2 m -64.55 138.77 58.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 t -69.06 -169.99 0.22 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.058 1.343 . . . . 0.0 112.12 -168.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -87.5 -27.13 22.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.567 162.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.57 14.39 24.9 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 128.412 2.685 . . . . 0.0 112.309 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.46 4.55 65.19 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.559 1.552 . . . . 0.0 114.727 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -88.94 -154.55 0.3 Allowed 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.097 1.359 . . . . 0.0 107.758 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -155.31 147.52 23.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.479 1.036 . . . . 0.0 112.422 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.99 137.53 3.9 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -83.16 64.92 7.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.917 -0.755 . . . . 0.0 109.397 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.12 161.89 34.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.121 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.06 -45.31 21.59 Favored 'Trans proline' 0 C--N 1.349 0.593 1 C-N-CA 125.323 4.016 . . . . 0.0 115.088 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -50.22 -33.78 20.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.788 0.835 . . . . 0.0 111.747 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.4 -52.06 4.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.122 0.969 . . . . 0.0 109.105 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.626 -168.006 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 123.544 1.64 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.41 61.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.262 -169.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 63.24 53.98 2.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.896 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.11 41.56 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.417 1.008 . . . . 0.0 113.402 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -141.94 130.61 22.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 107.707 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.77 166.87 25.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.167 1.387 . . . . 0.0 108.492 166.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.56 170.33 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.799 2.333 . . . . 0.0 112.661 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p 33.87 46.16 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.658 2.383 . . . . 0.0 115.403 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.9 48.45 9.34 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.37 1.462 . . . . 0.0 112.031 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.2 151.12 46.93 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -82.69 134.33 35.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -74.1 116.43 14.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.2 p -56.28 162.04 2.24 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.178 0.514 . . . . 0.0 111.045 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -53.02 -23.9 8.47 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.756 165.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -94.33 1.76 55.88 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 128.609 2.763 . . . . 0.0 113.406 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.57 2.18 84.37 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.252 0.93 . . . . 0.0 115.367 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.77 -164.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.42 146.62 21.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.792 1.178 . . . . 0.0 113.115 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.18 145.65 6.08 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -83.63 65.56 8.54 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.048 -0.677 . . . . 0.0 110.084 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.41 165.23 36.02 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.216 -0.992 . . . . 0.0 114.935 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.36 -39.37 27.89 Favored 'Trans proline' 0 C--N 1.349 0.582 1 C-N-CA 125.454 4.102 . . . . 0.0 114.478 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -51.21 -32.57 24.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.0 0.52 . . . . 0.0 111.629 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -94.23 -60.13 1.8 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.457 -0.098 0 C-N-CA 125.874 1.67 . . . . 0.0 113.114 -165.142 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.511 0.672 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.04 67.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.556 1.646 . . . . 0.0 106.838 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 47.83 51.64 13.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.633 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.07 29.8 10.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.949 1.737 . . . . 0.0 113.792 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -141.86 128.44 20.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.733 2.013 . . . . 0.0 106.804 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.49 164.33 42.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.2 1.0 . . . . 0.0 109.059 166.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -65.03 171.33 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.431 2.087 . . . . 0.0 112.602 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p 40.54 43.74 1.61 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.967 1.707 . . . . 0.0 115.32 169.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.38 47.55 28.27 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.818 1.199 . . . . 0.0 112.152 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 60.9 mtt -71.46 148.8 46.48 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.6 m -83.71 136.98 33.98 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 170.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -73.06 138.27 45.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 166.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -69.81 -166.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 123.037 1.399 . . . . 0.0 109.576 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -102.44 -22.15 14.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.36 1.864 . . . . 0.0 107.855 162.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.12 9.63 37.0 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 127.777 2.431 . . . . 0.0 112.253 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.92 83.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.525 1.536 . . . . 0.0 115.0 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.54 -169.1 2.12 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.0 p -157.89 155.43 29.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 109.971 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.0 152.37 8.16 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -83.22 77.57 9.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.26 162.08 33.2 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.14 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.59 -42.41 29.36 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 125.179 3.92 . . . . 0.0 114.076 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -50.59 -31.67 16.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.072 0.949 . . . . 0.0 111.592 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.97 -56.4 2.88 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.759 0.824 . . . . 0.0 109.185 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.467 0.419 0 C-N-CA 123.723 0.809 . . . . 0.0 111.516 -167.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 122.993 1.378 . . . . 0.0 107.776 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.95 81.13 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 52.61 51.1 16.75 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.63 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.73 27.24 73.51 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.611 0.625 . . . . 0.0 113.354 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -145.34 152.67 40.25 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.2 2.6 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.47 165.37 34.75 Favored Pre-proline 0 C--N 1.325 -0.468 0 C-N-CA 123.614 0.766 . . . . 0.0 109.63 167.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.2 170.96 17.82 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.735 2.29 . . . . 0.0 109.641 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.0 p 43.52 35.29 0.93 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.08 1.752 . . . . 0.0 114.688 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.45 48.01 5.75 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 126.204 1.859 . . . . 0.0 111.527 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.32 142.43 47.11 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 168.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.6 m -83.22 139.36 33.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.21 127.97 34.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 t -62.52 170.76 2.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.465 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.26 -28.83 69.98 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -93.58 8.23 41.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.037 2.535 . . . . 0.0 112.335 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.42 77.9 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.122 0.868 . . . . 0.0 114.636 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.18 -153.17 0.26 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.9 149.77 23.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.552 1.069 . . . . 0.0 112.557 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.14 138.02 2.66 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -83.95 72.64 10.42 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.765 -0.844 . . . . 0.0 110.366 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.01 162.72 34.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.297 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.07 -49.58 11.11 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.0 3.8 . . . . 0.0 114.343 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -53.18 -29.95 34.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.848 0.859 . . . . 0.0 112.371 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -94.98 -48.28 6.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.841 -178.046 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 122.028 0.918 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.87 73.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 59.58 54.68 4.41 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.067 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.88 15.62 77.07 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.449 1.023 . . . . 0.0 115.086 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -137.52 136.96 38.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.5 m -121.11 160.21 46.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.86 1.264 . . . . 0.0 110.199 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.78 169.22 19.45 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.443 2.095 . . . . 0.0 112.097 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t 33.61 47.26 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.645 2.378 . . . . 0.0 115.524 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.57 40.5 55.18 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.798 1.189 . . . . 0.0 112.795 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.86 149.13 28.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 166.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -83.34 137.8 33.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.8 t -72.35 114.06 10.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -62.0 151.39 35.28 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.009 1.724 . . . . 0.0 110.944 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.45 -28.08 18.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 168.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -93.73 9.18 38.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.037 2.535 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.48 8.05 83.5 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.786 1.184 . . . . 0.0 114.972 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.07 -167.69 1.78 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 124.612 1.165 . . . . 0.0 109.638 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.0 m -127.36 145.87 50.66 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.059 -1.026 . . . . 0.0 109.604 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.67 144.64 4.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 165.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -83.83 67.44 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.482 1.113 . . . . 0.0 108.12 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.16 164.83 35.67 Favored Glycine 0 CA--C 1.528 0.901 0 O-C-N 122.145 -0.347 . . . . 0.0 113.077 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -66.76 -42.96 7.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.686 3.59 . . . . 0.0 113.312 -167.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -49.53 -33.4 14.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.913 0.885 . . . . 0.0 111.903 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.02 -54.63 3.65 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.958 1.303 . . . . 0.0 108.901 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.449 -0.52 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 -171.409 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 122.158 0.98 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.32 97.49 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 49.4 45.56 23.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.552 0.741 . . . . 0.0 110.671 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.21 68.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.314 1.435 . . . . 0.0 114.078 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -132.25 160.78 35.17 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 127.392 2.277 . . . . 0.0 105.698 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -137.2 161.52 60.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 C-N-CA 125.669 1.587 . . . . 0.0 109.414 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.58 168.28 18.65 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.222 1.948 . . . . 0.0 111.938 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t 31.87 49.53 0.13 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.998 2.519 . . . . 0.0 115.251 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.22 44.3 51.73 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.214 0.911 . . . . 0.0 112.86 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.82 153.06 26.62 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 166.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.03 134.82 35.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -72.7 107.23 5.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 165.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p -54.47 156.57 3.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.383 1.473 . . . . 0.0 110.003 -170.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -56.53 -23.61 40.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 170.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.82 11.56 31.13 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.465 2.306 . . . . 0.0 112.281 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.0 84.97 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.244 1.402 . . . . 0.0 114.494 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -113.32 -169.97 1.6 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.468 1.907 . . . . 0.0 107.378 169.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -126.58 136.34 52.42 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 120.197 1.362 . . . . 0.0 110.198 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.92 142.77 5.28 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 166.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -83.8 68.32 9.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.02 168.33 41.1 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.911 -1.138 . . . . 0.0 114.531 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.31 -35.18 32.76 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.549 3.499 . . . . 0.0 111.771 -169.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -49.68 -34.78 19.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.68 0.392 . . . . 0.0 111.436 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -94.65 -60.34 1.73 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.0 109.945 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.235 0.309 0 C-N-CA 126.418 1.887 . . . . 0.0 113.747 -168.722 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m . . . . . 0 C--O 1.235 0.299 0 CA-C-O 122.612 1.196 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -83.79 75.4 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 mmt-85 49.94 51.22 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.711 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 4.78 72.86 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.818 1.199 . . . . 0.0 114.702 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -132.75 165.79 23.72 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.07 167.83 18.53 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.184 . . . . 0.0 109.133 167.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -68.1 175.03 7.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.027 2.485 . . . . 0.0 112.69 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 32.19 55.22 0.34 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.501 2.32 . . . . 0.0 115.335 166.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.46 44.21 36.28 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.726 1.155 . . . . 0.0 112.35 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.0 mmt -91.77 134.85 34.37 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.8 m -81.66 133.31 35.35 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.8 t -74.13 114.2 12.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.5 p -60.36 154.95 19.05 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.57 -16.34 24.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 167.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.66 3.63 55.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.931 2.492 . . . . 0.0 112.95 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.0 90.52 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -96.28 -170.85 2.17 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -156.51 157.16 34.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.237 1.38 . . . . 0.0 112.483 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.76 155.9 8.7 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -84.08 79.05 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.036 0.935 . . . . 0.0 109.047 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.3 171.05 38.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.986 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.36 -25.5 10.22 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 126.079 4.52 . . . . 0.0 115.165 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -51.04 -54.86 20.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.653 -0.655 . . . . 0.0 109.593 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.86 -66.19 0.95 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.533 -0.729 . . . . 0.0 109.236 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 122.653 1.216 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.46 92.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.933 2.093 . . . . 0.0 106.656 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 49.24 52.14 14.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.45 0.643 . . . . 0.0 110.015 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.16 31.62 66.29 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.972 1.273 . . . . 0.0 113.686 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -141.74 139.82 32.96 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.749 2.02 . . . . 0.0 107.185 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.23 168.94 14.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 125.432 1.493 . . . . 0.0 108.502 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.82 169.38 5.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.543 2.162 . . . . 0.0 112.746 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.4 p 33.08 49.22 0.17 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.562 2.345 . . . . 0.0 115.078 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.29 48.08 27.22 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.313 1.435 . . . . 0.0 112.465 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.7 mtt -75.81 145.79 40.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.4 m -83.98 139.25 32.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 m -75.42 125.13 28.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 p -63.06 159.94 16.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.24 -20.72 29.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -91.58 2.96 56.09 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 127.54 2.336 . . . . 0.0 111.858 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.71 6.78 85.42 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.332 0.968 . . . . 0.0 114.655 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.89 -167.15 1.67 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -158.55 152.82 24.09 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.466 1.03 . . . . 0.0 112.928 -172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.14 149.65 7.9 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -82.55 72.27 9.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.32 160.39 33.16 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 119.964 -1.112 . . . . 0.0 114.307 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.16 -40.75 42.26 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.052 3.835 . . . . 0.0 113.942 -176.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -49.73 -34.53 19.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.881 0.872 . . . . 0.0 111.391 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.44 -60.15 1.78 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.451 -0.421 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.124 -165.562 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 122.039 0.923 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -84.94 67.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.69 53.18 8.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.137 2.575 . . . . 0.0 110.103 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.76 -10.24 30.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.875 2.655 . . . . 0.0 113.793 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.4 mtt85 -106.93 110.84 23.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.0 m -113.51 157.95 39.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.703 1.601 . . . . 0.0 109.567 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.87 170.55 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.909 2.406 . . . . 0.0 111.024 -171.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p 43.41 42.69 3.94 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.837 1.655 . . . . 0.0 114.941 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.56 42.96 27.91 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.918 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -82.7 151.03 26.4 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 167.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.1 m -91.12 138.09 31.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.19 116.49 13.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.5 p -68.64 -177.46 0.97 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.006 1.722 . . . . 0.0 113.295 -169.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.32 -26.06 61.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 167.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.54 8.41 42.29 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.645 2.378 . . . . 0.0 112.403 -173.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.24 13.32 57.74 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.679 1.133 . . . . 0.0 114.055 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -94.77 -175.93 3.72 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.191 1.396 . . . . 0.0 109.41 168.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.7 m -127.17 137.06 52.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 109.278 -170.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 146.36 7.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.66 75.99 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.98 155.81 27.31 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 120.493 -0.861 . . . . 0.0 114.159 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.98 -46.38 28.26 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.108 3.872 . . . . 0.0 115.127 -169.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -51.23 -31.77 21.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.756 0.823 . . . . 0.0 111.68 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -95.73 -53.7 3.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.558 1.143 . . . . 0.0 108.562 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -170.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 123.134 1.445 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.26 78.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 127.03 2.132 . . . . 0.0 106.243 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 46.97 50.42 13.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.219 -1.81 . . . . 0.0 110.225 -172.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.45 23.53 12.37 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.443 1.497 . . . . 0.0 114.928 172.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -138.41 118.14 13.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.604 1.962 . . . . 0.0 109.305 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -124.32 162.93 39.26 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 166.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.23 170.54 7.67 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.594 2.196 . . . . 0.0 112.627 -178.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.2 p 42.23 39.58 1.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.232 1.813 . . . . 0.0 115.481 171.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.84 48.81 9.21 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.656 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 55.7 mtt -64.19 150.6 45.43 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -83.69 136.37 34.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.0 m -69.82 138.38 52.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -73.33 -168.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.594 0.712 . . . . 0.0 109.787 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 -7.19 26.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.355 0.662 . . . . 0.0 110.418 165.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.93 1.65 55.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.845 2.458 . . . . 0.0 112.494 -176.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.97 4.63 72.7 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.022 1.296 . . . . 0.0 113.763 -169.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -93.95 -158.83 0.65 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.38 165.11 29.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.655 0.782 . . . . 0.0 110.834 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.05 152.17 6.93 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -83.51 65.73 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.098 -0.648 . . . . 0.0 109.915 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.89 160.8 33.93 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.514 -0.85 . . . . 0.0 114.38 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.65 -41.87 37.01 Favored 'Trans proline' 0 C--N 1.35 0.64 1 C-N-CA 125.361 4.041 . . . . 0.0 114.611 -174.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -50.8 -33.55 23.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 111.582 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -94.93 -54.36 3.49 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.531 0.732 . . . . 0.0 109.772 173.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 112.679 -167.194 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.235 0.314 0 CA-C-O 122.361 1.077 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -86.21 59.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 124.05 1.881 . . . . 0.0 108.059 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.454 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 3.4 mmp_? 57.85 54.98 5.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.043 -169.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.69 25.0 36.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.427 1.489 . . . . 0.0 115.093 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -138.13 146.97 43.45 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 127.757 2.423 . . . . 0.0 105.201 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.4 m -129.24 163.4 46.36 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 125.888 1.675 . . . . 0.0 110.199 -176.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.62 172.44 3.96 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.25 2.633 . . . . 0.0 110.3 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 42.6 41.84 2.56 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.139 1.776 . . . . 0.0 115.215 171.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.89 45.05 18.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.018 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mtt -84.92 157.14 20.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 167.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -98.07 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.35 117.58 9.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.155 163.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.503 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 9.4 p -50.86 154.52 1.42 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 168.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -59.04 -16.42 18.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.773 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.26 4.32 53.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.915 2.886 . . . . 0.0 112.498 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 9.3 86.97 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.455 1.502 . . . . 0.0 116.031 169.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.24 178.95 5.57 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 118.479 1.14 . . . . 0.0 108.91 168.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.7 m -112.8 138.18 50.02 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.896 -174.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.76 138.0 4.48 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -84.22 75.27 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.94 162.62 32.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.856 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.44 -41.17 44.32 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.834 3.69 . . . . 0.0 113.763 -176.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -49.83 -33.5 17.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.539 0.735 . . . . 0.0 111.652 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 14.0 m-85 -96.22 -60.35 1.64 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.573 -166.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.12 80.11 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -176.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 68.04 50.06 0.83 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.751 2.42 . . . . 0.0 109.799 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.77 10.44 50.26 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -141.65 167.54 21.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.719 2.808 . . . . 0.0 104.585 173.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.7 167.22 20.29 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 124.752 1.221 . . . . 0.0 108.844 169.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.78 174.91 11.87 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.429 2.086 . . . . 0.0 110.773 -171.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p 46.92 39.95 8.39 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.884 1.674 . . . . 0.0 114.322 178.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.19 44.89 27.25 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.974 -175.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -70.62 148.98 47.51 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.07 133.69 34.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.12 114.87 10.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 164.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 p -63.01 179.94 0.34 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.779 1.632 . . . . 0.0 112.959 -166.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -78.67 -16.37 57.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.767 1.627 . . . . 0.0 111.857 167.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -96.77 5.54 50.41 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.117 2.167 . . . . 0.0 112.885 -178.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 6.87 43.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.254 0.93 . . . . 0.0 114.076 -171.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.9 -165.05 1.26 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 167.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.26 153.83 28.15 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 110.156 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.61 158.02 17.59 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -84.97 69.08 10.76 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.245 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.4 162.18 33.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.865 170.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -50.09 -39.36 51.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 125.14 3.893 . . . . 0.0 113.817 -178.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -48.0 -39.1 18.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.998 178.29 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.17 -54.54 3.9 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.239 0.533 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.133 -167.332 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.912 0.863 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.13 97.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 47.89 45.94 18.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.74 0.816 . . . . 0.0 110.682 -174.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.15 13.24 72.94 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.078 -0.846 . . . . 0.0 114.751 175.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.22 173.01 12.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.022 2.129 . . . . 0.0 108.394 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.01 167.63 18.49 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 125.487 1.515 . . . . 0.0 108.157 165.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -61.64 174.72 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.035 3.157 . . . . 0.0 113.288 -178.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.9 p 46.15 41.61 8.82 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.842 1.657 . . . . 0.0 114.403 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.84 45.32 25.15 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.873 -175.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.8 mtt -69.67 156.03 39.59 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.07 151.34 21.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -93.12 114.29 26.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.0 p -59.3 161.52 5.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.022 0.529 . . . . 0.0 111.09 -171.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.86 -24.6 37.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.343 167.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.17 3.83 54.49 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.742 2.417 . . . . 0.0 112.313 -174.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 6.01 83.77 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.861 -0.966 . . . . 0.0 115.145 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -94.78 -171.47 2.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 164.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 150.8 36.44 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.659 1.118 . . . . 0.0 112.086 -173.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.72 153.88 10.14 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -88.46 68.9 8.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.334 1.053 . . . . 0.0 109.705 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.86 44.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 119.561 -1.304 . . . . 0.0 115.007 175.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.58 -19.7 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.048 3.832 . . . . 0.0 112.186 -171.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -53.85 -43.7 69.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -91.49 -63.62 1.23 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 O-C-N 124.824 1.328 . . . . 0.0 109.788 -167.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -86.38 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 123.673 1.701 . . . . 0.0 106.468 174.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.404 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? 49.64 53.54 12.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 111.776 -2.466 . . . . 0.0 110.83 -174.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.93 31.72 7.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.435 1.969 . . . . 0.0 113.408 172.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -139.06 123.49 18.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.27 2.228 . . . . 0.0 105.155 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -129.49 159.75 67.82 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.724 1.21 . . . . 0.0 109.578 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.25 168.95 21.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.416 2.077 . . . . 0.0 111.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 32.21 51.21 0.2 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.787 2.435 . . . . 0.0 115.127 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.81 45.29 8.94 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.824 1.202 . . . . 0.0 111.959 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -82.51 151.01 26.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 169.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.0 m -84.58 134.97 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -68.75 109.55 3.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.85 155.19 10.81 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.812 0.845 . . . . 0.0 111.304 -170.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -52.55 -26.48 13.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 168.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.01 1.1 57.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.89 2.476 . . . . 0.0 112.52 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.67 16.02 79.87 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.35 1.452 . . . . 0.0 114.782 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -94.77 -164.48 1.17 Allowed 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -136.6 132.22 34.81 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.36 -0.837 . . . . 0.0 109.069 -172.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.33 147.27 8.16 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 168.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -83.34 70.6 10.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 108.616 -178.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.32 164.59 33.49 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 122.077 -0.39 . . . . 0.0 113.318 177.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.97 -41.95 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.674 3.582 . . . . 0.0 112.914 -167.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -47.82 -34.96 9.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.424 1.09 . . . . 0.0 111.672 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -93.34 -52.08 4.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.123 1.369 . . . . 0.0 108.756 -176.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.821 -174.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 m . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 122.245 1.021 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.51 99.97 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 127.025 2.13 . . . . 0.0 105.996 175.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 49.08 44.63 22.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.888 0.875 . . . . 0.0 111.374 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.33 73.65 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.779 0.705 . . . . 0.0 114.019 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -136.59 171.58 14.28 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 127.409 2.283 . . . . 0.0 105.617 171.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.15 167.97 17.91 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.794 0.837 . . . . 0.0 109.437 168.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.19 172.37 5.21 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.839 2.359 . . . . 0.0 112.1 176.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.8 p 43.48 42.19 3.77 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.077 1.751 . . . . 0.0 114.863 171.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.59 16.07 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.427 1.489 . . . . 0.0 111.867 -177.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.58 133.91 33.68 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -84.89 142.11 29.93 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.26 122.12 22.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 109.843 174.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.0 p -60.32 -177.55 0.07 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.667 1.187 . . . . 0.0 111.546 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -81.3 -21.44 39.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.949 0.9 . . . . 0.0 110.727 166.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.68 7.28 46.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.472 2.309 . . . . 0.0 112.456 -172.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.29 9.1 76.67 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.548 1.071 . . . . 0.0 114.19 -178.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -98.55 -167.93 1.57 Allowed 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 166.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -160.47 158.96 30.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.962 1.255 . . . . 0.0 111.384 -172.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.8 152.52 8.21 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -82.82 76.15 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.68 161.43 31.81 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.873 172.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.81 -36.05 19.58 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.633 3.555 . . . . 0.0 111.698 -168.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -46.22 -42.58 14.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.882 0.873 . . . . 0.0 111.102 174.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.16 -44.69 7.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.018 1.327 . . . . 0.0 110.695 -172.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.229 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.24 -59.45 7.88 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.223 0.952 . . . . 0.0 112.224 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -164.59 148.37 9.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 172.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.07 172.05 2.59 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 123.386 1.565 . . . . 0.0 111.993 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.23 69.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 48.46 51.94 14.46 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 112.691 -2.049 . . . . 0.0 110.649 -173.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.28 28.36 36.88 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.953 0.787 . . . . 0.0 113.584 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -135.32 140.53 45.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.136 2.175 . . . . 0.0 106.302 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.53 164.36 36.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 124.233 1.013 . . . . 0.0 109.154 168.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.83 172.97 10.65 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.234 2.623 . . . . 0.0 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.7 t 37.8 41.87 0.37 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.515 1.926 . . . . 0.0 114.163 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.15 46.01 8.02 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.229 1.871 . . . . 0.0 111.942 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 mtt -77.68 141.92 39.11 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 88.2 m -83.74 134.56 34.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.5 m -76.06 116.68 17.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.1 p -55.11 164.8 0.79 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.438 0.695 . . . . 0.0 110.586 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.27 -20.89 20.61 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.929 166.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.33 2.44 56.38 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.224 2.21 . . . . 0.0 111.972 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.03 9.32 66.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.134 0.874 . . . . 0.0 114.002 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -91.73 -173.64 3.59 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 166.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.88 151.52 27.2 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 119.617 1.099 . . . . 0.0 113.745 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.1 148.59 6.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 106.686 -2.566 . . . . 0.0 106.686 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -82.77 66.38 8.35 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.054 -0.674 . . . . 0.0 110.191 -170.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.89 165.23 37.51 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.406 -0.902 . . . . 0.0 114.684 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.34 -29.93 18.84 Favored 'Trans proline' 0 C--N 1.351 0.664 1 C-N-CA 125.856 4.371 . . . . 0.0 115.051 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.2 -44.29 32.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -92.79 -60.66 1.76 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.21 -27.09 68.18 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.584 1.954 . . . . 0.0 114.024 -165.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.84 159.19 18.23 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 126.349 1.86 . . . . 0.0 112.477 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.616 -0.706 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.35 -61.06 0.25 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 11.4 tm-20 101.97 123.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 128.305 2.642 . . . . 0.0 107.181 -170.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.5 147.45 44.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.147 -173.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.34 59.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? 53.64 55.59 8.35 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 112.385 -2.188 . . . . 0.0 111.453 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.61 11.85 32.01 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.822 1.677 . . . . 0.0 114.242 168.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -137.05 125.55 23.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 126.798 2.039 . . . . 0.0 107.245 -169.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -135.78 163.33 51.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.339 1.456 . . . . 0.0 107.704 167.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.59 175.02 11.51 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.234 1.956 . . . . 0.0 111.349 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t 34.82 53.19 0.63 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.85 2.06 . . . . 0.0 113.633 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.96 46.87 40.95 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.837 1.208 . . . . 0.0 112.224 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -85.81 136.36 33.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.7 m -83.6 140.08 32.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.0 t -70.34 114.89 8.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -57.48 148.8 22.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.903 1.281 . . . . 0.0 111.328 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.4 -27.96 4.62 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.836 167.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -92.93 7.55 43.47 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 128.029 2.532 . . . . 0.0 112.579 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 2.73 84.72 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.501 1.048 . . . . 0.0 114.591 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 84.9 m-85 -91.2 -163.38 1.03 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.89 162.81 38.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 120.265 1.393 . . . . 0.0 111.33 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.46 161.21 13.95 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -83.74 77.51 9.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.23 165.36 37.16 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.623 -0.673 . . . . 0.0 113.319 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.35 -41.19 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.438 3.426 . . . . 0.0 112.149 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -49.35 -32.34 11.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.048 0.939 . . . . 0.0 111.799 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -93.2 -57.71 2.54 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.719 1.208 . . . . 0.0 109.653 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -63.38 -37.69 88.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.604 -170.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.8 146.92 26.21 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.795 1.188 . . . . 0.0 112.936 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 . . . . . 0 C--O 1.225 -0.205 0 C-N-CA 125.105 1.362 . . . . 0.0 108.395 171.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 158.45 -49.95 0.41 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 76.2 mt-10 83.11 118.27 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 126.703 2.001 . . . . 0.0 108.411 -168.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.6 m -73.4 164.21 26.99 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.6 1.191 . . . . 0.0 110.541 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.12 77.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.768 1.627 . . . . 0.0 107.284 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 58.19 53.5 6.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.884 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.95 28.07 55.14 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -140.15 138.14 34.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.25 2.22 . . . . 0.0 106.697 172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 168.91 11.01 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 125.024 1.33 . . . . 0.0 107.987 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.53 172.5 3.47 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.528 2.152 . . . . 0.0 111.869 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t 32.48 47.51 0.1 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.784 2.434 . . . . 0.0 115.134 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.94 48.0 14.2 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.512 1.529 . . . . 0.0 112.356 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 mmt -73.0 149.44 43.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.7 m -82.33 137.87 34.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 m -73.34 122.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -57.04 157.23 6.04 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.56 -13.12 12.24 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 169.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -92.09 2.26 56.69 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.742 2.417 . . . . 0.0 112.244 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.55 0.51 87.48 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.372 0.987 . . . . 0.0 114.737 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 59.6 m-85 -89.65 -169.33 2.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 167.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 p -159.43 151.49 20.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.471 1.032 . . . . 0.0 113.424 -170.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.3 151.09 9.86 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -82.78 72.04 9.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.76 165.02 32.1 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.784 -1.198 . . . . 0.0 114.981 169.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.71 -35.27 17.08 Favored 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 125.899 4.4 . . . . 0.0 114.584 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.7 -42.12 11.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.441 0.696 . . . . 0.0 110.073 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -93.13 -59.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.57 -29.83 69.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.776 2.03 . . . . 0.0 115.114 -165.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.56 -176.9 37.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.33 0.967 . . . . 0.0 114.353 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 . . . . . 0 CA--C 1.531 0.236 0 C-N-CA 126.181 1.793 . . . . 0.0 110.612 170.448 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.99 58.28 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -164.1 169.32 17.98 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.7 171.13 3.54 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.591 1.186 . . . . 0.0 108.783 165.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.8 t -106.87 100.15 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.167 1.787 . . . . 0.0 106.365 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 51.72 44.64 29.1 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 110.549 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.06 32.45 82.31 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.734 0.683 . . . . 0.0 113.172 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -141.03 148.42 40.22 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.78 2.032 . . . . 0.0 107.65 172.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -132.72 163.75 48.61 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.349 1.86 . . . . 0.0 106.644 166.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.62 174.97 9.25 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.281 1.987 . . . . 0.0 110.855 -170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.6 t 34.65 54.1 0.65 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 127.073 2.149 . . . . 0.0 113.872 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.41 46.28 36.34 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.857 1.217 . . . . 0.0 112.239 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.446 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.7 mmm -90.15 133.77 34.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 168.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.1 m -83.99 134.95 34.62 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.8 m -67.91 120.47 14.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 165.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.3 p -69.6 163.26 25.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.337 1.055 . . . . 0.0 111.15 -171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -50.15 -26.41 4.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.434 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -93.1 -1.41 56.48 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 126.859 2.064 . . . . 0.0 112.828 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.17 6.65 83.54 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.106 0.86 . . . . 0.0 113.974 -175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -90.36 -160.13 0.67 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.35 158.87 27.63 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 120.006 1.275 . . . . 0.0 112.989 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.61 157.92 11.98 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 107.693 -2.163 . . . . 0.0 107.693 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -82.97 77.31 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.53 158.4 27.65 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.382 -1.39 . . . . 0.0 114.914 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.99 -39.69 59.48 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.806 3.671 . . . . 0.0 113.764 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -43.42 -45.89 6.44 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 110.288 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -90.54 -55.17 3.69 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.286 1.034 . . . . 0.0 109.192 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t -71.34 37.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.558 3.543 . . . . 0.0 113.475 -168.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.24 -161.74 52.09 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 125.423 1.487 . . . . 0.0 112.157 169.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? . . . . . 0 C--O 1.226 -0.134 0 C-N-CA 124.123 0.969 . . . . 0.0 108.724 -176.175 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 117.162 -1.399 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.97 -85.17 1.85 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.45 154.04 2.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.059 2.144 . . . . 0.0 105.478 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.8 m -61.14 146.13 48.59 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.54 1.064 . . . . 0.0 109.052 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -89.6 61.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 123.344 1.545 . . . . 0.0 108.33 -171.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? 63.06 53.73 2.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.628 -2.078 . . . . 0.0 109.687 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.33 27.62 54.8 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.762 1.172 . . . . 0.0 113.119 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -135.99 156.31 48.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 128.029 2.531 . . . . 0.0 106.122 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 m -135.87 165.78 33.35 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 127.108 2.163 . . . . 0.0 108.599 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.3 175.13 4.12 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.946 3.097 . . . . 0.0 109.272 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 33.21 48.97 0.18 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.535 2.334 . . . . 0.0 115.159 170.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.06 44.02 5.73 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.675 1.607 . . . . 0.0 112.083 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.1 mtt -85.69 165.01 17.31 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -101.74 133.49 46.38 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.45 106.97 1.89 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -57.54 148.08 24.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.906 0.882 . . . . 0.0 110.569 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -51.93 -25.21 7.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -92.63 7.55 42.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.987 2.515 . . . . 0.0 112.374 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.91 8.83 87.59 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.473 1.511 . . . . 0.0 114.825 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -93.24 -163.82 1.1 Allowed 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.766 1.226 . . . . 0.0 108.828 169.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.7 t -141.11 138.5 33.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 119.22 0.918 . . . . 0.0 109.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.08 22.19 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.9 tttp -90.24 70.14 7.16 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.635 1.574 . . . . 0.0 110.458 -171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.82 160.46 33.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.016 -1.087 . . . . 0.0 115.492 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.99 -46.92 29.33 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.787 3.658 . . . . 0.0 114.249 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -48.6 -35.36 13.38 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.208 1.003 . . . . 0.0 111.933 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -93.43 -51.11 5.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 108.503 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -66.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.304 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.23 -146.46 1.53 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.559 1.552 . . . . 0.0 112.078 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.874 1.27 . . . . 0.0 112.983 169.291 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.307 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.6 -49.9 61.96 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.099 0.874 . . . . 0.0 113.177 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -165.64 153.18 10.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -72.93 165.38 25.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.263 1.506 . . . . 0.0 108.981 167.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.9 t -85.98 69.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.533 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? 49.78 52.98 13.56 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.195 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.05 25.22 32.27 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.563 1.554 . . . . 0.0 114.351 170.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -139.9 138.94 36.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 128.101 2.56 . . . . 0.0 105.665 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 164.87 35.99 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 124.106 0.963 . . . . 0.0 109.415 168.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.34 174.3 6.12 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.36 2.707 . . . . 0.0 110.281 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t 34.42 51.15 0.44 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.011 2.125 . . . . 0.0 113.866 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.07 46.21 26.77 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.128 1.347 . . . . 0.0 112.247 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -92.4 133.68 35.66 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.68 140.44 29.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.0 m -71.27 117.71 13.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.877 0.846 . . . . 0.0 110.244 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -55.03 173.07 0.1 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.368 1.467 . . . . 0.0 111.636 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -63.13 -24.24 67.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.574 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -94.66 4.86 53.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.214 2.206 . . . . 0.0 112.823 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.47 11.54 65.15 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.005 0.812 . . . . 0.0 113.677 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -92.07 -164.59 1.2 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 160.11 22.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 120.105 1.321 . . . . 0.0 113.378 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.08 162.06 25.16 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -83.8 79.15 9.57 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.24 162.43 35.72 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.288 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.79 -35.58 21.1 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.486 3.457 . . . . 0.0 111.687 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -43.72 -41.99 5.14 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.911 1.284 . . . . 0.0 111.113 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -94.44 -50.6 5.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 110.372 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -43.1 99.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.125 -170.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.25 -117.81 7.46 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 127.704 2.402 . . . . 0.0 114.33 170.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.04 -43.56 3.15 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.712 1.148 . . . . 0.0 110.29 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 174.24 144.73 0.05 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.757 2.423 . . . . 0.0 107.906 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.61 168.79 17.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 123.074 1.416 . . . . 0.0 108.269 166.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.49 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 123.643 1.687 . . . . 0.0 106.742 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 53.54 53.26 11.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.956 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.77 16.17 49.6 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.047 1.784 . . . . 0.0 115.575 169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.49 147.17 32.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 128.185 2.594 . . . . 0.0 105.415 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.6 OUTLIER -135.56 168.24 18.44 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 124.654 1.182 . . . . 0.0 108.01 167.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -61.75 169.94 6.45 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.53 2.153 . . . . 0.0 112.953 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.5 p 32.71 51.33 0.24 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.44 2.296 . . . . 0.0 115.031 169.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.7 47.9 37.2 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.92 1.248 . . . . 0.0 112.5 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 61.2 mtt -78.24 144.03 36.58 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 167.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -84.91 136.44 33.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 m -69.52 139.04 53.8 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -73.32 -174.19 1.56 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.853 0.835 . . . . 0.0 111.857 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.255 2.0 pm0 -69.43 -28.95 66.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.749 -0.594 . . . . 0.0 111.324 168.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.44 9.26 35.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.518 2.327 . . . . 0.0 111.264 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.27 28.16 70.4 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.372 0.987 . . . . 0.0 112.667 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -90.41 -156.02 0.41 Allowed 'General case' 0 C--N 1.338 0.077 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.79 152.18 13.4 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.93 159.99 23.18 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 107.161 -2.375 . . . . 0.0 107.161 169.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -83.5 79.15 9.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.27 163.49 37.16 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.858 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.48 -35.48 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 124.455 3.437 . . . . 0.0 111.434 -169.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -45.29 -39.6 6.75 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.043 1.337 . . . . 0.0 111.295 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -93.75 -51.8 4.74 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.068 1.347 . . . . 0.0 109.782 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -59.81 -52.76 64.06 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -171.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 133.02 40.29 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? . . . . . 0 CA--C 1.535 0.382 0 O-C-N 121.785 -0.832 . . . . 0.0 110.525 -173.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.4 -57.0 12.39 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -174.08 170.54 3.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.401 2.28 . . . . 0.0 104.901 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.5 m -64.49 169.83 4.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 122.576 1.179 . . . . 0.0 109.281 166.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -114.17 101.0 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 106.188 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 52.48 45.71 28.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.19 0.596 . . . . 0.0 110.38 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.33 85.67 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.781 1.181 . . . . 0.0 113.168 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -141.45 144.32 34.35 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.308 2.243 . . . . 0.0 106.293 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.86 19.19 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 124.807 1.243 . . . . 0.0 108.468 167.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.75 172.62 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.604 2.203 . . . . 0.0 111.839 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t 33.02 49.0 0.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.74 2.416 . . . . 0.0 115.211 168.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.96 49.18 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.383 1.468 . . . . 0.0 112.276 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 mmt -88.09 135.13 33.56 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -82.65 140.37 33.19 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.1 m -73.63 124.42 25.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 168.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 p -59.89 156.66 13.94 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -56.75 -19.49 17.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 168.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -90.06 -7.36 54.05 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 127.002 2.121 . . . . 0.0 112.307 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.12 65.18 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 115.094 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -92.55 -172.52 3.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.92 150.27 29.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.626 1.103 . . . . 0.0 113.516 -173.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.92 148.62 7.49 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -82.42 74.09 9.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.89 166.99 39.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.393 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.62 -24.68 41.33 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.88 3.72 . . . . 0.0 112.194 -169.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -49.75 -40.39 40.85 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -92.62 -65.86 0.97 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.96 -31.27 70.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.319 1.848 . . . . 0.0 113.696 -165.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.61 161.18 39.74 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 . . . . . 0 CA--C 1.53 0.174 0 C-N-CA 126.511 1.925 . . . . 0.0 110.641 169.77 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 116.977 -1.487 . . . . 0.0 107.497 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.99 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -174.96 171.77 3.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 128.034 2.534 . . . . 0.0 104.856 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.6 m -57.78 155.53 10.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.171 0.986 . . . . 0.0 111.166 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.19 69.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 69.82 51.4 0.44 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.758 2.023 . . . . 0.0 109.184 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.23 26.26 74.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.414 1.007 . . . . 0.0 113.258 177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -136.47 124.31 22.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.371 2.268 . . . . 0.0 106.352 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.2 m -106.74 160.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.88 1.272 . . . . 0.0 109.849 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.54 167.49 22.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.998 1.798 . . . . 0.0 111.747 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.8 p 32.68 47.67 0.11 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 127.373 2.269 . . . . 0.0 116.373 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.9 44.7 61.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.732 1.158 . . . . 0.0 112.818 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.32 151.43 25.58 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.5 m -89.86 145.26 25.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.1 m -66.43 132.87 49.25 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.674 164.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.491 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 33.0 p -61.68 161.23 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 118.516 -1.274 . . . . 0.0 108.463 168.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -58.57 -19.86 41.82 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.566 -0.709 . . . . 0.0 111.447 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -92.8 6.51 47.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.206 2.602 . . . . 0.0 112.328 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.13 24.0 77.12 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.951 1.262 . . . . 0.0 115.314 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -97.64 -168.51 1.69 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.24 134.81 46.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.512 1.506 . . . . 0.0 111.302 -171.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.55 138.54 4.63 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -84.7 72.02 10.76 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.839 0.856 . . . . 0.0 108.717 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.19 163.71 33.23 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.515 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.35 -39.98 35.72 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 125.131 3.887 . . . . 0.0 114.205 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -48.97 -35.79 16.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.589 0.756 . . . . 0.0 111.436 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 23.7 m-85 -94.98 -57.14 2.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -28.91 67.96 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.622 0.769 . . . . 0.0 112.732 -166.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.42 141.75 16.54 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 168.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? . . . . . 0 C--N 1.332 -0.163 0 O-C-N 121.958 -0.731 . . . . 0.0 110.553 -177.878 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 118.269 -0.872 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.27 92.18 0.43 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -171.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -53.65 115.9 2.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m -67.54 157.65 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.395 1.569 . . . . 0.0 111.322 -170.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.29 66.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.163 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 59.59 54.56 4.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.787 -169.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.96 23.45 45.37 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 167.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm-85 -139.57 141.45 37.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.545 2.338 . . . . 0.0 106.005 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 169.57 10.14 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 124.556 1.142 . . . . 0.0 109.57 168.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.99 171.57 5.95 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.842 2.361 . . . . 0.0 112.017 173.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.7 t 34.23 44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 127.69 2.396 . . . . 0.0 114.942 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.63 46.62 18.14 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.865 1.697 . . . . 0.0 112.043 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.6 mtt -78.41 142.57 37.48 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 167.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.5 m -83.64 145.81 28.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.2 m -75.05 154.12 38.11 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 p -89.61 170.39 10.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -56.79 -24.82 53.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.795 -0.565 . . . . 0.0 111.514 167.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -92.11 5.36 50.57 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 127.834 2.453 . . . . 0.0 111.996 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.17 71.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-O 119.08 -0.845 . . . . 0.0 114.651 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -91.11 -172.63 3.38 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 166.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.0 154.11 36.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 147.08 7.56 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -81.85 72.16 8.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.55 161.27 32.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.817 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.04 -35.98 34.03 Favored 'Trans proline' 0 C--N 1.351 0.658 1 C-N-CA 125.431 4.087 . . . . 0.0 114.489 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -49.59 -37.97 29.75 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -93.97 -59.5 1.96 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.29 -33.24 70.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.84 1.256 . . . . 0.0 114.331 -166.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.66 155.53 24.61 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.436 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 126.477 1.911 . . . . 0.0 114.979 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 116.583 -1.675 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.41 81.41 0.51 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 121.204 1.82 . . . . 0.0 110.607 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 116.42 1.4 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m -61.79 165.55 5.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.984 1.373 . . . . 0.0 111.143 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.75 101.18 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 127.155 2.182 . . . . 0.0 105.64 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 51.3 44.57 28.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.615 0.766 . . . . 0.0 110.675 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.57 36.05 92.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.571 0.605 . . . . 0.0 112.899 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -139.16 146.34 40.48 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.482 1.913 . . . . 0.0 107.959 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -130.7 166.35 27.89 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 126.9 2.08 . . . . 0.0 107.063 167.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.77 164.19 19.5 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.372 2.048 . . . . 0.0 113.294 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.5 p 42.15 36.92 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.943 2.097 . . . . 0.0 115.59 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.27 41.14 46.78 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.611 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.423 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 50.3 mtt -59.77 146.83 40.18 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 166.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -83.42 133.25 34.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.42 135.32 51.54 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 167.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.1 p -69.52 -166.13 0.09 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.041 2.136 . . . . 0.0 111.514 -170.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -87.47 -11.61 48.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 110.739 166.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -117.0 17.51 14.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.077 2.151 . . . . 0.0 112.704 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.86 -0.13 30.6 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.761 1.172 . . . . 0.0 114.723 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -90.05 -159.24 0.58 Allowed 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.27 173.5 14.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.106 0.867 . . . . 0.0 112.221 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.53 154.58 8.41 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -83.8 65.45 8.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.634 0.774 . . . . 0.0 109.17 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.98 159.86 32.59 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.269 -0.967 . . . . 0.0 114.75 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.36 -42.2 41.44 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 125.297 3.998 . . . . 0.0 114.775 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -48.64 -38.98 22.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.399 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -93.21 -51.13 5.16 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.375 1.083 . . . . 0.0 108.909 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -59.02 -52.28 66.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.861 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.33 -139.24 7.09 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.13 0.872 . . . . 0.0 112.459 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 126.648 1.979 . . . . 0.0 113.853 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.95 -87.23 1.49 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.62 166.97 3.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.742 2.417 . . . . 0.0 105.11 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.2 m -53.84 166.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 123.494 1.616 . . . . 0.0 112.221 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.25 59.7 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 123.876 1.798 . . . . 0.0 108.41 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? 58.88 54.65 5.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 112.194 -2.276 . . . . 0.0 110.124 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.5 25.02 34.28 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.407 1.003 . . . . 0.0 113.659 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -144.9 136.21 25.15 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.874 2.47 . . . . 0.0 107.249 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.89 166.28 28.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 124.731 1.212 . . . . 0.0 109.201 165.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.82 164.8 17.81 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.7 2.266 . . . . 0.0 112.452 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.6 p 34.96 38.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.85 2.46 . . . . 0.0 115.751 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.85 43.04 30.1 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.345 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mmm -62.01 138.95 58.44 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 167.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.94 136.39 35.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.2 m -64.55 138.77 58.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 t -69.06 -169.99 0.22 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.058 1.343 . . . . 0.0 112.12 -168.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -87.5 -27.13 22.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.702 -1.59 . . . . 0.0 107.567 162.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.57 14.39 24.9 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 128.412 2.685 . . . . 0.0 112.309 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.46 4.55 65.19 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.559 1.552 . . . . 0.0 114.727 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -88.94 -154.55 0.3 Allowed 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.097 1.359 . . . . 0.0 107.758 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -155.31 147.52 23.73 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.479 1.036 . . . . 0.0 112.422 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.99 137.53 3.9 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -83.16 64.92 7.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.917 -0.755 . . . . 0.0 109.397 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.12 161.89 34.6 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.121 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -47.06 -45.31 21.59 Favored 'Trans proline' 0 C--N 1.349 0.593 1 C-N-CA 125.323 4.016 . . . . 0.0 115.088 -172.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -50.22 -33.78 20.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.788 0.835 . . . . 0.0 111.747 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.4 -52.06 4.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.122 0.969 . . . . 0.0 109.105 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -60.98 -39.82 91.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.626 -168.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.42 -128.04 10.33 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 123.768 0.699 . . . . 0.0 112.253 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.409 ' H ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.023 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.16 31.43 80.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.642 0.589 . . . . 0.0 113.608 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.08 134.69 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.135 1.374 . . . . 0.0 112.561 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.87 156.34 37.36 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 123.544 1.64 . . . . 0.0 110.594 174.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -91.41 61.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 112.862 -1.972 . . . . 0.0 108.262 -169.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? 63.24 53.98 2.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 112.396 -2.184 . . . . 0.0 109.896 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.11 41.56 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.417 1.008 . . . . 0.0 113.402 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -141.94 130.61 22.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.498 2.319 . . . . 0.0 107.707 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.77 166.87 25.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.167 1.387 . . . . 0.0 108.492 166.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.56 170.33 5.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.799 2.333 . . . . 0.0 112.661 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.1 p 33.87 46.16 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.658 2.383 . . . . 0.0 115.403 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.9 48.45 9.34 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.37 1.462 . . . . 0.0 112.031 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.2 151.12 46.93 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.1 m -82.69 134.33 35.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -74.1 116.43 14.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.2 p -56.28 162.04 2.24 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.178 0.514 . . . . 0.0 111.045 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -53.02 -23.9 8.47 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.756 165.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -94.33 1.76 55.88 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 128.609 2.763 . . . . 0.0 113.406 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.57 2.18 84.37 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.252 0.93 . . . . 0.0 115.367 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.77 -164.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.42 146.62 21.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.792 1.178 . . . . 0.0 113.115 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.18 145.65 6.08 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -83.63 65.56 8.54 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.048 -0.677 . . . . 0.0 110.084 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.41 165.23 36.02 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.216 -0.992 . . . . 0.0 114.935 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.36 -39.37 27.89 Favored 'Trans proline' 0 C--N 1.349 0.582 1 C-N-CA 125.454 4.102 . . . . 0.0 114.478 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -51.21 -32.57 24.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.0 0.52 . . . . 0.0 111.629 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -94.23 -60.13 1.8 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.36 -42.22 95.33 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 125.874 1.67 . . . . 0.0 113.114 -165.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.72 -119.92 6.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 122.12 0.844 . . . . 0.0 112.749 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 126.206 1.802 . . . . 0.0 110.877 -175.901 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 117.048 -1.453 . . . . 0.0 107.356 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.97 -64.29 3.22 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -178.05 169.03 1.98 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 m -63.23 147.36 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.511 0.672 . . . . 0.0 109.856 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.04 67.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 123.556 1.646 . . . . 0.0 106.838 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 47.83 51.64 13.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.633 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.07 29.8 10.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.949 1.737 . . . . 0.0 113.792 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -141.86 128.44 20.23 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.733 2.013 . . . . 0.0 106.804 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.49 164.33 42.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 124.2 1.0 . . . . 0.0 109.059 166.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -65.03 171.33 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.431 2.087 . . . . 0.0 112.602 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p 40.54 43.74 1.61 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.967 1.707 . . . . 0.0 115.32 169.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.38 47.55 28.27 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.818 1.199 . . . . 0.0 112.152 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 60.9 mtt -71.46 148.8 46.48 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.6 m -83.71 136.98 33.98 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 170.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -73.06 138.27 45.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 166.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -69.81 -166.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 123.037 1.399 . . . . 0.0 109.576 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -102.44 -22.15 14.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.36 1.864 . . . . 0.0 107.855 162.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.12 9.63 37.0 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 127.777 2.431 . . . . 0.0 112.253 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.92 83.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.525 1.536 . . . . 0.0 115.0 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -92.54 -169.1 2.12 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.0 p -157.89 155.43 29.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 109.971 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.0 152.37 8.16 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -83.22 77.57 9.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.26 162.08 33.2 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.14 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.59 -42.41 29.36 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 125.179 3.92 . . . . 0.0 114.076 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -50.59 -31.67 16.52 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.072 0.949 . . . . 0.0 111.592 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.97 -56.4 2.88 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 123.759 0.824 . . . . 0.0 109.185 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 m -57.11 -35.82 69.91 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.723 0.809 . . . . 0.0 111.516 -167.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.69 143.06 5.18 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? . . . . . 0 CA--C 1.53 0.183 0 CA-C-N 117.658 0.729 . . . . 0.0 110.646 179.862 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.01 -41.58 3.09 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -168.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.45 172.58 8.17 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 129.851 3.261 . . . . 0.0 104.373 169.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.83 170.17 15.25 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.993 1.378 . . . . 0.0 107.776 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.95 81.13 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 52.61 51.1 16.75 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.63 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.73 27.24 73.51 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.611 0.625 . . . . 0.0 113.354 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -145.34 152.67 40.25 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.2 2.6 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.47 165.37 34.75 Favored Pre-proline 0 C--N 1.325 -0.468 0 C-N-CA 123.614 0.766 . . . . 0.0 109.63 167.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.2 170.96 17.82 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.735 2.29 . . . . 0.0 109.641 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.0 p 43.52 35.29 0.93 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.08 1.752 . . . . 0.0 114.688 -174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 42.45 48.01 5.75 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 126.204 1.859 . . . . 0.0 111.527 -172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.32 142.43 47.11 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 168.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.6 m -83.22 139.36 33.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.21 127.97 34.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 t -62.52 170.76 2.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.465 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.26 -28.83 69.98 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 166.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -93.58 8.23 41.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.037 2.535 . . . . 0.0 112.335 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.42 77.9 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.122 0.868 . . . . 0.0 114.636 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.18 -153.17 0.26 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.9 149.77 23.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.552 1.069 . . . . 0.0 112.557 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.14 138.02 2.66 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -83.95 72.64 10.42 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.765 -0.844 . . . . 0.0 110.366 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.01 162.72 34.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.297 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.07 -49.58 11.11 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.0 3.8 . . . . 0.0 114.343 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -53.18 -29.95 34.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.848 0.859 . . . . 0.0 112.371 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -94.98 -48.28 6.05 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.887 0.875 . . . . 0.0 109.81 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.3 m -60.56 -60.36 3.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.841 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.5 -132.36 3.66 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.12 1.343 . . . . 0.0 111.391 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 123.861 0.864 . . . . 0.0 110.815 167.811 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.67 -72.4 0.15 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 122.23 126.93 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 129.94 3.296 . . . . 0.0 107.086 -172.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -74.64 144.59 43.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.028 0.918 . . . . 0.0 110.175 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -93.87 73.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 59.58 54.68 4.41 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.067 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.88 15.62 77.07 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.449 1.023 . . . . 0.0 115.086 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -137.52 136.96 38.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.5 m -121.11 160.21 46.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 124.86 1.264 . . . . 0.0 110.199 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.78 169.22 19.45 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.443 2.095 . . . . 0.0 112.097 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.1 t 33.61 47.26 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.645 2.378 . . . . 0.0 115.524 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 52.57 40.5 55.18 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.798 1.189 . . . . 0.0 112.795 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.86 149.13 28.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 166.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -83.34 137.8 33.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.8 t -72.35 114.06 10.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -62.0 151.39 35.28 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.009 1.724 . . . . 0.0 110.944 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.45 -28.08 18.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 168.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -93.73 9.18 38.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.037 2.535 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.48 8.05 83.5 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.786 1.184 . . . . 0.0 114.972 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.07 -167.69 1.78 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 124.612 1.165 . . . . 0.0 109.638 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.0 m -127.36 145.87 50.66 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.059 -1.026 . . . . 0.0 109.604 -174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.67 144.64 4.81 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 165.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -83.83 67.44 9.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.482 1.113 . . . . 0.0 108.12 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -162.16 164.83 35.67 Favored Glycine 0 CA--C 1.528 0.901 0 O-C-N 122.145 -0.347 . . . . 0.0 113.077 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -66.76 -42.96 7.93 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.686 3.59 . . . . 0.0 113.312 -167.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -49.53 -33.4 14.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.913 0.885 . . . . 0.0 111.903 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -93.02 -54.63 3.65 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.958 1.303 . . . . 0.0 108.901 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -60.66 -52.01 66.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.12 -136.0 6.95 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.187 0.899 . . . . 0.0 112.11 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 126.352 1.861 . . . . 0.0 112.306 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 117.041 -1.456 . . . . 0.0 107.468 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.09 -56.61 15.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.74 178.48 7.84 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.916 2.087 . . . . 0.0 105.537 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.8 160.49 5.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.158 0.98 . . . . 0.0 111.835 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.32 97.49 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 49.4 45.56 23.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.552 0.741 . . . . 0.0 110.671 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.88 18.21 68.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.314 1.435 . . . . 0.0 114.078 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -132.25 160.78 35.17 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 127.392 2.277 . . . . 0.0 105.698 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -137.2 161.52 60.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 C-N-CA 125.669 1.587 . . . . 0.0 109.414 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.58 168.28 18.65 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.222 1.948 . . . . 0.0 111.938 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t 31.87 49.53 0.13 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.998 2.519 . . . . 0.0 115.251 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.22 44.3 51.73 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.214 0.911 . . . . 0.0 112.86 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.82 153.06 26.62 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 166.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.03 134.82 35.02 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -72.7 107.23 5.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 165.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p -54.47 156.57 3.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.383 1.473 . . . . 0.0 110.003 -170.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -56.53 -23.61 40.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 170.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.82 11.56 31.13 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.465 2.306 . . . . 0.0 112.281 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.0 84.97 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.244 1.402 . . . . 0.0 114.494 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -113.32 -169.97 1.6 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 126.468 1.907 . . . . 0.0 107.378 169.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -126.58 136.34 52.42 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 120.197 1.362 . . . . 0.0 110.198 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.92 142.77 5.28 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 166.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -83.8 68.32 9.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.02 168.33 41.1 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 119.911 -1.138 . . . . 0.0 114.531 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.31 -35.18 32.76 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.549 3.499 . . . . 0.0 111.771 -169.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -49.68 -34.78 19.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.68 0.392 . . . . 0.0 111.436 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -94.65 -60.34 1.73 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.004 0.907 . . . . 0.0 109.945 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 t -73.39 -38.89 65.48 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.418 1.887 . . . . 0.0 113.747 -168.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.99 123.14 1.21 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 126.792 2.139 . . . . 0.0 113.44 -167.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 126.06 1.744 . . . . 0.0 108.911 178.599 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.57 -54.67 14.5 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 124.408 1.068 . . . . 0.0 110.667 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.39 172.07 3.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -57.15 153.34 11.91 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.612 1.196 . . . . 0.0 110.643 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -83.79 75.4 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 22.2 mmt-85 49.94 51.22 17.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 112.986 -1.915 . . . . 0.0 110.711 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 4.78 72.86 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.818 1.199 . . . . 0.0 114.702 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.5 mtp-105 -132.75 165.79 23.72 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.07 167.83 18.53 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.184 . . . . 0.0 109.133 167.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -68.1 175.03 7.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.027 2.485 . . . . 0.0 112.69 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 32.19 55.22 0.34 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.501 2.32 . . . . 0.0 115.335 166.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.46 44.21 36.28 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.726 1.155 . . . . 0.0 112.35 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.0 mmt -91.77 134.85 34.37 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.8 m -81.66 133.31 35.35 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.8 t -74.13 114.2 12.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.5 p -60.36 154.95 19.05 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.57 -16.34 24.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 167.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.66 3.63 55.18 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 127.931 2.492 . . . . 0.0 112.95 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.0 90.52 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -96.28 -170.85 2.17 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -156.51 157.16 34.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.237 1.38 . . . . 0.0 112.483 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.76 155.9 8.7 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -84.08 79.05 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.036 0.935 . . . . 0.0 109.047 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.3 171.05 38.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.119 -1.515 . . . . 0.0 114.986 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.36 -25.5 10.22 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 126.079 4.52 . . . . 0.0 115.165 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -51.04 -54.86 20.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.653 -0.655 . . . . 0.0 109.593 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -90.86 -66.19 0.95 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.533 -0.729 . . . . 0.0 109.236 -166.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.5 -127.43 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.52 1.057 . . . . 0.0 111.79 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.509 ' H ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 125.272 1.429 . . . . 0.0 112.552 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 117.075 -1.44 . . . . 0.0 107.402 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.77 -84.13 0.59 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 170.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -155.3 174.11 15.68 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 170.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.59 165.36 14.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 122.653 1.216 . . . . 0.0 109.549 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.46 92.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.933 2.093 . . . . 0.0 106.656 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 49.24 52.14 14.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.45 0.643 . . . . 0.0 110.015 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.16 31.62 66.29 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.972 1.273 . . . . 0.0 113.686 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -141.74 139.82 32.96 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 126.749 2.02 . . . . 0.0 107.185 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.23 168.94 14.78 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 125.432 1.493 . . . . 0.0 108.502 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.82 169.38 5.81 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.543 2.162 . . . . 0.0 112.746 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.4 p 33.08 49.22 0.17 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.562 2.345 . . . . 0.0 115.078 169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.29 48.08 27.22 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.313 1.435 . . . . 0.0 112.465 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.7 mtt -75.81 145.79 40.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.4 m -83.98 139.25 32.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 m -75.42 125.13 28.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 p -63.06 159.94 16.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -57.24 -20.72 29.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.673 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -91.58 2.96 56.09 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 127.54 2.336 . . . . 0.0 111.858 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.71 6.78 85.42 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.332 0.968 . . . . 0.0 114.655 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -92.89 -167.15 1.67 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 p -158.55 152.82 24.09 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.466 1.03 . . . . 0.0 112.928 -172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.14 149.65 7.9 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -82.55 72.27 9.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.32 160.39 33.16 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 119.964 -1.112 . . . . 0.0 114.307 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.16 -40.75 42.26 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 125.052 3.835 . . . . 0.0 113.942 -176.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -49.73 -34.53 19.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.881 0.872 . . . . 0.0 111.391 -178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -94.44 -60.15 1.78 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 t -58.4 -51.79 68.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.124 -165.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.3 -17.99 0.02 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 129.148 3.261 . . . . 0.0 120.477 168.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 . . . . . 0 C--N 1.317 -0.831 0 C-N-CA 127.95 2.5 . . . . 0.0 109.636 -172.84 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 117.261 -1.352 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.81 -52.5 0.83 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 20' ' ' TYR . 32.7 tt0 105.34 135.85 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 128.653 2.781 . . . . 0.0 108.651 -171.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.93 148.59 49.95 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 122.039 0.923 . . . . 0.0 109.232 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 t -84.94 67.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.69 53.18 8.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.137 2.575 . . . . 0.0 110.103 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.76 -10.24 30.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.875 2.655 . . . . 0.0 113.793 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.4 mtt85 -106.93 110.84 23.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.0 m -113.51 157.95 39.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.703 1.601 . . . . 0.0 109.567 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.87 170.55 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.909 2.406 . . . . 0.0 111.024 -171.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.5 p 43.41 42.69 3.94 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.837 1.655 . . . . 0.0 114.941 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.56 42.96 27.91 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.918 -175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -82.7 151.03 26.4 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 167.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.1 m -91.12 138.09 31.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.19 116.49 13.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.5 p -68.64 -177.46 0.97 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.006 1.722 . . . . 0.0 113.295 -169.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.32 -26.06 61.8 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 167.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.54 8.41 42.29 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.645 2.378 . . . . 0.0 112.403 -173.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.24 13.32 57.74 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.679 1.133 . . . . 0.0 114.055 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . 31.9 m-85 -94.77 -175.93 3.72 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.191 1.396 . . . . 0.0 109.41 168.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.7 m -127.17 137.06 52.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.519 1.128 . . . . 0.0 109.278 -170.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.99 146.36 7.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.66 75.99 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.98 155.81 27.31 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 120.493 -0.861 . . . . 0.0 114.159 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.98 -46.38 28.26 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 125.108 3.872 . . . . 0.0 115.127 -169.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -51.23 -31.77 21.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.756 0.823 . . . . 0.0 111.68 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -95.73 -53.7 3.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.558 1.143 . . . . 0.0 108.562 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -23.69 66.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -170.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.9 163.98 1.96 Allowed Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 168.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.466 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 C-N-CA 125.969 1.708 . . . . 0.0 115.532 -169.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.96 -52.14 0.78 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 80.27 119.61 0.05 Allowed 'General case' 0 C--N 1.338 0.086 0 C-N-CA 127.565 2.346 . . . . 0.0 109.461 -174.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 m -73.84 157.17 36.85 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 123.134 1.445 . . . . 0.0 111.304 -177.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.26 78.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 127.03 2.132 . . . . 0.0 106.243 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 46.97 50.42 13.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.219 -1.81 . . . . 0.0 110.225 -172.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.45 23.53 12.37 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.443 1.497 . . . . 0.0 114.928 172.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -138.41 118.14 13.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.604 1.962 . . . . 0.0 109.305 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 13' ' ' MET . 0.8 OUTLIER -124.32 162.93 39.26 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 166.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.23 170.54 7.67 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.594 2.196 . . . . 0.0 112.627 -178.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.2 p 42.23 39.58 1.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.232 1.813 . . . . 0.0 115.481 171.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.84 48.81 9.21 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.656 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 55.7 mtt -64.19 150.6 45.43 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -83.69 136.37 34.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 171.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.0 m -69.82 138.38 52.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.463 ' C ' HH22 ' A' ' 30' ' ' ARG . 79.2 p -73.33 -168.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.594 0.712 . . . . 0.0 109.787 -173.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 -7.19 26.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.355 0.662 . . . . 0.0 110.418 165.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.93 1.65 55.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.845 2.458 . . . . 0.0 112.494 -176.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.97 4.63 72.7 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.022 1.296 . . . . 0.0 113.763 -169.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -93.95 -158.83 0.65 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.38 165.11 29.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.655 0.782 . . . . 0.0 110.834 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.05 152.17 6.93 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -83.51 65.73 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.098 -0.648 . . . . 0.0 109.915 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.89 160.8 33.93 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.514 -0.85 . . . . 0.0 114.38 174.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -48.65 -41.87 37.01 Favored 'Trans proline' 0 C--N 1.35 0.64 1 C-N-CA 125.361 4.041 . . . . 0.0 114.611 -174.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -50.8 -33.55 23.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.356 0.662 . . . . 0.0 111.582 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -94.93 -54.36 3.49 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.531 0.732 . . . . 0.0 109.772 173.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -58.76 -32.59 69.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 112.679 -167.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.67 143.85 6.11 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 168.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.463 HH22 ' C ' ' A' ' 16' ' ' SER . 6.8 mmp_? . . . . . 0 CA--C 1.532 0.255 0 O-C-N 122.11 -0.641 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 117.654 -1.165 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.19 89.65 0.72 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 172.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -44.69 119.13 1.81 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.129 1.372 . . . . 0.0 109.186 172.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -50.42 163.62 0.16 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.284 1.434 . . . . 0.0 112.131 -169.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t -86.21 59.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 124.05 1.881 . . . . 0.0 108.059 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.454 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 3.4 mmp_? 57.85 54.98 5.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 112.249 -2.25 . . . . 0.0 109.043 -169.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.69 25.0 36.67 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.427 1.489 . . . . 0.0 115.093 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -138.13 146.97 43.45 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 127.757 2.423 . . . . 0.0 105.201 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 69.4 m -129.24 163.4 46.36 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 125.888 1.675 . . . . 0.0 110.199 -176.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.62 172.44 3.96 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.25 2.633 . . . . 0.0 110.3 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p 42.6 41.84 2.56 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.139 1.776 . . . . 0.0 115.215 171.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.89 45.05 18.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.002 -1.454 . . . . 0.0 112.018 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mtt -84.92 157.14 20.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 167.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.0 m -98.07 145.05 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.35 117.58 9.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.155 163.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.503 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 9.4 p -50.86 154.52 1.42 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 168.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -59.04 -16.42 18.46 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.773 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.26 4.32 53.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.915 2.886 . . . . 0.0 112.498 176.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.64 9.3 86.97 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.455 1.502 . . . . 0.0 116.031 169.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -93.24 178.95 5.57 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 118.479 1.14 . . . . 0.0 108.91 168.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.7 m -112.8 138.18 50.02 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.896 -174.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.76 138.0 4.48 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -84.22 75.27 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.94 162.62 32.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.856 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.44 -41.17 44.32 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.834 3.69 . . . . 0.0 113.763 -176.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -49.83 -33.5 17.01 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.539 0.735 . . . . 0.0 111.652 178.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 14.0 m-85 -96.22 -60.35 1.64 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.29 -27.32 67.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.573 -166.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -48.11 139.8 10.41 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 167.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 109.182 177.146 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.74 -43.9 2.73 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -176.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -178.96 170.89 1.44 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.138 2.575 . . . . 0.0 106.076 174.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.6 m -73.89 163.28 28.13 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 165.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.12 80.11 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -176.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 68.04 50.06 0.83 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.751 2.42 . . . . 0.0 109.799 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.77 10.44 50.26 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -141.65 167.54 21.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.719 2.808 . . . . 0.0 104.585 173.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.7 167.22 20.29 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 124.752 1.221 . . . . 0.0 108.844 169.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.78 174.91 11.87 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.429 2.086 . . . . 0.0 110.773 -171.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p 46.92 39.95 8.39 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.884 1.674 . . . . 0.0 114.322 178.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 48.19 44.89 27.25 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.974 -175.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -70.62 148.98 47.51 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 167.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.07 133.69 34.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 t -72.12 114.87 10.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 164.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 p -63.01 179.94 0.34 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.779 1.632 . . . . 0.0 112.959 -166.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -78.67 -16.37 57.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.767 1.627 . . . . 0.0 111.857 167.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -96.77 5.54 50.41 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.117 2.167 . . . . 0.0 112.885 -178.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 6.87 43.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.254 0.93 . . . . 0.0 114.076 -171.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.9 -165.05 1.26 Allowed 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 167.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.26 153.83 28.15 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 110.156 -178.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.61 158.02 17.59 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -84.97 69.08 10.76 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.927 0.891 . . . . 0.0 110.245 -175.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.4 162.18 33.21 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.865 170.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -50.09 -39.36 51.05 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 125.14 3.893 . . . . 0.0 113.817 -178.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -48.0 -39.1 18.6 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.998 178.29 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.17 -54.54 3.9 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 t -59.23 -47.05 86.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.133 -167.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.33 -132.82 0.44 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 127.829 2.633 . . . . 0.0 115.018 169.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.001 0.92 . . . . 0.0 111.354 -178.233 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.82 -50.36 3.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 103.487 -3.845 . . . . 0.0 103.487 -162.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.39 -179.67 6.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.517 3.127 . . . . 0.0 105.506 165.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -68.94 159.93 31.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.272 1.029 . . . . 0.0 111.159 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.13 97.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 47.89 45.94 18.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.74 0.816 . . . . 0.0 110.682 -174.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.15 13.24 72.94 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.078 -0.846 . . . . 0.0 114.751 175.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.22 173.01 12.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.022 2.129 . . . . 0.0 108.394 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.01 167.63 18.49 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 125.487 1.515 . . . . 0.0 108.157 165.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -61.64 174.72 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.035 3.157 . . . . 0.0 113.288 -178.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.9 p 46.15 41.61 8.82 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.842 1.657 . . . . 0.0 114.403 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.84 45.32 25.15 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.873 -175.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.8 mtt -69.67 156.03 39.59 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.07 151.34 21.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -93.12 114.29 26.77 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 167.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.0 p -59.3 161.52 5.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.022 0.529 . . . . 0.0 111.09 -171.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -55.86 -24.6 37.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.343 167.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.17 3.83 54.49 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 127.742 2.417 . . . . 0.0 112.313 -174.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 6.01 83.77 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.861 -0.966 . . . . 0.0 115.145 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -94.78 -171.47 2.47 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 164.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -146.32 150.8 36.44 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.659 1.118 . . . . 0.0 112.086 -173.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.72 153.88 10.14 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -88.46 68.9 8.91 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.334 1.053 . . . . 0.0 109.705 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.86 44.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 119.561 -1.304 . . . . 0.0 115.007 175.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.58 -19.7 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 125.048 3.832 . . . . 0.0 112.186 -171.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -53.85 -43.7 69.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -91.49 -63.62 1.23 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.46 -65.91 0.62 Allowed 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 124.824 1.328 . . . . 0.0 109.788 -167.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 30.33 -118.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.41 1.957 . . . . 0.0 114.749 168.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.509 0 C-N-CA 126.256 1.822 . . . . 0.0 109.871 -177.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 116.899 -1.524 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.94 -88.29 1.05 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 175.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -152.28 174.67 13.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.3 m -61.99 147.77 45.98 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -86.38 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 123.673 1.701 . . . . 0.0 106.468 174.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' H ' ' HE ' ' A' ' 6' ' ' ARG . 5.2 mmp_? 49.64 53.54 12.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 111.776 -2.466 . . . . 0.0 110.83 -174.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.93 31.72 7.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.435 1.969 . . . . 0.0 113.408 172.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -139.06 123.49 18.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.27 2.228 . . . . 0.0 105.155 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -129.49 159.75 67.82 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.724 1.21 . . . . 0.0 109.578 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.25 168.95 21.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.416 2.077 . . . . 0.0 111.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t 32.21 51.21 0.2 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 127.787 2.435 . . . . 0.0 115.127 169.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.81 45.29 8.94 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.824 1.202 . . . . 0.0 111.959 -178.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -82.51 151.01 26.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 169.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.0 m -84.58 134.97 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.4 t -68.75 109.55 3.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.85 155.19 10.81 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.812 0.845 . . . . 0.0 111.304 -170.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -52.55 -26.48 13.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 168.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -92.01 1.1 57.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.89 2.476 . . . . 0.0 112.52 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.67 16.02 79.87 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.35 1.452 . . . . 0.0 114.782 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -94.77 -164.48 1.17 Allowed 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.8 m -136.6 132.22 34.81 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.36 -0.837 . . . . 0.0 109.069 -172.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.33 147.27 8.16 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 168.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -83.34 70.6 10.19 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 108.616 -178.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.32 164.59 33.49 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 122.077 -0.39 . . . . 0.0 113.318 177.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.97 -41.95 4.76 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.674 3.582 . . . . 0.0 112.914 -167.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -47.82 -34.96 9.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.424 1.09 . . . . 0.0 111.672 176.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -93.34 -52.08 4.69 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.123 1.369 . . . . 0.0 108.756 -176.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -53.13 61.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.821 -174.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.92 -134.79 9.2 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.181 0.896 . . . . 0.0 111.912 175.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 127.294 2.237 . . . . 0.0 114.041 169.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.91 -57.92 1.46 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 171.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -166.76 172.07 10.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 m -58.25 153.17 15.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.245 1.021 . . . . 0.0 110.923 175.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.51 99.97 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 127.025 2.13 . . . . 0.0 105.996 175.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 49.08 44.63 22.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.888 0.875 . . . . 0.0 111.374 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.33 73.65 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.779 0.705 . . . . 0.0 114.019 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -136.59 171.58 14.28 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 127.409 2.283 . . . . 0.0 105.617 171.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.15 167.97 17.91 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.794 0.837 . . . . 0.0 109.437 168.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.19 172.37 5.21 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.839 2.359 . . . . 0.0 112.1 176.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.8 p 43.48 42.19 3.77 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.077 1.751 . . . . 0.0 114.863 171.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.59 16.07 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.427 1.489 . . . . 0.0 111.867 -177.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 mmt -86.58 133.91 33.68 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -84.89 142.11 29.93 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.26 122.12 22.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 109.843 174.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 64.0 p -60.32 -177.55 0.07 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.667 1.187 . . . . 0.0 111.546 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -81.3 -21.44 39.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.949 0.9 . . . . 0.0 110.727 166.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.68 7.28 46.3 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.472 2.309 . . . . 0.0 112.456 -172.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.29 9.1 76.67 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.548 1.071 . . . . 0.0 114.19 -178.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -98.55 -167.93 1.57 Allowed 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 166.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -160.47 158.96 30.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.962 1.255 . . . . 0.0 111.384 -172.274 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.8 152.52 8.21 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -82.82 76.15 9.67 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.68 161.43 31.81 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.873 172.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.81 -36.05 19.58 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.633 3.555 . . . . 0.0 111.698 -168.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -46.22 -42.58 14.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.882 0.873 . . . . 0.0 111.102 174.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.16 -44.69 7.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.018 1.327 . . . . 0.0 110.695 -172.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -50.91 71.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.229 -179.339 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.35 -130.12 5.88 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.95 1.262 . . . . 0.0 112.307 170.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.292 1.037 . . . . 0.0 111.533 169.269 . . . . . . . . 0 0 . 1 stop_ save_